data_1y1b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y1b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.549 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.87 0.366 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 56.1 Cg_endo -95.88 -163.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.492 2.795 . . . . 0.0 112.374 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 mp -132.09 58.54 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 61.2 mt 65.1 102.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.38 -84.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -169.5 178.98 3.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.235 0.541 . . . . 0.0 112.119 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.421 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -110.58 11.67 22.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.226 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.71 67.6 1.6 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.1 96.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.409 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.415 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -120.78 58.93 7.09 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 Cg_endo -48.77 115.55 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.646 2.897 . . . . 0.0 113.442 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 45' ' ' LYS . 16.8 m -121.99 133.59 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 119.36 22.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.823 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.12 139.63 14.87 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.048 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 t -49.71 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.243 -0.979 . . . . 0.0 109.585 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' SER . 5.5 t0 170.48 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.352 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.55 2.98 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.607 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.2 mm -139.05 141.55 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.12 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -96.86 99.02 10.6 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.995 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' HD22 ' A' ' 29' ' ' LEU . 47.4 m-85 -82.26 138.94 34.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -40.69 -29.27 0.25 Allowed Glycine 0 CA--C 1.505 -0.593 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.717 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 10.1 p30 -173.89 147.01 1.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.088 0.471 . . . . 0.0 110.833 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 15' ' ' VAL . . . -49.57 -26.24 3.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.513 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.1 m -72.66 -43.44 63.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.43 0.633 . . . . 0.0 110.222 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 1.8 mmm -61.46 -17.57 55.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.169 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -76.62 -50.52 13.6 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.598 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -48.61 -34.71 12.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -34.01 67.33 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -71.32 -61.69 1.68 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.619 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.571 ' CB ' ' CG1' ' A' ' 40' ' ' ILE . 0.8 OUTLIER -48.79 -28.46 3.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.135 0.493 . . . . 0.0 110.017 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -73.42 -32.3 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.603 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.27 56.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 7.7 t -108.91 -71.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -173.78 -36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.211 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.527 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.06 174.98 2.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 38' ' ' THR . 56.4 Cg_endo -71.98 92.16 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.549 2.166 . . . . 0.0 112.013 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.571 ' CG1' ' CB ' ' A' ' 33' ' ' SER . 22.8 pt -83.4 167.28 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.505 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.4 mm-40 -149.38 -176.68 5.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.3 140.15 48.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.701 0.286 . . . . 0.0 110.812 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -122.5 -47.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.438 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -136.65 133.9 36.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.81 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 19.6 pttt -86.02 64.72 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.22 -150.01 9.5 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.175 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -90.3 53.9 2.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.818 0.342 . . . . 0.0 110.49 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' OXT' ' O ' ' A' ' 47' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.958 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.823 0.344 . . . . 0.0 110.525 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 88.8 Cg_endo -78.16 -169.45 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.68 2.253 . . . . 0.0 112.211 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -125.66 64.0 1.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.648 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.3 mp 70.37 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -84.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.947 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -152.7 172.7 16.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -104.13 16.68 25.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' TYR . 84.8 mt-30 -73.66 59.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -25.66 92.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.132 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.509 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -121.9 65.51 19.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.186 178.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.3 Cg_endo -49.02 96.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.182 2.588 . . . . 0.0 112.053 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 10.2 m -105.58 131.64 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.409 0.623 . . . . 0.0 111.186 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.575 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -105.12 142.79 15.56 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.598 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 12.5 m -47.92 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.686 0.874 . . . . 0.0 109.079 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 168.73 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.457 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.95 33.54 2.78 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.975 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.0 mm -140.71 139.36 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.988 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 9.2 m -94.84 100.93 12.73 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.606 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.627 ' CE1' HD22 ' A' ' 29' ' ' LEU . 21.6 m-85 -83.87 139.73 32.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.391 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -48.56 -20.75 1.77 Allowed Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 36.5 m-20 -177.92 150.76 0.64 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' HD22 ' A' ' 30' ' ' LEU . . . -50.93 -29.04 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.623 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.5 m -73.32 -43.92 59.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.731 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -63.31 -19.98 65.08 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.693 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.627 HD22 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -68.64 -59.4 3.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.098 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -46.44 -33.12 3.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.12 -37.67 55.46 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.82 -54.46 15.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.313 -0.443 . . . . 0.0 110.848 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.31 -25.42 64.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.523 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 p -75.81 -32.04 59.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 0.0 110.716 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -107.91 11.78 27.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 t -87.65 -93.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.226 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.87 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.32 . . . . 0.0 110.955 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.49 158.75 72.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.22 89.68 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.831 2.354 . . . . 0.0 112.491 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 9.0 mt -71.02 149.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 4.6 mt-10 -133.28 -176.63 4.2 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.904 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -102.38 132.33 48.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.66 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 9.6 p -123.44 -34.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.66 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -146.51 142.73 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.345 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 61.09 2.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 110.83 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.29 -153.87 11.87 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -90.3 53.89 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 110.603 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.06 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.781 0.324 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 61.2 Cg_endo -75.31 156.79 41.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.785 2.323 . . . . 0.0 113.62 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 1.1 tt 172.61 40.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt 61.68 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.223 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.34 -83.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.92 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -114.68 131.97 56.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.8 17.08 18.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.143 0.497 . . . . 0.0 110.296 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' TYR . 9.1 mt-30 -102.91 71.86 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.253 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.572 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 2.7 t0 -124.51 62.01 30.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.99 112.96 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.346 2.697 . . . . 0.0 112.978 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.563 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 16.9 m -121.02 130.53 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.747 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 128.13 33.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.367 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -105.52 137.57 13.81 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.124 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -50.55 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.578 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' SER . 21.1 t70 170.4 -29.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.832 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.99 33.14 2.25 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.607 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.6 mm -137.56 132.28 44.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.4 m -93.25 102.78 15.06 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.661 ' CE2' HD23 ' A' ' 29' ' ' LEU . 32.1 m-85 -81.47 166.58 20.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.218 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -78.71 -13.59 82.98 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.842 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 29.2 m-20 -179.4 149.81 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.632 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.54 5.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.454 0.645 . . . . 0.0 109.281 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -75.4 -45.62 37.9 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.991 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.43 ' HE1' ' HA3' ' A' ' 24' ' ' GLY . 5.3 mmm -55.89 -30.02 60.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.661 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -64.36 -51.07 65.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.887 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 27' ' ' CYS . 1.4 pp -47.0 -39.9 13.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 35' ' ' ARG . . . -65.28 -35.65 91.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.873 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -60.33 -45.99 91.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.743 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.27 -50.34 73.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.849 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 15.6 t -70.12 -35.09 73.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.87 -32.93 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.725 0.298 . . . . 0.0 111.25 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 t -88.19 -93.68 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.779 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.81 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.043 0.449 . . . . 0.0 110.389 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -90.51 136.15 28.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.818 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 3.0 Cg_exo -74.68 64.29 5.73 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.512 ' CD1' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -44.05 166.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt-10 -132.45 -177.63 4.56 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.47 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.33 132.4 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.134 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -127.4 -42.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.463 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.9 m-70 -128.38 115.35 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.835 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -76.62 53.53 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.35 -147.21 5.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 57.25 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 110.464 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.866 0.365 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.2 Cg_endo -93.17 42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.172 2.581 . . . . 0.0 112.627 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 5' ' ' PRO . 3.7 mt 27.02 61.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.88 102.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -90.68 -86.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 11' ' ' GLN . 9.7 t -171.58 -154.57 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.52 ' O ' ' C ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -107.41 -47.88 3.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.335 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 9.15 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.13 0.894 . . . . 0.0 111.892 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -32.41 90.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.302 0.572 . . . . 0.0 111.362 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' GLN . 37.5 t0 -129.91 57.01 27.74 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.291 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.26 87.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.051 2.501 . . . . 0.0 112.076 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.0 m -91.95 127.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.413 0.625 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.48 115.08 17.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.485 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.25 140.41 14.86 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.762 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -51.21 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.379 -0.911 . . . . 0.0 109.905 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.01 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.171 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.68 33.56 1.7 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.329 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -140.39 152.54 21.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' HG22 ' A' ' 21' ' ' ILE . 97.2 m -109.51 98.36 7.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.974 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 39.3 m-85 -80.8 134.74 35.84 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.67 -23.62 0.19 Allowed Glycine 0 CA--C 1.507 -0.423 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.426 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 28' ' ' MET . 14.1 p30 -178.52 149.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.271 0.557 . . . . 0.0 111.142 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.14 -24.49 4.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.484 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 10.0 m -74.22 -39.96 62.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.25 0.548 . . . . 0.0 110.402 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.03 -21.64 66.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.89 -179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD23 ' CD1' ' A' ' 23' ' ' TYR . 2.2 mt -75.13 -51.54 13.2 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.494 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 92.9 mt -48.86 -33.79 11.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.01 -27.4 64.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.856 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.03 -54.76 5.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.498 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -26.66 68.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 7.0 p -84.07 -31.39 25.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.634 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 9.1 mmm180 -100.71 3.64 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.594 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 38.4 t -93.89 -98.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' SER . 8.9 t70 179.11 -31.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.973 0.416 . . . . 0.0 110.644 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.0 m -115.68 103.4 53.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.253 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.27 92.75 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.102 2.535 . . . . 0.0 112.943 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.48 177.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.415 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.9 mt-10 -135.92 -177.86 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.531 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.587 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.68 137.11 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.081 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -116.47 -53.14 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.303 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.566 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.14 148.66 52.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -93.3 56.71 2.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.748 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' PRO . . . -178.69 -156.21 16.48 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.266 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.03 56.78 3.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.33 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' C ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.004 0.43 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 97.6 Cg_endo -93.31 -162.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.266 2.644 . . . . 0.0 113.112 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' HD21 ' A' ' 6' ' ' LEU . 1.3 pt? -159.69 51.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.902 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm 60.72 87.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.426 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.62 -80.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.5 t -168.63 -179.41 3.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.161 0.505 . . . . 0.0 111.77 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.3 OUTLIER -111.24 21.36 16.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.251 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 12' ' ' TYR . 7.3 mm-40 -78.23 59.7 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.929 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -21.43 94.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.496 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -123.37 65.94 32.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.58 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.349 2.699 . . . . 0.0 112.907 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' HB ' HD12 ' A' ' 42' ' ' LEU . 35.7 m -108.84 131.09 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.09 114.56 17.08 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.132 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -96.97 134.33 11.73 Favored Glycine 0 C--O 1.25 1.094 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.991 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -56.81 90.96 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.851 0.834 . . . . 0.0 109.32 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' GLY . 4.1 t70 -175.97 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.16 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.13 26.77 0.88 Allowed Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.324 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.586 HG23 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -148.09 168.83 3.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 30.3 m -119.79 99.3 6.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.088 -1.414 . . . . 0.0 109.356 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.651 ' CD2' HD23 ' A' ' 29' ' ' LEU . 16.1 m-85 -82.8 136.17 34.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -43.81 -26.98 0.86 Allowed Glycine 0 CA--C 1.506 -0.515 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.752 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 76.3 m-20 -169.79 146.82 3.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -51.22 -28.35 11.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.659 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HA ' HD13 ' A' ' 30' ' ' LEU . 95.1 m -73.38 -44.23 59.01 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.741 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.507 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 3.1 mtp -61.31 -19.82 62.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.651 HD23 ' CD2' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -70.19 -47.14 62.83 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.82 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB3' ' C ' ' A' ' 4' ' ' CYS . 1.3 mt -47.97 -36.62 12.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' NE ' ' A' ' 35' ' ' ARG . . . -71.27 -31.54 66.07 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.54 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -72.21 -56.5 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.089 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -41.01 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 109.646 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.02 -39.74 79.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.871 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 31' ' ' GLY . 10.0 mtt180 -74.66 -22.31 58.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.02 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -86.13 -99.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.536 0.207 . . . . 0.0 110.99 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.54 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.996 0.427 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.77 159.51 29.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.28 83.92 2.15 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.808 2.338 . . . . 0.0 112.588 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.556 HG23 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -38.45 152.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.756 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.5 mm-40 -119.21 -179.74 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.428 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' CD2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -126.31 137.36 53.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.608 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 HG11 ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -115.65 -45.4 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.148 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.547 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -144.5 125.13 14.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.04 58.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -176.56 -153.48 10.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.95 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -87.48 56.44 3.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.547 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 8.8 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.933 0.396 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.539 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 90.7 Cg_endo -91.39 179.12 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.882 2.388 . . . . 0.0 113.579 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -165.11 41.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.375 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt 58.08 86.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.282 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -85.3 -70.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.795 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -165.74 151.96 9.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.23 23.72 7.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -83.04 64.71 7.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.67 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.27 95.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.578 -178.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.532 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 1.1 t0 -123.55 63.07 25.51 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.081 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.6 Cg_endo -50.04 102.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.142 2.561 . . . . 0.0 112.351 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 42' ' ' LEU . 34.4 m -108.74 139.37 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.914 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 117.11 19.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -101.39 134.3 11.67 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.838 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -51.55 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.698 -0.751 . . . . 0.0 109.557 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 177.23 -35.66 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.789 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.47 33.38 0.95 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.863 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.3 mt -146.06 157.99 11.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 85.9 m -110.01 98.35 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.195 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.641 ' CD2' HD21 ' A' ' 29' ' ' LEU . 28.4 m-85 -82.18 134.76 35.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -42.17 -27.14 0.4 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.774 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 76.3 m-20 -168.36 146.07 4.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.201 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.52 -28.0 28.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.405 0.621 . . . . 0.0 109.505 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.9 m -73.37 -40.68 64.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.608 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.1 mmt -66.99 -15.84 63.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.091 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -74.03 -61.91 1.69 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.442 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -48.87 -32.1 8.31 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.644 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -73.18 -31.77 61.14 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.68 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.59 -56.87 4.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.568 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.51 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.96 -32.91 2.99 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 109.792 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -68.6 -47.84 65.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.142 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 4.0 mmm180 -60.38 -26.71 66.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.478 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -87.85 -108.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.322 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -179.52 33.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.878 0.371 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -158.27 124.54 2.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 15.3 Cg_exo -67.85 71.2 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.852 2.368 . . . . 0.0 112.61 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.539 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.43 176.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.825 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HB2' ' OG ' ' A' ' 18' ' ' SER . 7.5 mt-10 -139.2 -177.21 4.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.561 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.597 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.0 140.67 49.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 1.5 t -123.66 -43.28 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.4 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -141.68 149.1 40.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.95 61.21 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.16 -149.79 11.07 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.05 56.5 4.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.972 0.415 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.549 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.5 m . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.984 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.857 0.36 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 78.0 Cg_endo -98.64 -173.82 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.387 2.724 . . . . 0.0 112.214 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.11 61.74 1.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.681 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 7' ' ' ILE . 3.7 mm 63.04 87.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.828 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.98 -79.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.1 t -169.72 -178.58 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.175 0.512 . . . . 0.0 111.714 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -107.54 11.83 28.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.518 179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 12' ' ' TYR . 19.2 mm100 -66.91 62.37 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -22.54 94.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -117.34 58.63 2.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.7 Cg_endo -50.39 102.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.359 2.706 . . . . 0.0 112.745 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 34.2 m -113.42 123.23 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 116.6 18.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.418 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -95.59 135.65 12.47 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.365 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -50.0 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.692 0.758 . . . . 0.0 109.882 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 171.23 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.78 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 110.47 33.19 2.54 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.204 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -135.31 124.57 41.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -90.15 98.8 11.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.596 ' CE2' HD23 ' A' ' 29' ' ' LEU . 13.6 m-85 -80.76 148.66 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.91 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -59.16 -11.5 12.74 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.416 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 9.6 p30 163.85 155.23 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.24 -25.22 0.89 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.304 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 63.7 m -77.02 -46.23 24.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.62 0.724 . . . . 0.0 110.009 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -61.95 -22.46 65.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.454 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.596 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -68.05 -49.06 63.72 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.864 177.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 mt -47.87 -38.32 15.96 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -64.4 -35.55 92.09 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.4 -64.83 0.82 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.099 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -46.86 -36.83 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.054 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 13.1 t -54.96 -47.8 74.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.495 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.434 ' HG3' ' C ' ' A' ' 34' ' ' CYS . 7.3 mtp180 -143.57 51.18 1.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 13.4 t -97.03 -73.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 110.529 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.71 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.523 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -152.15 159.62 32.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.233 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 18.4 Cg_endo -59.54 87.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.624 2.216 . . . . 0.0 112.146 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.514 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -64.72 145.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.099 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm-40 -113.29 -177.31 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 ' CD2' HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -115.08 136.3 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.431 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -122.3 -49.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.607 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.67 143.49 48.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.815 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -94.23 57.2 2.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.128 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.28 -150.64 7.58 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.013 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -89.43 57.43 3.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 68.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.342 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.516 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 6.0 Cg_endo -48.59 137.52 26.02 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.939 2.426 . . . . 0.0 112.605 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -160.77 44.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.748 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 27.95 105.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -104.04 -79.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.036 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.528 HG23 ' CG ' ' A' ' 11' ' ' GLN . 1.7 t -163.15 -178.44 6.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.901 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 12' ' ' TYR . 1.8 mtm -114.85 10.12 16.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.033 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' CG ' HG23 ' A' ' 9' ' ' THR . 0.3 OUTLIER -67.06 62.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 109.968 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.492 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.43 93.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.433 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -119.87 65.39 9.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.89 108.69 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.019 2.48 . . . . 0.0 112.748 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 19.4 m -120.0 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.151 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 117.83 20.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 139.64 14.5 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.073 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 38.8 t -50.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.808 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' OD1' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 171.56 -29.32 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.812 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.17 32.13 3.11 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.372 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 34.1 mm -135.64 133.61 51.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -94.76 98.33 10.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.095 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.629 ' CE2' HD23 ' A' ' 29' ' ' LEU . 24.8 m-85 -79.27 153.27 30.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.939 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 25' ' ' ASN . . . -64.03 -10.14 38.4 Favored Glycine 0 C--N 1.328 0.124 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.5 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 28' ' ' MET . 12.3 p30 166.8 153.31 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 0.0 110.184 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.71 -26.21 2.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 9.0 m -75.12 -43.87 50.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.546 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.67 -18.53 65.06 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.905 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.17 -57.41 4.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.285 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -49.44 -35.82 20.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 5' ' ' PRO . . . -71.51 -27.85 70.57 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -76.8 -58.75 3.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.563 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 40' ' ' ILE . 3.7 t -42.1 -37.34 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.453 0.644 . . . . 0.0 109.347 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 21.6 t -64.61 -50.52 66.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.406 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 8.9 mmm180 -77.24 -10.47 59.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.049 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -82.65 -96.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 179.18 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.0 110.488 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 163.86 22.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.075 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.6 75.61 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.837 2.358 . . . . 0.0 112.048 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 29' ' ' LEU . 1.5 pt -52.5 154.01 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.117 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -122.66 -175.99 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -112.08 132.48 54.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.369 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.564 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -116.23 -53.14 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.258 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.564 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -132.99 144.8 50.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.923 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -91.36 65.41 5.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 172.63 -159.77 30.61 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.102 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -79.52 55.05 1.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 110.688 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 94.5 Cg_endo -94.83 -165.41 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.373 2.716 . . . . 0.0 112.891 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 tp -164.9 52.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.71 85.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -76.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.261 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -169.2 179.09 4.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.071 0.462 . . . . 0.0 111.502 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.52 19.38 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -73.19 58.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.963 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -25.49 97.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.544 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 1.4 t0 -126.48 61.71 44.64 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.055 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.8 Cg_endo -47.67 93.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.189 2.592 . . . . 0.0 112.035 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 10.8 m -102.76 131.85 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 121.64 24.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.328 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -100.73 141.4 15.35 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.39 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 66.3 m -53.29 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.184 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' GLY . 19.9 t70 176.57 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.261 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.33 32.49 1.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.885 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 22' ' ' THR . 6.7 mt -143.7 160.84 16.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 41.5 m -113.03 108.09 16.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.623 ' CE1' HD22 ' A' ' 29' ' ' LEU . 15.0 m-85 -93.06 136.32 33.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.323 0.582 . . . . 0.0 112.31 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -47.06 -22.98 1.44 Allowed Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.202 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 61.0 m-20 -174.08 150.38 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' O ' HD21 ' A' ' 30' ' ' LEU . . . -50.82 -28.9 10.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.348 0.594 . . . . 0.0 109.567 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.83 -45.5 58.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.501 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -60.56 -23.27 64.49 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.36 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD22 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -65.29 -50.77 64.45 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.381 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 2.1 mt -48.97 -36.3 17.21 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -65.2 -29.93 76.56 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.83 -64.67 0.99 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.95 -0.625 . . . . 0.0 110.179 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -30.09 12.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.186 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 7.4 t -63.43 -50.51 69.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.713 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 35' ' ' ARG . 1.2 mmm180 -100.87 18.74 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 9.7 t -103.42 -119.8 0.2 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' SER . 6.3 t70 178.84 29.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.064 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.461 HG21 ' HD2' ' A' ' 39' ' ' PRO . 2.4 m -160.47 139.66 7.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.371 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' HG21 ' A' ' 38' ' ' THR . 29.6 Cg_endo -63.81 82.18 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.628 2.219 . . . . 0.0 112.414 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.448 HG23 HD22 ' A' ' 29' ' ' LEU . 18.8 mt -67.43 139.54 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.666 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt-10 -126.3 -177.55 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.561 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -104.96 132.73 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.664 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -127.28 -32.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.328 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.664 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.7 m-70 -139.78 134.22 31.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.88 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -89.54 55.28 3.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . 177.08 -155.35 17.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.256 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 58.1 3.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.401 . . . . 0.0 110.606 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 89.7 Cg_endo -83.09 163.69 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.033 2.489 . . . . 0.0 112.597 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.5 tp -84.73 53.33 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.482 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 5.0 mt 68.57 96.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.29 -83.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.198 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -164.78 154.28 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.37 32.83 5.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.491 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -79.06 -104.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.247 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.43 91.67 0.09 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.19 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -129.46 53.32 11.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.1 Cg_endo -49.79 116.03 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.736 2.957 . . . . 0.0 113.902 -177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 26' ' ' ALA . 14.2 m -129.6 124.83 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.865 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.38 134.74 37.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.937 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.02 142.24 17.41 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.325 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.08 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.359 -0.92 . . . . 0.0 109.035 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' SER . 8.7 t70 167.58 -28.11 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.422 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 108.81 22.88 6.74 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.626 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.3 mp -123.21 152.54 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.56 0.695 . . . . 0.0 112.458 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 14.1 m -111.07 98.56 7.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.072 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' HD23 ' A' ' 29' ' ' LEU . 28.9 m-85 -81.09 138.95 35.93 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.986 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.63 -27.54 19.31 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.948 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 62.7 m-80 -164.08 148.41 10.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' N ' HG22 ' A' ' 15' ' ' VAL . . . -55.68 -26.96 47.48 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 62.7 m -73.81 -37.79 64.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.855 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.1 mtt -67.5 -19.33 65.31 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.866 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -72.13 -57.5 4.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.015 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -50.77 -31.43 16.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.59 -26.11 70.62 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.82 -59.57 2.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.019 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.485 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -54.32 -23.62 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.787 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' ARG . 11.9 p -89.96 -44.02 10.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.805 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.68 -30.16 59.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.964 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -73.76 -91.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.941 0.4 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.46 -35.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.372 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.23 116.11 64.26 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 49.0 Cg_endo -69.3 74.83 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.749 2.299 . . . . 0.0 112.328 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.81 177.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.3 mm-40 -134.69 -177.6 4.69 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.009 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -103.63 132.88 49.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 110.251 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.653 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 14.6 p -123.59 -40.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.235 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.653 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.7 m-70 -133.81 134.46 42.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.551 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 55.52 2.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -176.1 -145.08 5.41 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.203 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' CYS . 3.7 ptt85 -90.54 56.65 3.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 71.3 Cg_endo -94.96 -173.66 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.252 2.634 . . . . 0.0 112.426 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.75 57.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.8 mt 63.63 97.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.097 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.84 -85.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.2 t -170.68 -177.77 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 111.987 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' ' OG1' ' A' ' 9' ' ' THR . 2.8 ptt? -115.28 20.69 14.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.486 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.18 67.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.45 89.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.404 -178.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.39 61.05 14.33 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.9 Cg_endo -49.48 114.82 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.598 2.866 . . . . 0.0 112.942 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG22 ' CA ' ' A' ' 26' ' ' ALA . 16.7 m -119.04 133.64 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.424 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 117.83 19.55 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.57 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -98.42 134.48 11.72 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.079 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.548 ' HB3' ' CB ' ' A' ' 41' ' ' GLU . 30.8 t -51.34 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.412 0.713 . . . . 0.0 109.177 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 174.11 -31.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.491 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.11 30.63 2.24 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.678 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 15.6 mm -142.38 142.64 27.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -97.55 100.59 12.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.104 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.632 ' CD2' HD23 ' A' ' 29' ' ' LEU . 32.8 m-85 -79.97 142.49 35.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.367 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.71 -22.31 2.7 Favored Glycine 0 CA--C 1.507 -0.444 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 2.8 m-20 -173.04 146.15 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.882 0.372 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' CA ' HG22 ' A' ' 15' ' ' VAL . . . -52.91 -28.61 24.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.27 0.557 . . . . 0.0 109.518 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 88.9 m -71.79 -41.03 68.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.753 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 13.4 mtp -62.91 -23.43 67.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.959 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 HD23 ' CD2' ' A' ' 23' ' ' TYR . 1.2 mt -69.83 -48.62 58.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.43 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 7.2 mt -50.57 -33.51 22.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . -68.62 -31.16 73.18 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.13 -65.11 0.88 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.175 0.512 . . . . 0.0 109.9 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.552 ' CA ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -48.49 -27.88 2.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 16.5 t -75.1 -30.82 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.933 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -55.07 -35.89 65.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.465 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . 8.1 t -100.68 -64.14 1.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.795 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 33' ' ' SER . 20.9 t0 179.68 -69.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.154 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.552 ' H ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 t -160.87 37.26 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.769 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HD3' ' H ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -89.04 31.82 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 112.944 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' CD2' ' A' ' 29' ' ' LEU . 1.1 mm -138.06 133.06 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' CB ' ' HB3' ' A' ' 18' ' ' SER . 1.2 tt0 -127.81 -178.1 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.693 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -117.1 142.38 47.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.919 0.39 . . . . 0.0 110.73 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.584 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -127.06 -49.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.584 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.42 153.56 45.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.287 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -95.3 58.83 2.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.91 -153.78 15.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.9 57.77 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.625 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.519 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.007 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.466 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 4.9 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.918 0.389 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 54.8 Cg_endo -89.85 -165.6 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.227 2.618 . . . . 0.0 112.998 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.493 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 11.9 mt -133.96 57.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.205 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 7.2 mt 70.15 99.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.992 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -82.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.821 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 10' ' ' MET . 2.5 t -146.4 -39.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.718 0.294 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.46 11.85 4.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.596 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.7 -76.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.436 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.84 96.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.586 0.708 . . . . 0.0 112.399 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.7 t0 -138.96 51.3 3.31 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.0 Cg_endo -47.76 109.37 0.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.924 3.082 . . . . 0.0 113.516 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 26' ' ' ALA . 34.5 m -118.39 136.79 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 120.0 22.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.993 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -104.47 137.88 13.83 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.868 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 t -47.92 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.392 0.701 . . . . 0.0 109.395 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER 168.46 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.555 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.99 32.98 3.35 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.682 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.1 mm -137.68 132.49 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.839 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -89.26 98.01 11.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.149 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.624 ' CG ' ' HG ' ' A' ' 29' ' ' LEU . 56.8 m-85 -79.46 134.45 36.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.512 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -36.41 -31.94 0.05 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.551 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 55.8 m-80 -164.8 147.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.97 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.51 ' HA ' HG23 ' A' ' 15' ' ' VAL . . . -54.5 -27.2 36.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.282 0.563 . . . . 0.0 109.574 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.7 m -74.65 -40.14 61.65 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.404 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.486 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -59.63 -21.79 60.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.949 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' ' CG ' ' A' ' 23' ' ' TYR . 1.6 mt -75.91 -52.92 9.26 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.387 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 11.6 mt -49.0 -28.84 4.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -76.69 -32.03 51.81 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.512 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 36' ' ' SER . . . -79.77 -52.36 8.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.36 -0.42 . . . . 0.0 112.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.468 ' HB3' HD12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -61.68 -31.31 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.49 -23.38 22.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.6 mtt180 -113.82 8.77 17.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -100.97 -98.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -161.31 -40.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.64 131.83 21.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.745 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.87 72.67 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.548 2.165 . . . . 0.0 112.372 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.566 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.95 170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.1 mt-10 -134.13 -176.22 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.624 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -121.54 132.05 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.281 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.624 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -117.07 -38.61 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.217 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -146.17 147.07 31.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -94.87 57.7 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.303 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -174.44 -154.64 11.14 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.282 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.35 56.82 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.644 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.937 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.467 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 73.9 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.985 0.421 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 92.4 Cg_endo -90.54 173.6 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.173 2.582 . . . . 0.0 112.753 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.43 74.32 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.733 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mp 74.64 143.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.094 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -101.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 11' ' ' GLN . 9.8 t -173.12 -143.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.497 0.589 . . . . 0.0 110.863 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.559 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER 35.48 35.84 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' C ' ' O ' ' A' ' 10' ' ' MET . 3.2 tm0? -0.91 -64.25 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.25 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -121.33 84.48 2.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.719 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 10' ' ' MET . 4.7 t70 -123.5 61.88 22.12 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.4 Cg_endo -50.13 105.4 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.381 2.721 . . . . 0.0 113.348 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.6 m -118.84 122.59 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.269 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.49 128.8 34.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.805 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.561 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -110.78 144.42 17.25 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.782 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -50.38 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.709 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 170.43 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.767 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.61 31.52 3.42 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.212 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 14.0 mm -133.4 143.39 39.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.0 m -103.28 98.55 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.283 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.607 ' CE1' HD21 ' A' ' 29' ' ' LEU . 20.6 m-85 -81.46 141.8 33.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.08 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 25' ' ' ASN . . . -58.86 -12.5 14.97 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.446 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 10' ' ' MET . 50.5 t-20 178.61 149.55 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.396 . . . . 0.0 110.634 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.28 -30.72 18.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 1.5 m -76.02 -39.5 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.131 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG3' ' HB3' ' A' ' 25' ' ' ASN . 12.1 mtp -63.74 -17.56 63.14 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.609 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -71.3 -55.2 8.51 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.692 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -48.15 -31.73 6.04 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.467 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -71.41 -31.68 65.61 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.37 -55.52 4.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.193 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.586 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -48.24 -38.51 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 110.574 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.09 -29.64 34.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.6 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 7.4 ptm180 -84.92 -18.77 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.5 t -82.67 -96.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.636 0.255 . . . . 0.0 111.11 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 179.11 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -111.08 124.54 32.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.09 87.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.937 2.425 . . . . 0.0 112.99 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -67.07 175.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 26.1 mt-10 -138.94 -177.61 4.96 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.587 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -100.81 139.39 36.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.652 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -134.8 -43.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.317 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.652 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.4 m-70 -125.16 126.82 45.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -85.98 58.17 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 176.8 -144.29 6.78 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.865 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -90.61 58.45 3.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.892 0.377 . . . . 0.0 110.957 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.129 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 92.1 m . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.851 0.358 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HG3' HD13 ' A' ' 30' ' ' LEU . 98.2 Cg_endo -86.91 -171.9 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.957 2.438 . . . . 0.0 112.847 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -118.62 62.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.347 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 10.4 mt 67.4 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.333 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.59 -83.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 t -161.95 161.8 28.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.092 0.472 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.0 25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.401 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' TYR . 36.9 mt-30 -83.66 63.44 7.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.81 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.6 99.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.769 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -133.43 64.85 70.56 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.0 Cg_endo -50.31 121.82 8.34 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.256 2.637 . . . . 0.0 113.067 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.539 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 10.5 m -127.3 132.87 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.728 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.88 123.0 26.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.16 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 135.99 12.5 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.203 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . 12.0 t -49.43 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.097 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' GLY . 5.1 t0 169.15 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.845 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.24 31.79 2.97 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.729 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 mm -138.05 129.43 38.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 55.1 m -89.84 100.1 12.98 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.626 ' CE2' HD22 ' A' ' 29' ' ' LEU . 36.4 m-85 -79.34 163.84 24.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.253 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -69.42 -20.24 75.16 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.703 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 42.6 m-20 -174.23 147.96 1.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 110.878 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 30' ' ' LEU . . . -53.31 -25.16 13.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.023 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 18.2 m -76.64 -37.7 55.87 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 7.9 mtt -68.07 -18.94 64.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.974 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.626 HD22 ' CE2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -73.26 -60.84 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.905 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.524 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -48.79 -29.59 4.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -75.04 -28.77 61.76 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.87 -53.13 5.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.995 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -55.39 -34.53 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.156 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -76.12 -45.73 32.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.656 0.265 . . . . 0.0 111.132 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -87.74 9.4 21.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -97.71 -95.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.604 0.24 . . . . 0.0 111.517 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -180.0 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.404 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.42 144.45 28.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.27 78.53 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.723 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.479 HD12 HG22 ' A' ' 40' ' ' ILE . 3.7 mt -65.72 149.43 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.557 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mt-10 -137.12 -177.09 4.61 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.794 0.331 . . . . 0.0 111.517 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.68 132.94 52.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -121.76 -45.14 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.592 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER -132.8 138.75 47.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.906 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -91.78 57.59 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 179.14 -154.27 13.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.115 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 57.32 3.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.846 0.355 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.853 0.359 . . . . 0.0 110.768 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 31' ' ' GLY . 74.1 Cg_endo -79.22 131.72 9.9 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.649 2.232 . . . . 0.0 112.836 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.89 45.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 mt 44.76 86.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -78.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 156.63 8.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.33 17.52 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.517 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 5.8 tt0 -72.66 65.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.39 103.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.484 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -132.31 68.37 79.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.4 Cg_endo -58.87 93.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.132 2.555 . . . . 0.0 113.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.55 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 14.7 m -109.97 128.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.317 0.579 . . . . 0.0 111.178 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -79.9 130.68 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.78 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.3 149.9 18.7 Favored Glycine 0 C--O 1.25 1.111 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.152 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 t -48.59 93.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.067 -1.066 . . . . 0.0 109.586 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' SER . 10.3 t0 170.69 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.017 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.81 33.92 3.16 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.689 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 23' ' ' TYR . 26.5 mm -140.15 139.13 36.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 119.493 -0.883 . . . . 0.0 113.223 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 54.4 m -91.14 114.38 26.89 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.065 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.663 ' CG ' ' HB3' ' A' ' 29' ' ' LEU . 26.9 m-85 -99.92 135.7 40.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -49.12 -26.05 5.95 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.827 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -167.28 138.43 3.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.948 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . -55.72 -19.31 10.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 10.8 m -81.11 -33.98 32.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.32 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.478 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 3.0 mtt -73.57 -40.01 64.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.154 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.663 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -81.75 -17.82 46.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.445 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.07 -41.41 99.43 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -64.46 -35.65 92.21 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -57.72 -34.59 69.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.875 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -51.86 33.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.7 t -63.64 -26.83 68.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 5.0 ptm180 -80.04 -39.27 30.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.6 t -76.09 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t0 179.66 -33.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -94.49 117.66 66.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' ILE . 43.0 Cg_endo -68.22 75.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.335 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.555 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.28 176.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.43 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.8 mm-40 -137.84 -177.16 4.69 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.377 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.13 132.1 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.65 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 12.0 p -122.63 -35.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.064 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.65 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.3 m-70 -136.11 140.39 43.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 57.58 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.96 -143.33 6.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -90.12 57.54 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.112 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.988 0.423 . . . . 0.0 111.678 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.534 ' CG ' HD11 ' A' ' 30' ' ' LEU . 63.0 Cg_endo -94.3 -163.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.442 2.761 . . . . 0.0 112.159 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 tp -124.07 61.39 1.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 68.73 107.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.19 -75.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -161.36 165.99 28.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.062 0.458 . . . . 0.0 111.68 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.9 mmm -100.87 23.91 9.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.438 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 2.0 mt-30 -83.18 61.29 6.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -20.4 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.494 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -123.35 60.91 18.69 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.6 Cg_endo -47.83 116.29 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.403 2.736 . . . . 0.0 112.773 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.477 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 16.1 m -125.4 129.73 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.577 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.37 127.21 31.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.571 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -107.7 140.54 15.44 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.333 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.75 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.631 -0.785 . . . . 0.0 109.113 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' GLY . 6.0 t70 167.8 -27.97 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.722 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.02 31.81 3.73 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.556 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.2 mm -136.56 135.97 48.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 56.4 m -93.86 98.24 10.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.463 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.612 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 30.4 m-85 -79.53 147.88 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.158 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -56.32 -21.71 34.44 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.215 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 49.5 m-20 -173.69 147.13 1.36 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.667 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' N ' HG23 ' A' ' 15' ' ' VAL . . . -51.77 -27.48 12.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.575 . . . . 0.0 109.772 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.0 m -72.27 -42.62 65.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.683 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.45 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -64.84 -16.38 63.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.102 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' HG ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -75.08 -55.5 5.68 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.232 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 27' ' ' CYS . 1.0 OUTLIER -47.38 -35.89 8.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -73.45 -30.95 61.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.805 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -72.09 -52.25 17.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.755 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.472 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -60.76 -22.52 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.573 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -39.66 36.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.984 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.24 6.4 44.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.491 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t -81.69 -95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.07 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.8 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.69 146.65 62.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.99 94.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 0.0 112.638 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.482 HG21 HD13 ' A' ' 40' ' ' ILE . 18.1 mt -71.86 156.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 4.1 mm-40 -135.46 -176.51 4.3 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.627 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.601 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -115.77 142.03 47.29 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.518 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.551 HG12 ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -137.15 -37.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.467 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.551 ' CE1' HG12 ' A' ' 43' ' ' VAL . 1.5 m-70 -135.4 136.81 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.922 0.391 . . . . 0.0 111.337 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' HG11 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -94.48 57.15 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.869 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.87 -143.54 5.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -90.23 52.97 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.798 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.159 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.563 ' CD ' ' HB3' ' A' ' 30' ' ' LEU . 49.6 Cg_endo -103.62 -161.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 113.232 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -162.46 55.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.979 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 8.3 mt 69.74 118.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -110.75 -84.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.1 t -166.87 -175.73 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.471 ' N ' ' OG1' ' A' ' 9' ' ' THR . 43.0 mmm -109.41 17.37 21.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.349 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -69.88 60.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -24.4 96.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.351 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -130.96 66.17 78.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.61 107.08 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.411 2.741 . . . . 0.0 112.902 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.535 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.0 m -109.14 127.4 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.628 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.69 117.94 20.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.824 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -102.32 140.6 14.93 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.063 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 6.7 t -50.18 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.09 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.37 -29.82 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.947 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 114.33 25.7 3.99 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.387 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.7 mp -132.82 154.38 39.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 CA-C-O 121.651 0.739 . . . . 0.0 112.5 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 53.8 m -112.29 99.28 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.047 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CD2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -79.05 135.96 37.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 112.082 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -46.0 -23.45 1.09 Allowed Glycine 0 CA--C 1.506 -0.506 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.272 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 66.8 m-20 -175.55 152.23 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 0.0 110.715 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 30' ' ' LEU . . . -51.85 -28.75 16.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 109.523 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 30' ' ' LEU . 89.8 m -74.43 -42.67 58.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.512 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -61.72 -23.26 66.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.638 HD22 ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.49 -53.72 31.94 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.7 177.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 mp -42.75 -40.41 2.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -67.24 -31.22 76.78 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.251 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.99 -44.17 18.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.589 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.11 -50.46 73.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 111.13 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 12.4 m -74.83 -26.5 59.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 13.1 mmm180 -94.0 -13.07 27.4 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 40.5 t -79.1 -93.08 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.819 0.342 . . . . 0.0 111.127 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.37 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.459 . . . . 0.0 110.116 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.33 127.09 26.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.539 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.79 92.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.444 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -66.1 167.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.405 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 17.6 mt-10 -123.67 -177.46 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.82 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -120.77 134.59 55.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.109 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -119.88 -46.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.481 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -147.78 126.69 12.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.803 0.335 . . . . 0.0 111.09 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' HG13 ' A' ' 15' ' ' VAL . 74.4 mttt -74.56 67.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.48 -164.75 30.49 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.057 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 53.0 2.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.998 0.427 . . . . 0.0 110.665 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.122 179.839 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 74.5 Cg_endo -93.03 177.69 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.166 2.577 . . . . 0.0 112.215 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -102.88 48.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.437 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 27.2 mt 68.17 98.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -89.97 -82.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.167 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -170.76 138.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.63 29.03 3.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.603 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 -104.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.651 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 101.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.442 0.639 . . . . 0.0 112.444 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -139.32 50.08 2.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.5 Cg_endo -48.59 114.19 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.626 2.884 . . . . 0.0 113.278 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.52 HG22 ' CA ' ' A' ' 26' ' ' ALA . 16.1 m -127.03 134.59 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.97 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.51 121.65 24.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.911 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.16 134.56 11.9 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -51.72 96.62 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.611 0.719 . . . . 0.0 110.116 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' SER . 62.1 t0 172.53 -29.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.716 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.71 2.04 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.257 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.2 mm -138.59 146.79 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -107.45 98.2 7.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.287 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.624 ' CG ' ' HG ' ' A' ' 29' ' ' LEU . 28.8 m-85 -82.39 139.76 33.87 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.404 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -47.74 -31.29 7.38 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.642 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.57 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 63.7 m-20 -160.09 144.94 14.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.514 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' CA ' HG22 ' A' ' 15' ' ' VAL . . . -54.6 -30.11 53.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.675 0.75 . . . . 0.0 109.236 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 88.8 m -72.45 -38.69 68.2 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.851 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.501 ' HE1' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -61.32 -18.56 59.15 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' ' CG ' ' A' ' 23' ' ' TYR . 1.3 mt -74.98 -51.47 13.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.257 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 2.4 mt -47.71 -32.72 6.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' CD ' ' A' ' 35' ' ' ARG . . . -75.56 -32.24 54.96 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.09 -55.61 9.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.239 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.67 -27.08 66.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.284 0.564 . . . . 0.0 109.586 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 t -82.22 -15.95 51.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.258 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -92.86 -32.53 14.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.272 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -94.76 -111.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.137 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -176.32 30.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.78 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 m -142.8 114.69 6.02 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.33 78.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.68 2.253 . . . . 0.0 112.684 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CD1' ' OG ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -59.31 168.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.2 mt-10 -126.56 -177.27 3.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.446 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.8 137.42 53.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.587 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -119.47 -52.04 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.487 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.21 151.65 50.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.067 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' HG11 ' A' ' 15' ' ' VAL . 3.3 mmtt -95.24 61.75 2.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.72 -153.54 14.26 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.39 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -83.65 55.9 3.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.6 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.009 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 4' ' ' CYS . 33.8 Cg_endo -97.5 -164.49 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.94 2.427 . . . . 0.0 113.921 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.87 55.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.666 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 1.1 mp 71.44 160.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.508 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.79 -166.81 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.332 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.15 157.06 37.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.11 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtt -91.77 18.22 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.898 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -72.29 60.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.08 98.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.457 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -123.62 61.49 22.09 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.06 109.68 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.106 2.537 . . . . 0.0 112.093 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.38 125.48 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 111.175 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 118.49 20.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.214 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -97.95 136.51 12.77 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.931 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -53.18 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.614 179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 177.25 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.372 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.14 31.29 1.44 Allowed Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.91 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.6 mm -142.0 142.86 27.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.5 m -101.35 98.85 9.17 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.991 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.621 ' CE1' HD22 ' A' ' 29' ' ' LEU . 28.2 m-85 -80.0 159.21 26.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -67.08 -10.8 57.39 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.972 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 6.5 p30 165.99 156.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.34 -24.98 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.173 0.511 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 8.8 m -74.84 -49.44 20.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.773 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.522 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -61.38 -21.99 64.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.9 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -66.84 -59.18 3.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.581 ' CD1' ' HB3' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -53.88 -29.39 41.42 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.97 75.64 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -79.5 -52.7 7.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.752 -0.724 . . . . 0.0 110.06 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.437 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -52.74 -35.92 56.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.286 179.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -35.03 63.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.404 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 4.7 ptm180 -73.52 -27.66 61.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.403 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 t -83.38 -94.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.338 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t0 179.69 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.43 147.84 34.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.909 0.385 . . . . 0.0 111.175 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.66 79.7 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.963 2.442 . . . . 0.0 112.416 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 HG22 HD21 ' A' ' 29' ' ' LEU . 74.4 mt -44.19 152.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.474 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 22.7 mt-10 -123.34 -177.29 3.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.345 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -118.82 147.27 44.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -133.89 -43.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.55 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -142.23 135.97 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.04 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -88.99 66.36 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.08 -155.38 16.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.166 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.09 54.1 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 0.0 110.515 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 1.6 m . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.8 Cg_endo -103.14 42.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.492 2.795 . . . . 0.0 113.189 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 5' ' ' PRO . 9.8 mt 28.7 49.58 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.229 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 13.6 mm 68.72 161.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.746 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.12 -166.53 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.462 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 10' ' ' MET . 0.7 OUTLIER -69.63 179.21 2.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.339 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.47 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.31 28.66 8.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.503 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 4.1 mm-40 -80.85 62.98 5.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.275 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.63 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.159 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -122.8 63.75 21.29 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.8 Cg_endo -49.06 101.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.077 2.518 . . . . 0.0 112.192 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.507 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 33.3 m -108.0 126.63 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.308 0.575 . . . . 0.0 110.921 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.85 121.87 25.37 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.733 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -99.88 137.33 13.19 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.229 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -50.25 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.803 0.811 . . . . 0.0 109.376 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' OD2' ' OH ' ' A' ' 23' ' ' TYR . 2.5 p30 172.12 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.477 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.08 31.44 2.25 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.643 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 33.0 mm -137.8 138.86 43.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.5 m -99.13 102.93 14.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.357 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.651 ' CD2' HD22 ' A' ' 29' ' ' LEU . 21.0 m-85 -84.34 143.01 29.77 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.381 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -53.75 -16.59 5.78 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.374 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 15.6 m-20 177.41 150.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.16 -29.4 21.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 56.6 m -73.65 -39.84 64.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.268 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.439 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.45 -25.78 68.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -65.77 -54.37 28.02 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.252 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 5.8 mt -48.71 -39.98 26.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -59.6 -31.92 72.25 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -73.72 -57.39 4.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.451 -0.874 . . . . 0.0 110.699 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.531 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 30.3 t -56.74 -50.49 72.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.605 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -61.08 -27.41 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.923 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.1 mtp180 -109.79 8.95 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 27.9 t -104.35 -98.98 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.505 0.193 . . . . 0.0 111.463 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.6 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 131.62 22.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 59.8 Cg_endo -71.12 82.24 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.623 2.215 . . . . 0.0 112.277 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG13 HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -54.84 174.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.665 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 37.7 mt-10 -131.16 -177.65 4.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.507 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -113.03 132.25 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.194 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.561 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -111.85 -51.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.383 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.561 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.36 129.93 17.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.875 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 62.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.42 -168.59 33.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.13 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -80.3 51.71 1.46 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.741 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.022 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.832 0.349 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.489 ' HG2' ' CB ' ' A' ' 33' ' ' SER . 10.3 Cg_endo -52.19 -164.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.87 2.38 . . . . 0.0 112.295 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 15.0 p-10 -128.48 -166.29 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.549 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -108.03 157.56 35.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 56.1 Cg_endo -95.88 -163.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.492 2.795 . . . . 0.0 112.374 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 mp -132.09 58.54 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 61.2 mt 65.1 102.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.38 -84.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -169.5 178.98 3.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.235 0.541 . . . . 0.0 112.119 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.421 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -110.58 11.67 22.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.226 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.71 67.6 1.6 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.1 96.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.409 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.415 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -120.78 58.93 7.09 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 Cg_endo -48.77 115.55 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.646 2.897 . . . . 0.0 113.442 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 45' ' ' LYS . 16.8 m -121.99 133.59 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 119.36 22.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.823 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.12 139.63 14.87 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.048 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 t -49.71 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.243 -0.979 . . . . 0.0 109.585 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' SER . 5.5 t0 170.48 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.352 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.55 2.98 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.607 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.2 mm -139.05 141.55 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.12 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -96.86 99.02 10.6 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.995 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' HD22 ' A' ' 29' ' ' LEU . 47.4 m-85 -82.26 138.94 34.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -40.69 -29.27 0.25 Allowed Glycine 0 CA--C 1.505 -0.593 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.717 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 10.1 p30 -173.89 147.01 1.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.088 0.471 . . . . 0.0 110.833 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 15' ' ' VAL . . . -49.57 -26.24 3.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.513 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.1 m -72.66 -43.44 63.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.43 0.633 . . . . 0.0 110.222 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 1.8 mmm -61.46 -17.57 55.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.169 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -76.62 -50.52 13.6 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.598 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -48.61 -34.71 12.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -34.01 67.33 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -71.32 -61.69 1.68 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.619 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.571 ' CB ' ' CG1' ' A' ' 40' ' ' ILE . 0.8 OUTLIER -48.79 -28.46 3.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.135 0.493 . . . . 0.0 110.017 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -73.42 -32.3 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.603 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.27 56.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 7.7 t -108.91 -71.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -173.78 -36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.211 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.527 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.06 174.98 2.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 38' ' ' THR . 56.4 Cg_endo -71.98 92.16 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.549 2.166 . . . . 0.0 112.013 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.571 ' CG1' ' CB ' ' A' ' 33' ' ' SER . 22.8 pt -83.4 167.28 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.505 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.4 mm-40 -149.38 -176.68 5.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.616 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.3 140.15 48.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.701 0.286 . . . . 0.0 110.812 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -122.5 -47.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.438 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -136.65 133.9 36.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.81 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 19.6 pttt -86.02 64.72 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.22 -150.01 9.5 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.175 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -90.3 53.9 2.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.818 0.342 . . . . 0.0 110.49 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' OXT' ' O ' ' A' ' 47' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.958 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.765 0.317 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.88 -169.64 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.693 2.262 . . . . 0.0 112.115 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 17.6 t70 -179.08 166.62 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.38 133.25 28.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 88.8 Cg_endo -78.16 -169.45 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.68 2.253 . . . . 0.0 112.211 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -125.66 64.0 1.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.648 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.3 mp 70.37 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -84.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.947 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -152.7 172.7 16.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -104.13 16.68 25.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' TYR . 84.8 mt-30 -73.66 59.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -25.66 92.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.132 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.509 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -121.9 65.51 19.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.186 178.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.3 Cg_endo -49.02 96.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.182 2.588 . . . . 0.0 112.053 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 10.2 m -105.58 131.64 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.409 0.623 . . . . 0.0 111.186 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.575 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -105.12 142.79 15.56 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.598 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 12.5 m -47.92 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.686 0.874 . . . . 0.0 109.079 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 168.73 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.457 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.95 33.54 2.78 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.975 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.0 mm -140.71 139.36 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.988 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 9.2 m -94.84 100.93 12.73 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.606 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.627 ' CE1' HD22 ' A' ' 29' ' ' LEU . 21.6 m-85 -83.87 139.73 32.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.391 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -48.56 -20.75 1.77 Allowed Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 36.5 m-20 -177.92 150.76 0.64 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' HD22 ' A' ' 30' ' ' LEU . . . -50.93 -29.04 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.623 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.5 m -73.32 -43.92 59.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.731 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -63.31 -19.98 65.08 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.693 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.627 HD22 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -68.64 -59.4 3.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.098 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -46.44 -33.12 3.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.12 -37.67 55.46 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.82 -54.46 15.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.313 -0.443 . . . . 0.0 110.848 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.31 -25.42 64.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.523 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 p -75.81 -32.04 59.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 0.0 110.716 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -107.91 11.78 27.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 t -87.65 -93.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.226 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.87 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.32 . . . . 0.0 110.955 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.49 158.75 72.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.22 89.68 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.831 2.354 . . . . 0.0 112.491 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 9.0 mt -71.02 149.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 4.6 mt-10 -133.28 -176.63 4.2 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.904 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -102.38 132.33 48.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.66 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 9.6 p -123.44 -34.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.66 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -146.51 142.73 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.345 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 61.09 2.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 110.83 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.29 -153.87 11.87 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -90.3 53.89 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 110.603 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.06 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' PRO . 8.9 mttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.982 0.42 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 1' ' ' LYS . 71.7 Cg_exo -49.56 -166.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.907 2.405 . . . . 0.0 112.745 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.659 ' O ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -68.16 54.41 0.07 Allowed 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.976 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -113.22 166.55 10.9 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.903 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 61.2 Cg_endo -75.31 156.79 41.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.785 2.323 . . . . 0.0 113.62 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 1.1 tt 172.61 40.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt 61.68 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.223 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.34 -83.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.92 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -114.68 131.97 56.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.8 17.08 18.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.143 0.497 . . . . 0.0 110.296 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' TYR . 9.1 mt-30 -102.91 71.86 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.253 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.572 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 2.7 t0 -124.51 62.01 30.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.99 112.96 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.346 2.697 . . . . 0.0 112.978 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.563 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 16.9 m -121.02 130.53 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.747 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 128.13 33.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.367 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -105.52 137.57 13.81 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.124 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -50.55 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.578 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' SER . 21.1 t70 170.4 -29.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.832 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.99 33.14 2.25 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.607 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.6 mm -137.56 132.28 44.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.4 m -93.25 102.78 15.06 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.661 ' CE2' HD23 ' A' ' 29' ' ' LEU . 32.1 m-85 -81.47 166.58 20.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.218 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -78.71 -13.59 82.98 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.842 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 29.2 m-20 -179.4 149.81 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.632 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.54 5.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.454 0.645 . . . . 0.0 109.281 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -75.4 -45.62 37.9 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.991 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.43 ' HE1' ' HA3' ' A' ' 24' ' ' GLY . 5.3 mmm -55.89 -30.02 60.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.661 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -64.36 -51.07 65.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.887 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.659 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.4 pp -47.0 -39.9 13.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 35' ' ' ARG . . . -65.28 -35.65 91.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.873 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -60.33 -45.99 91.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.743 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.27 -50.34 73.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.849 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 15.6 t -70.12 -35.09 73.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.87 -32.93 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.725 0.298 . . . . 0.0 111.25 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 t -88.19 -93.68 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.779 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.81 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.043 0.449 . . . . 0.0 110.389 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -90.51 136.15 28.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.818 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 3.0 Cg_exo -74.68 64.29 5.73 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.512 ' CD1' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -44.05 166.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt-10 -132.45 -177.63 4.56 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.47 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.33 132.4 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.134 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -127.4 -42.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.463 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.9 m-70 -128.38 115.35 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.835 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -76.62 53.53 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.35 -147.21 5.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 57.25 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 110.464 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.868 0.366 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HG2' HD22 ' A' ' 30' ' ' LEU . 57.8 Cg_endo -71.04 -171.87 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.766 2.31 . . . . 0.0 112.458 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -149.98 172.68 14.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.625 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -30.64 139.11 0.17 Allowed Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.734 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.2 Cg_endo -93.17 42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.172 2.581 . . . . 0.0 112.627 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 5' ' ' PRO . 3.7 mt 27.02 61.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.88 102.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -90.68 -86.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 11' ' ' GLN . 9.7 t -171.58 -154.57 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.52 ' O ' ' C ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -107.41 -47.88 3.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.335 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 9.15 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.13 0.894 . . . . 0.0 111.892 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -32.41 90.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.302 0.572 . . . . 0.0 111.362 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' GLN . 37.5 t0 -129.91 57.01 27.74 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.291 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.26 87.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.051 2.501 . . . . 0.0 112.076 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.0 m -91.95 127.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.413 0.625 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.48 115.08 17.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.485 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.25 140.41 14.86 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.762 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -51.21 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.379 -0.911 . . . . 0.0 109.905 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.01 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.171 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.68 33.56 1.7 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.329 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -140.39 152.54 21.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' HG22 ' A' ' 21' ' ' ILE . 97.2 m -109.51 98.36 7.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.974 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 39.3 m-85 -80.8 134.74 35.84 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.67 -23.62 0.19 Allowed Glycine 0 CA--C 1.507 -0.423 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.426 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 28' ' ' MET . 14.1 p30 -178.52 149.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.271 0.557 . . . . 0.0 111.142 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.14 -24.49 4.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.484 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 10.0 m -74.22 -39.96 62.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.25 0.548 . . . . 0.0 110.402 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.03 -21.64 66.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.89 -179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD23 ' CD1' ' A' ' 23' ' ' TYR . 2.2 mt -75.13 -51.54 13.2 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 92.9 mt -48.86 -33.79 11.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.01 -27.4 64.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.856 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.03 -54.76 5.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.498 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -26.66 68.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 7.0 p -84.07 -31.39 25.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.634 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 9.1 mmm180 -100.71 3.64 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.594 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 38.4 t -93.89 -98.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' SER . 8.9 t70 179.11 -31.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.973 0.416 . . . . 0.0 110.644 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.0 m -115.68 103.4 53.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.253 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.27 92.75 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.102 2.535 . . . . 0.0 112.943 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.48 177.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.415 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.9 mt-10 -135.92 -177.86 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.531 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.587 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.68 137.11 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.081 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -116.47 -53.14 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.303 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.566 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.14 148.66 52.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -93.3 56.71 2.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.748 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' PRO . . . -178.69 -156.21 16.48 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.266 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.03 56.78 3.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.33 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.818 0.342 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 1' ' ' LYS . 86.8 Cg_endo -83.69 172.19 10.29 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.836 2.357 . . . . 0.0 112.537 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER 179.51 46.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.538 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' C ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -156.77 146.19 15.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 97.6 Cg_endo -93.31 -162.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.266 2.644 . . . . 0.0 113.112 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' N ' HD21 ' A' ' 6' ' ' LEU . 1.3 pt? -159.69 51.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.902 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm 60.72 87.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.426 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.62 -80.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.5 t -168.63 -179.41 3.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.161 0.505 . . . . 0.0 111.77 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.3 OUTLIER -111.24 21.36 16.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.251 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 12' ' ' TYR . 7.3 mm-40 -78.23 59.7 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.929 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -21.43 94.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.496 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -123.37 65.94 32.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.58 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.349 2.699 . . . . 0.0 112.907 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' HB ' HD12 ' A' ' 42' ' ' LEU . 35.7 m -108.84 131.09 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.09 114.56 17.08 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.132 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -96.97 134.33 11.73 Favored Glycine 0 C--O 1.25 1.094 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.991 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -56.81 90.96 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.851 0.834 . . . . 0.0 109.32 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' GLY . 4.1 t70 -175.97 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.16 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.13 26.77 0.88 Allowed Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.324 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.586 HG23 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -148.09 168.83 3.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 30.3 m -119.79 99.3 6.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.088 -1.414 . . . . 0.0 109.356 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.651 ' CD2' HD23 ' A' ' 29' ' ' LEU . 16.1 m-85 -82.8 136.17 34.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -43.81 -26.98 0.86 Allowed Glycine 0 CA--C 1.506 -0.515 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.752 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 76.3 m-20 -169.79 146.82 3.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -51.22 -28.35 11.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.659 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HA ' HD13 ' A' ' 30' ' ' LEU . 95.1 m -73.38 -44.23 59.01 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.741 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.507 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 3.1 mtp -61.31 -19.82 62.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.651 HD23 ' CD2' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -70.19 -47.14 62.83 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.82 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB3' ' C ' ' A' ' 4' ' ' CYS . 1.3 mt -47.97 -36.62 12.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' NE ' ' A' ' 35' ' ' ARG . . . -71.27 -31.54 66.07 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.54 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -72.21 -56.5 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.089 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -41.01 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 109.646 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.02 -39.74 79.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.871 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 31' ' ' GLY . 10.0 mtt180 -74.66 -22.31 58.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.02 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -86.13 -99.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.536 0.207 . . . . 0.0 110.99 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.54 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.996 0.427 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.77 159.51 29.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.28 83.92 2.15 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.808 2.338 . . . . 0.0 112.588 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.556 HG23 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -38.45 152.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.756 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.5 mm-40 -119.21 -179.74 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.428 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' CD2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -126.31 137.36 53.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.608 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 HG11 ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -115.65 -45.4 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.148 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.547 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -144.5 125.13 14.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.04 58.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -176.56 -153.48 10.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.95 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -87.48 56.44 3.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.547 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 mttt . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.445 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 17.9 Cg_endo -60.08 -165.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.659 2.239 . . . . 0.0 112.308 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 4' ' ' CYS . 12.9 p-10 -172.02 -158.01 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 3' ' ' ASP . 8.8 m -40.04 169.78 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.226 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.539 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 90.7 Cg_endo -91.39 179.12 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.882 2.388 . . . . 0.0 113.579 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -165.11 41.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.375 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt 58.08 86.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.282 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -85.3 -70.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.795 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -165.74 151.96 9.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.23 23.72 7.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -83.04 64.71 7.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.67 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.27 95.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.578 -178.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.532 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 1.1 t0 -123.55 63.07 25.51 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.081 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.6 Cg_endo -50.04 102.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.142 2.561 . . . . 0.0 112.351 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 42' ' ' LEU . 34.4 m -108.74 139.37 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.914 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 117.11 19.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -101.39 134.3 11.67 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.838 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -51.55 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.698 -0.751 . . . . 0.0 109.557 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 177.23 -35.66 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.789 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.47 33.38 0.95 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.863 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.3 mt -146.06 157.99 11.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 85.9 m -110.01 98.35 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.195 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.641 ' CD2' HD21 ' A' ' 29' ' ' LEU . 28.4 m-85 -82.18 134.76 35.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -42.17 -27.14 0.4 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.774 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 76.3 m-20 -168.36 146.07 4.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.201 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.52 -28.0 28.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.405 0.621 . . . . 0.0 109.505 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.9 m -73.37 -40.68 64.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.608 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.1 mmt -66.99 -15.84 63.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.091 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -74.03 -61.91 1.69 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.442 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -48.87 -32.1 8.31 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.644 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -73.18 -31.77 61.14 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.68 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.59 -56.87 4.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.568 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.51 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.96 -32.91 2.99 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 109.792 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -68.6 -47.84 65.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.142 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 4.0 mmm180 -60.38 -26.71 66.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.478 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -87.85 -108.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.322 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -179.52 33.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.878 0.371 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -158.27 124.54 2.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 15.3 Cg_exo -67.85 71.2 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.852 2.368 . . . . 0.0 112.61 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.539 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.43 176.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.825 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HB2' ' OG ' ' A' ' 18' ' ' SER . 7.5 mt-10 -139.2 -177.21 4.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.561 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.597 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.0 140.67 49.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 1.5 t -123.66 -43.28 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.4 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -141.68 149.1 40.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.95 61.21 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.16 -149.79 11.07 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.05 56.5 4.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.972 0.415 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.549 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.5 m . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.984 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.974 0.416 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.85 -159.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.821 2.348 . . . . 0.0 112.496 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -82.86 44.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.052 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m -150.58 144.73 17.63 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 78.0 Cg_endo -98.64 -173.82 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.387 2.724 . . . . 0.0 112.214 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.11 61.74 1.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.681 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 7' ' ' ILE . 3.7 mm 63.04 87.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.828 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.98 -79.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.1 t -169.72 -178.58 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.175 0.512 . . . . 0.0 111.714 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -107.54 11.83 28.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.518 179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 12' ' ' TYR . 19.2 mm100 -66.91 62.37 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -22.54 94.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -117.34 58.63 2.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.7 Cg_endo -50.39 102.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.359 2.706 . . . . 0.0 112.745 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 34.2 m -113.42 123.23 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 116.6 18.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.418 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -95.59 135.65 12.47 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.365 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -50.0 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.692 0.758 . . . . 0.0 109.882 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 171.23 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.78 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 110.47 33.19 2.54 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.204 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -135.31 124.57 41.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -90.15 98.8 11.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.596 ' CE2' HD23 ' A' ' 29' ' ' LEU . 13.6 m-85 -80.76 148.66 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.91 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -59.16 -11.5 12.74 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.416 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 9.6 p30 163.85 155.23 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.24 -25.22 0.89 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.304 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 63.7 m -77.02 -46.23 24.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.62 0.724 . . . . 0.0 110.009 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -61.95 -22.46 65.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.454 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.596 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -68.05 -49.06 63.72 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.864 177.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 mt -47.87 -38.32 15.96 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -64.4 -35.55 92.09 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.4 -64.83 0.82 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.099 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -46.86 -36.83 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.054 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 13.1 t -54.96 -47.8 74.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.495 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' HG3' ' C ' ' A' ' 34' ' ' CYS . 7.3 mtp180 -143.57 51.18 1.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 13.4 t -97.03 -73.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 110.529 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.71 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.523 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -152.15 159.62 32.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.233 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 18.4 Cg_endo -59.54 87.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.624 2.216 . . . . 0.0 112.146 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.514 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -64.72 145.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.099 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm-40 -113.29 -177.31 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 ' CD2' HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -115.08 136.3 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.431 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -122.3 -49.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.607 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.67 143.49 48.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.815 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -94.23 57.2 2.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.128 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.28 -150.64 7.58 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.013 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -89.43 57.43 3.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 1' ' ' LYS . 72.4 Cg_endo -79.41 -171.73 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 m-20 -155.86 56.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 68.6 m -161.78 160.42 22.5 Favored Pre-proline 0 C--O 1.23 0.064 0 O-C-N 123.504 0.503 . . . . 0.0 110.659 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.516 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 6.0 Cg_endo -48.59 137.52 26.02 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.939 2.426 . . . . 0.0 112.605 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -160.77 44.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.748 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 27.95 105.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -104.04 -79.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.036 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.528 HG23 ' CG ' ' A' ' 11' ' ' GLN . 1.7 t -163.15 -178.44 6.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.901 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 12' ' ' TYR . 1.8 mtm -114.85 10.12 16.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.033 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' CG ' HG23 ' A' ' 9' ' ' THR . 0.3 OUTLIER -67.06 62.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 109.968 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.492 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.43 93.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.433 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -119.87 65.39 9.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.89 108.69 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.019 2.48 . . . . 0.0 112.748 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 19.4 m -120.0 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.151 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 117.83 20.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 139.64 14.5 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.073 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 38.8 t -50.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.808 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' OD1' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 171.56 -29.32 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.812 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.17 32.13 3.11 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.372 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 34.1 mm -135.64 133.61 51.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -94.76 98.33 10.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.095 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.629 ' CE2' HD23 ' A' ' 29' ' ' LEU . 24.8 m-85 -79.27 153.27 30.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.939 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 25' ' ' ASN . . . -64.03 -10.14 38.4 Favored Glycine 0 C--N 1.328 0.124 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.5 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 28' ' ' MET . 12.3 p30 166.8 153.31 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 0.0 110.184 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.71 -26.21 2.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 9.0 m -75.12 -43.87 50.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.546 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.67 -18.53 65.06 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.905 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.17 -57.41 4.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.285 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -49.44 -35.82 20.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 5' ' ' PRO . . . -71.51 -27.85 70.57 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -76.8 -58.75 3.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.563 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 40' ' ' ILE . 3.7 t -42.1 -37.34 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.453 0.644 . . . . 0.0 109.347 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 21.6 t -64.61 -50.52 66.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.406 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 8.9 mmm180 -77.24 -10.47 59.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.049 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -82.65 -96.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 179.18 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.0 110.488 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 163.86 22.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.075 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.6 75.61 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.837 2.358 . . . . 0.0 112.048 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 29' ' ' LEU . 1.5 pt -52.5 154.01 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.117 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -122.66 -175.99 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -112.08 132.48 54.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.369 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.564 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -116.23 -53.14 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.258 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.564 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -132.99 144.8 50.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.923 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -91.36 65.41 5.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 172.63 -159.77 30.61 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.102 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -79.52 55.05 1.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 110.688 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.828 0.347 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.4 38.32 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.111 2.541 . . . . 0.0 112.269 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 m-20 -113.08 40.78 2.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m -152.07 147.37 19.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 94.5 Cg_endo -94.83 -165.41 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.373 2.716 . . . . 0.0 112.891 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 tp -164.9 52.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.71 85.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -76.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.261 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -169.2 179.09 4.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.071 0.462 . . . . 0.0 111.502 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.52 19.38 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -73.19 58.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.963 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -25.49 97.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.544 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 1.4 t0 -126.48 61.71 44.64 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.055 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.8 Cg_endo -47.67 93.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.189 2.592 . . . . 0.0 112.035 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 10.8 m -102.76 131.85 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 121.64 24.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.328 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -100.73 141.4 15.35 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.39 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 66.3 m -53.29 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.184 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' GLY . 19.9 t70 176.57 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.261 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.33 32.49 1.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.885 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 22' ' ' THR . 6.7 mt -143.7 160.84 16.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 41.5 m -113.03 108.09 16.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.623 ' CE1' HD22 ' A' ' 29' ' ' LEU . 15.0 m-85 -93.06 136.32 33.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.323 0.582 . . . . 0.0 112.31 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -47.06 -22.98 1.44 Allowed Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.202 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 61.0 m-20 -174.08 150.38 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' O ' HD21 ' A' ' 30' ' ' LEU . . . -50.82 -28.9 10.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.348 0.594 . . . . 0.0 109.567 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.83 -45.5 58.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.501 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -60.56 -23.27 64.49 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.36 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD22 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -65.29 -50.77 64.45 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.381 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 2.1 mt -48.97 -36.3 17.21 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -65.2 -29.93 76.56 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.83 -64.67 0.99 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.95 -0.625 . . . . 0.0 110.179 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -30.09 12.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.186 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 7.4 t -63.43 -50.51 69.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.713 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 35' ' ' ARG . 1.2 mmm180 -100.87 18.74 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 9.7 t -103.42 -119.8 0.2 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' SER . 6.3 t70 178.84 29.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.064 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.461 HG21 ' HD2' ' A' ' 39' ' ' PRO . 2.4 m -160.47 139.66 7.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.371 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' HG21 ' A' ' 38' ' ' THR . 29.6 Cg_endo -63.81 82.18 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.628 2.219 . . . . 0.0 112.414 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.448 HG23 HD22 ' A' ' 29' ' ' LEU . 18.8 mt -67.43 139.54 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.666 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt-10 -126.3 -177.55 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.561 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -104.96 132.73 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.664 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -127.28 -32.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.328 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.664 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.7 m-70 -139.78 134.22 31.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.88 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -89.54 55.28 3.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . 177.08 -155.35 17.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.256 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 58.1 3.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.401 . . . . 0.0 110.606 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 13.2 mttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.918 0.39 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.39 40.16 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.109 2.54 . . . . 0.0 112.202 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.94 -169.5 3.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.838 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 141.29 75.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 89.7 Cg_endo -83.09 163.69 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.033 2.489 . . . . 0.0 112.597 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.5 tp -84.73 53.33 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.482 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 5.0 mt 68.57 96.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.29 -83.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.198 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -164.78 154.28 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.37 32.83 5.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.491 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -79.06 -104.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.247 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.43 91.67 0.09 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.19 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -129.46 53.32 11.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.1 Cg_endo -49.79 116.03 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.736 2.957 . . . . 0.0 113.902 -177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 26' ' ' ALA . 14.2 m -129.6 124.83 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.865 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.38 134.74 37.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.937 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.02 142.24 17.41 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.325 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.08 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.359 -0.92 . . . . 0.0 109.035 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' SER . 8.7 t70 167.58 -28.11 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.422 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 108.81 22.88 6.74 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.626 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.3 mp -123.21 152.54 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.56 0.695 . . . . 0.0 112.458 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 14.1 m -111.07 98.56 7.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.072 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' HD23 ' A' ' 29' ' ' LEU . 28.9 m-85 -81.09 138.95 35.93 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.986 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.63 -27.54 19.31 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.948 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 62.7 m-80 -164.08 148.41 10.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' N ' HG22 ' A' ' 15' ' ' VAL . . . -55.68 -26.96 47.48 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 62.7 m -73.81 -37.79 64.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.855 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.1 mtt -67.5 -19.33 65.31 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.866 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -72.13 -57.5 4.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.015 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER -50.77 -31.43 16.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.59 -26.11 70.62 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.82 -59.57 2.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.019 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.485 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -54.32 -23.62 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.787 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' ARG . 11.9 p -89.96 -44.02 10.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.805 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.68 -30.16 59.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.964 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -73.76 -91.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.941 0.4 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.46 -35.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.372 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.23 116.11 64.26 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 49.0 Cg_endo -69.3 74.83 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.749 2.299 . . . . 0.0 112.328 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.81 177.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.3 mm-40 -134.69 -177.6 4.69 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.009 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -103.63 132.88 49.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 110.251 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.653 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 14.6 p -123.59 -40.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.235 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.653 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.7 m-70 -133.81 134.46 42.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.551 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 55.52 2.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -176.1 -145.08 5.41 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.203 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' CYS . 3.7 ptt85 -90.54 56.65 3.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 10.6 tttt . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 1' ' ' LYS . 34.2 Cg_endo -64.34 -173.18 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.327 2.018 . . . . 0.0 112.457 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 4' ' ' CYS . 13.9 m-20 -163.67 174.93 11.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -28.55 141.64 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.117 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 71.3 Cg_endo -94.96 -173.66 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.252 2.634 . . . . 0.0 112.426 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.75 57.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.8 mt 63.63 97.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.097 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.84 -85.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.2 t -170.68 -177.77 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 111.987 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' ' OG1' ' A' ' 9' ' ' THR . 2.8 ptt? -115.28 20.69 14.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.486 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.18 67.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.45 89.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.404 -178.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.39 61.05 14.33 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.9 Cg_endo -49.48 114.82 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.598 2.866 . . . . 0.0 112.942 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG22 ' CA ' ' A' ' 26' ' ' ALA . 16.7 m -119.04 133.64 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.424 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 117.83 19.55 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.57 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -98.42 134.48 11.72 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.079 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.548 ' HB3' ' CB ' ' A' ' 41' ' ' GLU . 30.8 t -51.34 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.412 0.713 . . . . 0.0 109.177 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 174.11 -31.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.491 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.11 30.63 2.24 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.678 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 15.6 mm -142.38 142.64 27.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -97.55 100.59 12.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.104 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.632 ' CD2' HD23 ' A' ' 29' ' ' LEU . 32.8 m-85 -79.97 142.49 35.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.367 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.71 -22.31 2.7 Favored Glycine 0 CA--C 1.507 -0.444 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 2.8 m-20 -173.04 146.15 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.882 0.372 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' CA ' HG22 ' A' ' 15' ' ' VAL . . . -52.91 -28.61 24.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.27 0.557 . . . . 0.0 109.518 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 88.9 m -71.79 -41.03 68.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.753 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 13.4 mtp -62.91 -23.43 67.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.959 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 HD23 ' CD2' ' A' ' 23' ' ' TYR . 1.2 mt -69.83 -48.62 58.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.43 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 7.2 mt -50.57 -33.51 22.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . -68.62 -31.16 73.18 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.13 -65.11 0.88 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.175 0.512 . . . . 0.0 109.9 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.552 ' CA ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -48.49 -27.88 2.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 16.5 t -75.1 -30.82 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.933 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -55.07 -35.89 65.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.465 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . 8.1 t -100.68 -64.14 1.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.795 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 33' ' ' SER . 20.9 t0 179.68 -69.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.154 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.552 ' H ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 t -160.87 37.26 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.769 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HD3' ' H ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -89.04 31.82 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 112.944 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' CD2' ' A' ' 29' ' ' LEU . 1.1 mm -138.06 133.06 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' CB ' ' HB3' ' A' ' 18' ' ' SER . 1.2 tt0 -127.81 -178.1 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.693 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.605 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -117.1 142.38 47.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.919 0.39 . . . . 0.0 110.73 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.584 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -127.06 -49.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.584 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.42 153.56 45.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.287 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -95.3 58.83 2.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.91 -153.78 15.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.9 57.77 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.625 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.519 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.007 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.41 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.2 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.269 2.646 . . . . 0.0 112.672 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.1 p-10 -142.78 170.09 16.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 4.9 m -31.8 141.87 0.15 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 54.8 Cg_endo -89.85 -165.6 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.227 2.618 . . . . 0.0 112.998 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 11.9 mt -133.96 57.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.205 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 7.2 mt 70.15 99.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.992 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -82.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.821 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 10' ' ' MET . 2.5 t -146.4 -39.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.718 0.294 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.46 11.85 4.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.596 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.7 -76.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.436 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.84 96.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.586 0.708 . . . . 0.0 112.399 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.7 t0 -138.96 51.3 3.31 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.0 Cg_endo -47.76 109.37 0.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.924 3.082 . . . . 0.0 113.516 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 26' ' ' ALA . 34.5 m -118.39 136.79 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 120.0 22.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.993 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -104.47 137.88 13.83 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.868 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 t -47.92 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.392 0.701 . . . . 0.0 109.395 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER 168.46 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.555 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.99 32.98 3.35 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.682 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.1 mm -137.68 132.49 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.839 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -89.26 98.01 11.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.149 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.624 ' CG ' ' HG ' ' A' ' 29' ' ' LEU . 56.8 m-85 -79.46 134.45 36.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.512 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -36.41 -31.94 0.05 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.551 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 55.8 m-80 -164.8 147.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.97 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.51 ' HA ' HG23 ' A' ' 15' ' ' VAL . . . -54.5 -27.2 36.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.282 0.563 . . . . 0.0 109.574 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.7 m -74.65 -40.14 61.65 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.404 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.486 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -59.63 -21.79 60.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.949 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' ' CG ' ' A' ' 23' ' ' TYR . 1.6 mt -75.91 -52.92 9.26 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.387 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 11.6 mt -49.0 -28.84 4.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -76.69 -32.03 51.81 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.512 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 36' ' ' SER . . . -79.77 -52.36 8.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.36 -0.42 . . . . 0.0 112.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.468 ' HB3' HD12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -61.68 -31.31 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.49 -23.38 22.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.6 mtt180 -113.82 8.77 17.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -100.97 -98.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -161.31 -40.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.64 131.83 21.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.745 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.87 72.67 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.548 2.165 . . . . 0.0 112.372 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.566 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.95 170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.1 mt-10 -134.13 -176.22 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.624 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -121.54 132.05 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.281 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.624 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -117.07 -38.61 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.217 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -146.17 147.07 31.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -94.87 57.7 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.303 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -174.44 -154.64 11.14 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.282 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.35 56.82 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.644 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.937 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.27 39.76 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.023 2.482 . . . . 0.0 112.477 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 58.3 p30 -126.26 150.49 48.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.062 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.467 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 73.9 m -80.53 127.58 75.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.007 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 92.4 Cg_endo -90.54 173.6 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.173 2.582 . . . . 0.0 112.753 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.43 74.32 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.733 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mp 74.64 143.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.094 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -101.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 11' ' ' GLN . 9.8 t -173.12 -143.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.497 0.589 . . . . 0.0 110.863 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.559 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER 35.48 35.84 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' C ' ' O ' ' A' ' 10' ' ' MET . 3.2 tm0? -0.91 -64.25 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.25 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -121.33 84.48 2.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.719 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 10' ' ' MET . 4.7 t70 -123.5 61.88 22.12 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.4 Cg_endo -50.13 105.4 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.381 2.721 . . . . 0.0 113.348 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.6 m -118.84 122.59 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.269 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.49 128.8 34.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.805 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.561 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -110.78 144.42 17.25 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.782 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -50.38 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.709 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 170.43 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.767 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.61 31.52 3.42 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.212 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 14.0 mm -133.4 143.39 39.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.0 m -103.28 98.55 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.283 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.607 ' CE1' HD21 ' A' ' 29' ' ' LEU . 20.6 m-85 -81.46 141.8 33.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.08 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 25' ' ' ASN . . . -58.86 -12.5 14.97 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.446 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 10' ' ' MET . 50.5 t-20 178.61 149.55 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.396 . . . . 0.0 110.634 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.28 -30.72 18.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 1.5 m -76.02 -39.5 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.131 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG3' ' HB3' ' A' ' 25' ' ' ASN . 12.1 mtp -63.74 -17.56 63.14 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.609 ' CD1' ' CD2' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -71.3 -55.2 8.51 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.692 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -48.15 -31.73 6.04 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.467 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -71.41 -31.68 65.61 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.37 -55.52 4.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.193 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.586 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -48.24 -38.51 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 110.574 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.09 -29.64 34.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.6 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 7.4 ptm180 -84.92 -18.77 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.5 t -82.67 -96.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.636 0.255 . . . . 0.0 111.11 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 179.11 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -111.08 124.54 32.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.09 87.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.937 2.425 . . . . 0.0 112.99 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -67.07 175.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 26.1 mt-10 -138.94 -177.61 4.96 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.587 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -100.81 139.39 36.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.652 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -134.8 -43.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.317 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.652 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.4 m-70 -125.16 126.82 45.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -85.98 58.17 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 176.8 -144.29 6.78 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.865 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -90.61 58.45 3.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.892 0.377 . . . . 0.0 110.957 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.129 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 1' ' ' LYS . 72.3 Cg_exo -49.01 -168.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.685 2.257 . . . . 0.0 112.572 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 5.5 p-10 -167.45 166.88 14.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 92.1 m -64.85 125.78 89.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.896 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HG3' HD13 ' A' ' 30' ' ' LEU . 98.2 Cg_endo -86.91 -171.9 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.957 2.438 . . . . 0.0 112.847 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -118.62 62.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.347 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 10.4 mt 67.4 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.333 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.59 -83.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 t -161.95 161.8 28.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.092 0.472 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.0 25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.401 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' TYR . 36.9 mt-30 -83.66 63.44 7.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.81 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.6 99.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.769 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -133.43 64.85 70.56 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.0 Cg_endo -50.31 121.82 8.34 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.256 2.637 . . . . 0.0 113.067 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.539 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 10.5 m -127.3 132.87 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.728 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.88 123.0 26.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.16 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 135.99 12.5 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.203 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . 12.0 t -49.43 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.097 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' GLY . 5.1 t0 169.15 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.845 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.24 31.79 2.97 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.729 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 mm -138.05 129.43 38.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 55.1 m -89.84 100.1 12.98 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.626 ' CE2' HD22 ' A' ' 29' ' ' LEU . 36.4 m-85 -79.34 163.84 24.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.253 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -69.42 -20.24 75.16 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.703 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 42.6 m-20 -174.23 147.96 1.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 110.878 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 30' ' ' LEU . . . -53.31 -25.16 13.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.023 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 18.2 m -76.64 -37.7 55.87 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 7.9 mtt -68.07 -18.94 64.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.974 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.626 HD22 ' CE2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -73.26 -60.84 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.905 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.524 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -48.79 -29.59 4.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -75.04 -28.77 61.76 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.87 -53.13 5.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.995 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -55.39 -34.53 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.156 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -76.12 -45.73 32.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.656 0.265 . . . . 0.0 111.132 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -87.74 9.4 21.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -97.71 -95.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.604 0.24 . . . . 0.0 111.517 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -180.0 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.404 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.42 144.45 28.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.27 78.53 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.723 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.479 HD12 HG22 ' A' ' 40' ' ' ILE . 3.7 mt -65.72 149.43 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.557 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mt-10 -137.12 -177.09 4.61 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.794 0.331 . . . . 0.0 111.517 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.68 132.94 52.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -121.76 -45.14 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.592 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER -132.8 138.75 47.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.906 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -91.78 57.59 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 179.14 -154.27 13.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.115 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 57.32 3.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.846 0.355 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.765 0.317 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' CYS . 37.3 Cg_endo -65.82 -161.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.71 2.274 . . . . 0.0 111.848 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.62 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 1.2 m-20 -49.88 82.96 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -116.91 162.72 25.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.768 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 31' ' ' GLY . 74.1 Cg_endo -79.22 131.72 9.9 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.649 2.232 . . . . 0.0 112.836 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.89 45.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 mt 44.76 86.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -78.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 156.63 8.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.33 17.52 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.517 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 5.8 tt0 -72.66 65.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.39 103.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.484 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -132.31 68.37 79.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.4 Cg_endo -58.87 93.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.132 2.555 . . . . 0.0 113.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 14.7 m -109.97 128.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.317 0.579 . . . . 0.0 111.178 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -79.9 130.68 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.78 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.3 149.9 18.7 Favored Glycine 0 C--O 1.25 1.111 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.152 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 t -48.59 93.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.067 -1.066 . . . . 0.0 109.586 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' SER . 10.3 t0 170.69 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.017 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.81 33.92 3.16 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.689 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 23' ' ' TYR . 26.5 mm -140.15 139.13 36.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 119.493 -0.883 . . . . 0.0 113.223 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 54.4 m -91.14 114.38 26.89 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.065 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.663 ' CG ' ' HB3' ' A' ' 29' ' ' LEU . 26.9 m-85 -99.92 135.7 40.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -49.12 -26.05 5.95 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.827 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -167.28 138.43 3.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.948 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . -55.72 -19.31 10.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 10.8 m -81.11 -33.98 32.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.32 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.478 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 3.0 mtt -73.57 -40.01 64.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.154 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.663 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -81.75 -17.82 46.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.445 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.07 -41.41 99.43 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -64.46 -35.65 92.21 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -57.72 -34.59 69.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.875 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -51.86 33.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 3.7 t -63.64 -26.83 68.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 5.0 ptm180 -80.04 -39.27 30.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.6 t -76.09 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t0 179.66 -33.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -94.49 117.66 66.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' ILE . 43.0 Cg_endo -68.22 75.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.335 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.555 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.28 176.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.43 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.8 mm-40 -137.84 -177.16 4.69 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.377 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.13 132.1 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.65 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 12.0 p -122.63 -35.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.064 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.65 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.3 m-70 -136.11 140.39 43.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 57.58 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.96 -143.33 6.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -90.12 57.54 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.112 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.881 0.372 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.73 -165.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.878 2.385 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 4' ' ' CYS . 41.2 m-20 -131.91 165.61 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -27.43 124.63 0.23 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.534 ' CG ' HD11 ' A' ' 30' ' ' LEU . 63.0 Cg_endo -94.3 -163.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.442 2.761 . . . . 0.0 112.159 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 tp -124.07 61.39 1.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 68.73 107.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.19 -75.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -161.36 165.99 28.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.062 0.458 . . . . 0.0 111.68 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.9 mmm -100.87 23.91 9.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.438 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 2.0 mt-30 -83.18 61.29 6.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -20.4 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.494 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -123.35 60.91 18.69 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.6 Cg_endo -47.83 116.29 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.403 2.736 . . . . 0.0 112.773 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.477 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 16.1 m -125.4 129.73 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.577 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.37 127.21 31.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.571 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -107.7 140.54 15.44 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.333 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.75 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.631 -0.785 . . . . 0.0 109.113 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' GLY . 6.0 t70 167.8 -27.97 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.722 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.02 31.81 3.73 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.556 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.2 mm -136.56 135.97 48.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 56.4 m -93.86 98.24 10.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.463 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.612 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 30.4 m-85 -79.53 147.88 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.158 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -56.32 -21.71 34.44 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.215 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 49.5 m-20 -173.69 147.13 1.36 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.667 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' N ' HG23 ' A' ' 15' ' ' VAL . . . -51.77 -27.48 12.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.575 . . . . 0.0 109.772 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.0 m -72.27 -42.62 65.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.683 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.45 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -64.84 -16.38 63.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.102 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' HG ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -75.08 -55.5 5.68 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.232 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 27' ' ' CYS . 1.0 OUTLIER -47.38 -35.89 8.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -73.45 -30.95 61.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.805 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -72.09 -52.25 17.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.755 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.472 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -60.76 -22.52 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.573 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -39.66 36.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.984 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.24 6.4 44.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.491 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t -81.69 -95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.07 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.8 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.69 146.65 62.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.99 94.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 0.0 112.638 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.482 HG21 HD13 ' A' ' 40' ' ' ILE . 18.1 mt -71.86 156.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 4.1 mm-40 -135.46 -176.51 4.3 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.627 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.601 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -115.77 142.03 47.29 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.518 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.551 HG12 ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -137.15 -37.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.467 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.551 ' CE1' HG12 ' A' ' 43' ' ' VAL . 1.5 m-70 -135.4 136.81 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.922 0.391 . . . . 0.0 111.337 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' HG11 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -94.48 57.15 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.869 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.87 -143.54 5.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -90.23 52.97 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.798 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.159 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.867 0.365 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -167.81 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.785 2.323 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p30 -87.57 177.22 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.82 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 87.0 m -86.01 -43.91 0.6 Allowed Pre-proline 0 CA--C 1.529 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.132 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.563 ' CD ' ' HB3' ' A' ' 30' ' ' LEU . 49.6 Cg_endo -103.62 -161.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 113.232 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -162.46 55.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.979 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 8.3 mt 69.74 118.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -110.75 -84.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.1 t -166.87 -175.73 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.471 ' N ' ' OG1' ' A' ' 9' ' ' THR . 43.0 mmm -109.41 17.37 21.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.349 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -69.88 60.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -24.4 96.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.351 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -130.96 66.17 78.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.61 107.08 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.411 2.741 . . . . 0.0 112.902 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.535 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.0 m -109.14 127.4 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.628 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.69 117.94 20.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.824 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -102.32 140.6 14.93 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.063 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 6.7 t -50.18 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.09 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.37 -29.82 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.947 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 114.33 25.7 3.99 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.387 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.7 mp -132.82 154.38 39.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 CA-C-O 121.651 0.739 . . . . 0.0 112.5 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 53.8 m -112.29 99.28 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.047 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CD2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -79.05 135.96 37.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 112.082 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -46.0 -23.45 1.09 Allowed Glycine 0 CA--C 1.506 -0.506 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.272 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 66.8 m-20 -175.55 152.23 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 0.0 110.715 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 30' ' ' LEU . . . -51.85 -28.75 16.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 109.523 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 30' ' ' LEU . 89.8 m -74.43 -42.67 58.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.512 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -61.72 -23.26 66.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.638 HD22 ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.49 -53.72 31.94 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.7 177.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 mp -42.75 -40.41 2.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -67.24 -31.22 76.78 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.251 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.99 -44.17 18.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.589 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.11 -50.46 73.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 111.13 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 12.4 m -74.83 -26.5 59.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 13.1 mmm180 -94.0 -13.07 27.4 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 40.5 t -79.1 -93.08 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.819 0.342 . . . . 0.0 111.127 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.37 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.459 . . . . 0.0 110.116 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.33 127.09 26.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.539 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.79 92.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.444 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -66.1 167.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.405 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 17.6 mt-10 -123.67 -177.46 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.82 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -120.77 134.59 55.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.109 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -119.88 -46.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.481 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -147.78 126.69 12.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.803 0.335 . . . . 0.0 111.09 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' HG13 ' A' ' 15' ' ' VAL . 74.4 mttt -74.56 67.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.48 -164.75 30.49 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.057 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 53.0 2.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.998 0.427 . . . . 0.0 110.665 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.122 179.839 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.99 -173.38 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.822 2.348 . . . . 0.0 112.129 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -172.08 155.31 3.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.272 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -29.27 149.17 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.929 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 74.5 Cg_endo -93.03 177.69 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.166 2.577 . . . . 0.0 112.215 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -102.88 48.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.437 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 27.2 mt 68.17 98.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -89.97 -82.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.167 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -170.76 138.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.63 29.03 3.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.603 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 -104.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.651 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 101.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.442 0.639 . . . . 0.0 112.444 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -139.32 50.08 2.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.5 Cg_endo -48.59 114.19 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.626 2.884 . . . . 0.0 113.278 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.52 HG22 ' CA ' ' A' ' 26' ' ' ALA . 16.1 m -127.03 134.59 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.97 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.51 121.65 24.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.911 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.16 134.56 11.9 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -51.72 96.62 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.611 0.719 . . . . 0.0 110.116 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' SER . 62.1 t0 172.53 -29.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.716 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.71 2.04 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.257 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.2 mm -138.59 146.79 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -107.45 98.2 7.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.287 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.624 ' CG ' ' HG ' ' A' ' 29' ' ' LEU . 28.8 m-85 -82.39 139.76 33.87 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.404 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -47.74 -31.29 7.38 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.642 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.57 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 63.7 m-20 -160.09 144.94 14.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.514 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' CA ' HG22 ' A' ' 15' ' ' VAL . . . -54.6 -30.11 53.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.675 0.75 . . . . 0.0 109.236 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 88.8 m -72.45 -38.69 68.2 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.851 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.501 ' HE1' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -61.32 -18.56 59.15 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' ' CG ' ' A' ' 23' ' ' TYR . 1.3 mt -74.98 -51.47 13.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.257 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 2.4 mt -47.71 -32.72 6.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' CD ' ' A' ' 35' ' ' ARG . . . -75.56 -32.24 54.96 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.09 -55.61 9.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.239 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.67 -27.08 66.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.284 0.564 . . . . 0.0 109.586 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 t -82.22 -15.95 51.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.258 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -92.86 -32.53 14.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.272 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -94.76 -111.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.137 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -176.32 30.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.78 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 m -142.8 114.69 6.02 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.33 78.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.68 2.253 . . . . 0.0 112.684 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CD1' ' OG ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -59.31 168.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.2 mt-10 -126.56 -177.27 3.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.446 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.8 137.42 53.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.587 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -119.47 -52.04 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.487 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.21 151.65 50.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.067 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' HG11 ' A' ' 15' ' ' VAL . 3.3 mmtt -95.24 61.75 2.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.72 -153.54 14.26 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.39 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -83.65 55.9 3.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.6 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.009 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.3 mttm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 48.0 Cg_endo -84.09 42.58 1.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 123.13 2.553 . . . . 0.0 112.302 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 122.91 28.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.34 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -39.6 -62.11 0.9 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.322 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 4' ' ' CYS . 33.8 Cg_endo -97.5 -164.49 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.94 2.427 . . . . 0.0 113.921 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.87 55.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.666 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 1.1 mp 71.44 160.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.508 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.79 -166.81 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.332 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.15 157.06 37.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.11 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtt -91.77 18.22 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.898 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -72.29 60.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.08 98.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.457 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -123.62 61.49 22.09 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.06 109.68 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.106 2.537 . . . . 0.0 112.093 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.38 125.48 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 111.175 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 118.49 20.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.214 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -97.95 136.51 12.77 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.931 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -53.18 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.614 179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 177.25 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.372 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.14 31.29 1.44 Allowed Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.91 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.6 mm -142.0 142.86 27.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.5 m -101.35 98.85 9.17 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.991 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.621 ' CE1' HD22 ' A' ' 29' ' ' LEU . 28.2 m-85 -80.0 159.21 26.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -67.08 -10.8 57.39 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.972 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 6.5 p30 165.99 156.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.34 -24.98 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.173 0.511 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 8.8 m -74.84 -49.44 20.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.773 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.522 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -61.38 -21.99 64.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.9 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -66.84 -59.18 3.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.581 ' CD1' ' HB3' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -53.88 -29.39 41.42 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.97 75.64 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -79.5 -52.7 7.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.752 -0.724 . . . . 0.0 110.06 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.437 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -52.74 -35.92 56.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.286 179.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -74.18 -35.03 63.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.404 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 4.7 ptm180 -73.52 -27.66 61.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.403 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 t -83.38 -94.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.338 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t0 179.69 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.43 147.84 34.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.909 0.385 . . . . 0.0 111.175 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.66 79.7 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.963 2.442 . . . . 0.0 112.416 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 HG22 HD21 ' A' ' 29' ' ' LEU . 74.4 mt -44.19 152.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.474 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 22.7 mt-10 -123.34 -177.29 3.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.345 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -118.82 147.27 44.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -133.89 -43.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.55 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -142.23 135.97 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.04 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -88.99 66.36 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.08 -155.38 16.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.166 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.09 54.1 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 0.0 110.515 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.811 0.338 . . . . 0.0 111.201 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 1' ' ' LYS . 64.9 Cg_exo -51.87 -160.16 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.814 2.342 . . . . 0.0 112.48 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' N ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -79.81 45.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.844 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 1.6 m -117.58 139.48 26.3 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.8 Cg_endo -103.14 42.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.492 2.795 . . . . 0.0 113.189 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 5' ' ' PRO . 9.8 mt 28.7 49.58 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.229 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 13.6 mm 68.72 161.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.746 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.12 -166.53 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.462 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 10' ' ' MET . 0.7 OUTLIER -69.63 179.21 2.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.339 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.47 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.31 28.66 8.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.503 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 4.1 mm-40 -80.85 62.98 5.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.275 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.63 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.159 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -122.8 63.75 21.29 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.8 Cg_endo -49.06 101.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.077 2.518 . . . . 0.0 112.192 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.507 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 33.3 m -108.0 126.63 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.308 0.575 . . . . 0.0 110.921 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.85 121.87 25.37 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.733 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -99.88 137.33 13.19 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.229 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -50.25 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.803 0.811 . . . . 0.0 109.376 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' OD2' ' OH ' ' A' ' 23' ' ' TYR . 2.5 p30 172.12 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.477 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.08 31.44 2.25 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.643 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 33.0 mm -137.8 138.86 43.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.5 m -99.13 102.93 14.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.357 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.651 ' CD2' HD22 ' A' ' 29' ' ' LEU . 21.0 m-85 -84.34 143.01 29.77 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.381 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -53.75 -16.59 5.78 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.374 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 15.6 m-20 177.41 150.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.16 -29.4 21.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 56.6 m -73.65 -39.84 64.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.268 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.439 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.45 -25.78 68.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -65.77 -54.37 28.02 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.252 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 5.8 mt -48.71 -39.98 26.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -59.6 -31.92 72.25 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -73.72 -57.39 4.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.451 -0.874 . . . . 0.0 110.699 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.531 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 30.3 t -56.74 -50.49 72.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.605 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -61.08 -27.41 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.923 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.1 mtp180 -109.79 8.95 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 27.9 t -104.35 -98.98 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.505 0.193 . . . . 0.0 111.463 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.6 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 131.62 22.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 59.8 Cg_endo -71.12 82.24 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.623 2.215 . . . . 0.0 112.277 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG13 HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -54.84 174.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.665 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 37.7 mt-10 -131.16 -177.65 4.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.507 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -113.03 132.25 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.194 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.561 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -111.85 -51.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.383 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.561 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.36 129.93 17.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.875 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 62.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.42 -168.59 33.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.13 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -80.3 51.71 1.46 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.741 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.022 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.549 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.87 0.366 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 56.1 Cg_endo -95.88 -163.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.492 2.795 . . . . 0.0 112.374 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 mp -132.09 58.54 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 61.2 mt 65.1 102.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.38 -84.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -169.5 178.98 3.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.235 0.541 . . . . 0.0 112.119 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.421 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -110.58 11.67 22.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.226 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.71 67.6 1.6 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.1 96.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.409 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -120.78 58.93 7.09 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 Cg_endo -48.77 115.55 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.646 2.897 . . . . 0.0 113.442 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.8 m -121.99 133.59 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 119.36 22.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.823 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -106.12 139.63 14.87 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.048 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 19.5 t -49.71 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.243 -0.979 . . . . 0.0 109.585 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 5.5 t0 170.48 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.352 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.55 2.98 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.607 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.2 mm -139.05 141.55 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.12 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -96.86 99.02 10.6 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.995 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.011 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.4 m-85 -82.26 138.94 34.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -40.69 -29.27 0.25 Allowed Glycine 0 CA--C 1.505 -0.593 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.717 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 10.1 p30 -173.89 147.01 1.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.088 0.471 . . . . 0.0 110.833 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.608 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -49.57 -26.24 3.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.513 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.1 m -72.66 -43.44 63.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.43 0.633 . . . . 0.0 110.222 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 1.8 mmm -61.46 -17.57 55.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.169 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 40' ' ' ILE . 1.8 mt -76.62 -50.52 13.6 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.598 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -48.61 -34.71 12.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.268 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -34.01 67.33 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -71.32 -61.69 1.68 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.619 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.823 ' N ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -48.79 -28.46 3.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.135 0.493 . . . . 0.0 110.017 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -73.42 -32.3 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.603 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.27 56.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 7.7 t -108.91 -71.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -173.78 -36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.211 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.64 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.06 174.98 2.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 38' ' ' THR . 56.4 Cg_endo -71.98 92.16 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.549 2.166 . . . . 0.0 112.013 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 29' ' ' LEU . 22.8 pt -83.4 167.28 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.505 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.4 mm-40 -149.38 -176.68 5.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.023 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.3 140.15 48.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.701 0.286 . . . . 0.0 110.812 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.5 -47.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 133.9 36.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.81 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG12 ' A' ' 15' ' ' VAL . 19.6 pttt -86.02 64.72 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.22 -150.01 9.5 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.175 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -90.3 53.9 2.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.818 0.342 . . . . 0.0 110.49 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' OXT' ' O ' ' A' ' 47' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.958 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.823 0.344 . . . . 0.0 110.525 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 88.8 Cg_endo -78.16 -169.45 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.68 2.253 . . . . 0.0 112.211 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -125.66 64.0 1.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.648 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.3 mp 70.37 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -84.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.947 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -152.7 172.7 16.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -104.13 16.68 25.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' TYR . 84.8 mt-30 -73.66 59.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -25.66 92.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.132 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.916 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -121.9 65.51 19.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.186 178.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.3 Cg_endo -49.02 96.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.182 2.588 . . . . 0.0 112.053 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.2 m -105.58 131.64 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.409 0.623 . . . . 0.0 111.186 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.502 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.575 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -105.12 142.79 15.56 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.598 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 12.5 m -47.92 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.686 0.874 . . . . 0.0 109.079 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.754 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER 168.73 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.457 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.95 33.54 2.78 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.975 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.0 mm -140.71 139.36 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.988 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 9.2 m -94.84 100.93 12.73 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.606 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.828 ' CE1' HD21 ' A' ' 29' ' ' LEU . 21.6 m-85 -83.87 139.73 32.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.391 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -48.56 -20.75 1.77 Allowed Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 36.5 m-20 -177.92 150.76 0.64 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.04 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.623 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.5 m -73.32 -43.92 59.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.731 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -63.31 -19.98 65.08 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.693 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.952 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -68.64 -59.4 3.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.098 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -46.44 -33.12 3.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.12 -37.67 55.46 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.82 -54.46 15.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.313 -0.443 . . . . 0.0 110.848 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.31 -25.42 64.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.523 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLY . 1.5 p -75.81 -32.04 59.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 0.0 110.716 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -107.91 11.78 27.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 t -87.65 -93.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.226 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.87 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.32 . . . . 0.0 110.955 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -129.49 158.75 72.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.868 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 29.4 Cg_exo -62.22 89.68 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.831 2.354 . . . . 0.0 112.491 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' A' ' 19' ' ' ASP . 9.0 mt -71.02 149.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 4.6 mt-10 -133.28 -176.63 4.2 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.904 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -102.38 132.33 48.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 44' ' ' HIS . 9.6 p -123.44 -34.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.898 ' CE1' HG22 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -146.51 142.73 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.345 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 61.09 2.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 110.83 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.29 -153.87 11.87 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -90.3 53.89 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 110.603 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.06 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.781 0.324 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 61.2 Cg_endo -75.31 156.79 41.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.785 2.323 . . . . 0.0 113.62 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 1.1 tt 172.61 40.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt 61.68 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.223 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.34 -83.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.92 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -114.68 131.97 56.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.8 17.08 18.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.143 0.497 . . . . 0.0 110.296 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' TYR . 9.1 mt-30 -102.91 71.86 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.253 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.572 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -124.51 62.01 30.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.99 112.96 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.346 2.697 . . . . 0.0 112.978 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.013 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.9 m -121.02 130.53 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.747 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 128.13 33.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.367 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -105.52 137.57 13.81 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.124 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -50.55 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.578 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' SER . 21.1 t70 170.4 -29.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.832 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.99 33.14 2.25 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.607 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.6 mm -137.56 132.28 44.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.4 m -93.25 102.78 15.06 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.666 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.1 m-85 -81.47 166.58 20.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.218 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -78.71 -13.59 82.98 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.842 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 29.2 m-20 -179.4 149.81 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.632 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.54 5.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.454 0.645 . . . . 0.0 109.281 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.835 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -75.4 -45.62 37.9 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.991 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -55.89 -30.02 60.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.36 -51.07 65.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.887 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.835 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.4 pp -47.0 -39.9 13.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' ARG . . . -65.28 -35.65 91.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.873 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -60.33 -45.99 91.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.743 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.507 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.27 -50.34 73.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.849 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 15.6 t -70.12 -35.09 73.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.87 -32.93 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.725 0.298 . . . . 0.0 111.25 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 t -88.19 -93.68 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.779 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.81 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.043 0.449 . . . . 0.0 110.389 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.506 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -90.51 136.15 28.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.818 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 3.0 Cg_exo -74.68 64.29 5.73 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -44.05 166.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt-10 -132.45 -177.63 4.56 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.47 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -106.33 132.4 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.134 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.767 HG22 ' CD2' ' A' ' 44' ' ' HIS . 7.4 p -127.4 -42.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.463 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.767 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -128.38 115.35 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.835 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 15' ' ' VAL . 1.4 mtmt -76.62 53.53 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.35 -147.21 5.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 57.25 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 110.464 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.866 0.365 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.2 Cg_endo -93.17 42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.172 2.581 . . . . 0.0 112.627 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 5' ' ' PRO . 3.7 mt 27.02 61.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.88 102.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -90.68 -86.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 10' ' ' MET . 9.7 t -171.58 -154.57 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.52 ' O ' ' C ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -107.41 -47.88 3.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.335 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER 9.15 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.13 0.894 . . . . 0.0 111.892 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -32.41 90.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.302 0.572 . . . . 0.0 111.362 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.884 ' O ' HG13 ' A' ' 15' ' ' VAL . 37.5 t0 -129.91 57.01 27.74 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.291 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.26 87.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.051 2.501 . . . . 0.0 112.076 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 13' ' ' ASP . 14.0 m -91.95 127.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.413 0.625 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.48 115.08 17.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.485 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.25 140.41 14.86 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.762 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -51.21 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.379 -0.911 . . . . 0.0 109.905 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.01 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.171 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.68 33.56 1.7 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.329 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -140.39 152.54 21.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 97.2 m -109.51 98.36 7.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.974 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 39.3 m-85 -80.8 134.74 35.84 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.67 -23.62 0.19 Allowed Glycine 0 CA--C 1.507 -0.423 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.426 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 28' ' ' MET . 14.1 p30 -178.52 149.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.271 0.557 . . . . 0.0 111.142 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.14 -24.49 4.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.484 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 10.0 m -74.22 -39.96 62.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.25 0.548 . . . . 0.0 110.402 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.03 -21.64 66.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.89 -179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 2.2 mt -75.13 -51.54 13.2 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 92.9 mt -48.86 -33.79 11.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.01 -27.4 64.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.856 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.03 -54.76 5.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.498 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -26.66 68.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 7.0 p -84.07 -31.39 25.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.634 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 9.1 mmm180 -100.71 3.64 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.594 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 38.4 t -93.89 -98.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' SER . 8.9 t70 179.11 -31.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.973 0.416 . . . . 0.0 110.644 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.0 m -115.68 103.4 53.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.253 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.27 92.75 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.102 2.535 . . . . 0.0 112.943 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.857 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.48 177.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.415 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.9 mt-10 -135.92 -177.86 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.531 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.891 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.68 137.11 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.081 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.47 -53.14 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.303 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 148.66 52.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -93.3 56.71 2.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.748 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' PRO . . . -178.69 -156.21 16.48 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.266 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.03 56.78 3.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.33 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.923 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' C ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.004 0.43 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 97.6 Cg_endo -93.31 -162.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.266 2.644 . . . . 0.0 113.112 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 6' ' ' LEU . 1.3 pt? -159.69 51.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.902 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm 60.72 87.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.426 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -80.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.5 t -168.63 -179.41 3.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.161 0.505 . . . . 0.0 111.77 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.3 OUTLIER -111.24 21.36 16.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.251 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 12' ' ' TYR . 7.3 mm-40 -78.23 59.7 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.929 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -21.43 94.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.496 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -123.37 65.94 32.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.58 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.349 2.699 . . . . 0.0 112.907 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.7 m -108.84 131.09 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.09 114.56 17.08 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.132 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -96.97 134.33 11.73 Favored Glycine 0 C--O 1.25 1.094 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.991 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -56.81 90.96 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.851 0.834 . . . . 0.0 109.32 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' GLY . 4.1 t70 -175.97 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.16 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.13 26.77 0.88 Allowed Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.324 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -148.09 168.83 3.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 21' ' ' ILE . 30.3 m -119.79 99.3 6.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.088 -1.414 . . . . 0.0 109.356 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.825 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 16.1 m-85 -82.8 136.17 34.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -43.81 -26.98 0.86 Allowed Glycine 0 CA--C 1.506 -0.515 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.752 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 76.3 m-20 -169.79 146.82 3.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -51.22 -28.35 11.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.659 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.626 ' HA ' HD12 ' A' ' 30' ' ' LEU . 95.1 m -73.38 -44.23 59.01 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.741 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.53 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 3.1 mtp -61.31 -19.82 62.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -70.19 -47.14 62.83 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.82 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.97 -36.62 12.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' NE ' ' A' ' 35' ' ' ARG . . . -71.27 -31.54 66.07 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.54 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -72.21 -56.5 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.089 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -41.01 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 109.646 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.02 -39.74 79.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.871 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 31' ' ' GLY . 10.0 mtt180 -74.66 -22.31 58.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.02 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -86.13 -99.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.536 0.207 . . . . 0.0 110.99 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.54 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.996 0.427 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.77 159.51 29.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.28 83.92 2.15 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.808 2.338 . . . . 0.0 112.588 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.807 HG21 HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -38.45 152.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.756 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.5 mm-40 -119.21 -179.74 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.428 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.843 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -126.31 137.36 53.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.608 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.553 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -115.65 -45.4 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.148 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.553 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -144.5 125.13 14.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -75.04 58.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -176.56 -153.48 10.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.95 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -87.48 56.44 3.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' HD12 ' A' ' 30' ' ' LEU . 8.8 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.933 0.396 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 90.7 Cg_endo -91.39 179.12 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.882 2.388 . . . . 0.0 113.579 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 6' ' ' LEU . 1.8 pt? -165.11 41.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.375 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt 58.08 86.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.282 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -85.3 -70.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.795 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -165.74 151.96 9.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.23 23.72 7.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -83.04 64.71 7.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.67 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.27 95.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.578 -178.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.1 t0 -123.55 63.07 25.51 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.081 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.6 Cg_endo -50.04 102.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.142 2.561 . . . . 0.0 112.351 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.4 m -108.74 139.37 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.914 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.93 117.11 19.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.39 134.3 11.67 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.838 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -51.55 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.698 -0.751 . . . . 0.0 109.557 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 177.23 -35.66 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.789 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.47 33.38 0.95 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.863 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.3 mt -146.06 157.99 11.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 85.9 m -110.01 98.35 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.195 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.845 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.4 m-85 -82.18 134.76 35.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -42.17 -27.14 0.4 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.774 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 76.3 m-20 -168.36 146.07 4.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.201 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.52 -28.0 28.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.405 0.621 . . . . 0.0 109.505 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.587 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.9 m -73.37 -40.68 64.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.608 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.49 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.1 mmt -66.99 -15.84 63.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.091 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.035 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -74.03 -61.91 1.69 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.442 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -48.87 -32.1 8.31 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.644 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.546 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -73.18 -31.77 61.14 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.68 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.59 -56.87 4.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.568 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.51 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.96 -32.91 2.99 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 109.792 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -68.6 -47.84 65.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.142 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 4.0 mmm180 -60.38 -26.71 66.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.478 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -87.85 -108.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.322 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -179.52 33.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.878 0.371 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -158.27 124.54 2.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 15.3 Cg_exo -67.85 71.2 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.852 2.368 . . . . 0.0 112.61 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.675 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.43 176.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.825 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' OG ' ' A' ' 18' ' ' SER . 7.5 mt-10 -139.2 -177.21 4.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.561 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.035 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.0 140.67 49.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.5 t -123.66 -43.28 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.4 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.68 149.1 40.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -93.95 61.21 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.16 -149.79 11.07 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.05 56.5 4.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.972 0.415 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.984 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.857 0.36 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 78.0 Cg_endo -98.64 -173.82 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.387 2.724 . . . . 0.0 112.214 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.11 61.74 1.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.681 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mm 63.04 87.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.828 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.98 -79.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.032 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.1 t -169.72 -178.58 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.175 0.512 . . . . 0.0 111.714 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -107.54 11.83 28.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.518 179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 12' ' ' TYR . 19.2 mm100 -66.91 62.37 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.513 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -22.54 94.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -117.34 58.63 2.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.7 Cg_endo -50.39 102.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.359 2.706 . . . . 0.0 112.745 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.05 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.2 m -113.42 123.23 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 116.6 18.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.418 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -95.59 135.65 12.47 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.365 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -50.0 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.692 0.758 . . . . 0.0 109.882 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 171.23 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.78 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.47 33.19 2.54 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -135.31 124.57 41.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -90.15 98.8 11.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.656 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 13.6 m-85 -80.76 148.66 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.91 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -59.16 -11.5 12.74 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.416 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 9.6 p30 163.85 155.23 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.24 -25.22 0.89 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.304 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.837 ' HA ' HD12 ' A' ' 30' ' ' LEU . 63.7 m -77.02 -46.23 24.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.62 0.724 . . . . 0.0 110.009 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -61.95 -22.46 65.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.454 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.656 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -68.05 -49.06 63.72 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.864 177.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.87 -38.32 15.96 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -64.4 -35.55 92.09 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.4 -64.83 0.82 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.099 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.438 ' N ' HD11 ' A' ' 40' ' ' ILE . 30.9 t -46.86 -36.83 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.054 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 13.1 t -54.96 -47.8 74.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.495 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 7.3 mtp180 -143.57 51.18 1.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 13.4 t -97.03 -73.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 110.529 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.71 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.523 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.499 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -152.15 159.62 32.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.233 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 18.4 Cg_endo -59.54 87.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.624 2.216 . . . . 0.0 112.146 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -64.72 145.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.099 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm-40 -113.29 -177.31 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.05 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.08 136.3 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.431 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.8 t -122.3 -49.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.514 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -133.67 143.49 48.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.815 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 15' ' ' VAL . 4.8 pttp -94.23 57.2 2.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.128 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.28 -150.64 7.58 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.013 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -89.43 57.43 3.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.944 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 30' ' ' LEU . 68.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.342 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.536 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 6.0 Cg_endo -48.59 137.52 26.02 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.939 2.426 . . . . 0.0 112.605 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -160.77 44.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.748 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 27.95 105.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -104.04 -79.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.036 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.486 HG21 ' HG2' ' A' ' 11' ' ' GLN . 1.7 t -163.15 -178.44 6.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.901 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 12' ' ' TYR . 1.8 mtm -114.85 10.12 16.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.033 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.3 OUTLIER -67.06 62.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 109.968 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.492 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.43 93.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.433 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -119.87 65.39 9.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.89 108.69 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.019 2.48 . . . . 0.0 112.748 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.92 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.4 m -120.0 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.151 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.592 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.57 117.83 20.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.566 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 139.64 14.5 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.073 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 38.8 t -50.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.808 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CG ' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 171.56 -29.32 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.812 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.17 32.13 3.11 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.372 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 34.1 mm -135.64 133.61 51.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -94.76 98.33 10.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.095 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.749 ' CE1' HD21 ' A' ' 29' ' ' LEU . 24.8 m-85 -79.27 153.27 30.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.939 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' ASN . . . -64.03 -10.14 38.4 Favored Glycine 0 C--N 1.328 0.124 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.5 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 28' ' ' MET . 12.3 p30 166.8 153.31 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 0.0 110.184 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.71 -26.21 2.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HA ' HD23 ' A' ' 30' ' ' LEU . 9.0 m -75.12 -43.87 50.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.546 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.67 -18.53 65.06 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.905 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.17 -57.41 4.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.285 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -49.44 -35.82 20.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 5' ' ' PRO . . . -71.51 -27.85 70.57 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -76.8 -58.75 3.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.563 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.617 ' N ' HD11 ' A' ' 40' ' ' ILE . 3.7 t -42.1 -37.34 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.453 0.644 . . . . 0.0 109.347 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 21.6 t -64.61 -50.52 66.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.406 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 8.9 mmm180 -77.24 -10.47 59.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.049 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -82.65 -96.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 179.18 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.0 110.488 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.636 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -117.76 163.86 22.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.075 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.636 ' HD2' HG22 ' A' ' 38' ' ' THR . 71.7 Cg_endo -77.6 75.61 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.837 2.358 . . . . 0.0 112.048 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 33' ' ' SER . 1.5 pt -52.5 154.01 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.117 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -122.66 -175.99 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.92 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -112.08 132.48 54.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.369 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.23 -53.14 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.258 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.424 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.99 144.8 50.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.923 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -91.36 65.41 5.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 172.63 -159.77 30.61 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.102 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -79.52 55.05 1.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 110.688 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.992 179.808 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 94.5 Cg_endo -94.83 -165.41 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.373 2.716 . . . . 0.0 112.891 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' LEU . 7.9 tp -164.9 52.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.928 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.0 mp 63.71 85.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.225 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -76.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.261 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -169.2 179.09 4.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.071 0.462 . . . . 0.0 111.502 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.52 19.38 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -73.19 58.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.963 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -25.49 97.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.928 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.4 t0 -126.48 61.71 44.64 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.055 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.8 Cg_endo -47.67 93.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.189 2.592 . . . . 0.0 112.035 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.036 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.8 m -102.76 131.85 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 121.64 24.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.328 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -100.73 141.4 15.35 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.39 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 66.3 m -53.29 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.184 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 40' ' ' ILE . 19.9 t70 176.57 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.261 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.33 32.49 1.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.885 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 22' ' ' THR . 6.7 mt -143.7 160.84 16.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 41.5 m -113.03 108.09 16.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 29' ' ' LEU . 15.0 m-85 -93.06 136.32 33.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.323 0.582 . . . . 0.0 112.31 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -47.06 -22.98 1.44 Allowed Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.202 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 61.0 m-20 -174.08 150.38 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.82 -28.9 10.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.348 0.594 . . . . 0.0 109.567 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.83 -45.5 58.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.501 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -60.56 -23.27 64.49 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.36 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -65.29 -50.77 64.45 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.381 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.1 mt -48.97 -36.3 17.21 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -65.2 -29.93 76.56 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.83 -64.67 0.99 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.95 -0.625 . . . . 0.0 110.179 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -30.09 12.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.186 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 7.4 t -63.43 -50.51 69.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.713 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 35' ' ' ARG . 1.2 mmm180 -100.87 18.74 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 9.7 t -103.42 -119.8 0.2 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' SER . 6.3 t70 178.84 29.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.064 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.439 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 2.4 m -160.47 139.66 7.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.371 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 29.6 Cg_endo -63.81 82.18 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.628 2.219 . . . . 0.0 112.414 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 29' ' ' LEU . 18.8 mt -67.43 139.54 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.666 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt-10 -126.3 -177.55 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.036 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -104.96 132.73 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -127.28 -32.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.328 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.895 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.7 m-70 -139.78 134.22 31.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.88 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -89.54 55.28 3.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . 177.08 -155.35 17.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.256 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 58.1 3.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.401 . . . . 0.0 110.606 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 89.7 Cg_endo -83.09 163.69 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.033 2.489 . . . . 0.0 112.597 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.5 tp -84.73 53.33 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.482 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 5.0 mt 68.57 96.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.29 -83.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.198 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -164.78 154.28 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.37 32.83 5.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.491 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -79.06 -104.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.247 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.43 91.67 0.09 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.19 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -129.46 53.32 11.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.1 Cg_endo -49.79 116.03 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.736 2.957 . . . . 0.0 113.902 -177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.2 m -129.6 124.83 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.865 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.38 134.74 37.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.937 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.02 142.24 17.41 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.325 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.08 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.359 -0.92 . . . . 0.0 109.035 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' SER . 8.7 t70 167.58 -28.11 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.422 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.795 ' C ' HD12 ' A' ' 21' ' ' ILE . . . 108.81 22.88 6.74 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.626 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.795 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.3 mp -123.21 152.54 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.56 0.695 . . . . 0.0 112.458 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 14.1 m -111.07 98.56 7.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.072 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.841 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.9 m-85 -81.09 138.95 35.93 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.986 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.63 -27.54 19.31 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.948 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 62.7 m-80 -164.08 148.41 10.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -55.68 -26.96 47.48 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 62.7 m -73.81 -37.79 64.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.855 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.1 mtt -67.5 -19.33 65.31 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.866 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -72.13 -57.5 4.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.015 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -50.77 -31.43 16.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.59 -26.11 70.62 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.82 -59.57 2.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.019 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.881 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -54.32 -23.62 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.787 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' ARG . 11.9 p -89.96 -44.02 10.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.805 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.68 -30.16 59.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.964 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -73.76 -91.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.941 0.4 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.46 -35.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.372 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.23 116.11 64.26 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 49.0 Cg_endo -69.3 74.83 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.749 2.299 . . . . 0.0 112.328 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.897 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.81 177.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.3 mm-40 -134.69 -177.6 4.69 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.009 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.63 132.88 49.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 110.251 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.674 HG22 ' NE2' ' A' ' 44' ' ' HIS . 14.6 p -123.59 -40.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.235 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.674 ' NE2' HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -133.81 134.46 42.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.551 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.767 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.87 55.52 2.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -176.1 -145.08 5.41 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.203 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' CYS . 3.7 ptt85 -90.54 56.65 3.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 71.3 Cg_endo -94.96 -173.66 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.252 2.634 . . . . 0.0 112.426 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.75 57.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.8 mt 63.63 97.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.097 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.84 -85.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.2 t -170.68 -177.77 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 111.987 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' ' OG1' ' A' ' 9' ' ' THR . 2.8 ptt? -115.28 20.69 14.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.486 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.18 67.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.45 89.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.404 -178.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.39 61.05 14.33 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.9 Cg_endo -49.48 114.82 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.598 2.866 . . . . 0.0 112.942 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.944 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.7 m -119.04 133.64 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.424 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.79 117.83 19.55 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -98.42 134.48 11.72 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.079 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' A' ' 41' ' ' GLU . 30.8 t -51.34 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.412 0.713 . . . . 0.0 109.177 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 174.11 -31.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.491 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.11 30.63 2.24 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.678 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 15.6 mm -142.38 142.64 27.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -97.55 100.59 12.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.104 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.859 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.8 m-85 -79.97 142.49 35.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.367 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.71 -22.31 2.7 Favored Glycine 0 CA--C 1.507 -0.444 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 2.8 m-20 -173.04 146.15 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.882 0.372 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -52.91 -28.61 24.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.27 0.557 . . . . 0.0 109.518 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 88.9 m -71.79 -41.03 68.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.753 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.52 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 13.4 mtp -62.91 -23.43 67.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.959 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -69.83 -48.62 58.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.43 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 7.2 mt -50.57 -33.51 22.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . -68.62 -31.16 73.18 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.13 -65.11 0.88 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.175 0.512 . . . . 0.0 109.9 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.58 ' CA ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -48.49 -27.88 2.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 16.5 t -75.1 -30.82 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.933 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -55.07 -35.89 65.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . 8.1 t -100.68 -64.14 1.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.795 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 33' ' ' SER . 20.9 t0 179.68 -69.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.154 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.583 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 t -160.87 37.26 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.769 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -89.04 31.82 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 112.944 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.039 HG21 HD22 ' A' ' 29' ' ' LEU . 1.1 mm -138.06 133.06 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 18' ' ' SER . 1.2 tt0 -127.81 -178.1 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.693 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.944 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -117.1 142.38 47.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.919 0.39 . . . . 0.0 110.73 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.6 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -127.06 -49.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.6 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.42 153.56 45.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.287 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.795 ' HA ' HG12 ' A' ' 15' ' ' VAL . 6.2 mmtp -95.3 58.83 2.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.91 -153.78 15.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.9 57.77 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.625 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.007 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 4.9 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.918 0.389 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 54.8 Cg_endo -89.85 -165.6 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.227 2.618 . . . . 0.0 112.998 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 11.9 mt -133.96 57.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.205 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 7.2 mt 70.15 99.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.992 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -82.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.821 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 10' ' ' MET . 2.5 t -146.4 -39.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.718 0.294 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.46 11.85 4.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.596 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.7 -76.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.436 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.84 96.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.586 0.708 . . . . 0.0 112.399 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -138.96 51.3 3.31 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.0 Cg_endo -47.76 109.37 0.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.924 3.082 . . . . 0.0 113.516 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.938 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.5 m -118.39 136.79 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.474 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.95 120.0 22.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.993 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -104.47 137.88 13.83 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.868 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.534 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 t -47.92 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.392 0.701 . . . . 0.0 109.395 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER 168.46 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.555 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.99 32.98 3.35 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.682 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.1 mm -137.68 132.49 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.839 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -89.26 98.01 11.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.149 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.902 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 56.8 m-85 -79.46 134.45 36.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.512 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -36.41 -31.94 0.05 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.551 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 55.8 m-80 -164.8 147.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.97 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -54.5 -27.2 36.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.282 0.563 . . . . 0.0 109.574 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.7 m -74.65 -40.14 61.65 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.404 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -59.63 -21.79 60.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.949 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.034 HD12 ' CD2' ' A' ' 42' ' ' LEU . 1.6 mt -75.91 -52.92 9.26 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.387 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 11.6 mt -49.0 -28.84 4.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -76.69 -32.03 51.81 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.512 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 36' ' ' SER . . . -79.77 -52.36 8.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.36 -0.42 . . . . 0.0 112.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -61.68 -31.31 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.49 -23.38 22.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.6 mtt180 -113.82 8.77 17.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -100.97 -98.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -161.31 -40.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.64 131.83 21.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.745 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.87 72.67 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.548 2.165 . . . . 0.0 112.372 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.795 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.95 170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.1 mt-10 -134.13 -176.22 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.624 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.034 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -121.54 132.05 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.281 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.7 t -117.07 -38.61 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.217 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -146.17 147.07 31.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -94.87 57.7 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.303 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -174.44 -154.64 11.14 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.282 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.35 56.82 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.644 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.937 179.854 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 73.9 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.985 0.421 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 30' ' ' LEU . 92.4 Cg_endo -90.54 173.6 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.173 2.582 . . . . 0.0 112.753 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.43 74.32 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.733 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mp 74.64 143.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.094 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -132.14 -101.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.686 HG23 ' N ' ' A' ' 10' ' ' MET . 9.8 t -173.12 -143.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.497 0.589 . . . . 0.0 110.863 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.686 ' N ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER 35.48 35.84 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' C ' ' O ' ' A' ' 10' ' ' MET . 3.2 tm0? -0.91 -64.25 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.25 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -121.33 84.48 2.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.719 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 15' ' ' VAL . 4.7 t70 -123.5 61.88 22.12 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.4 Cg_endo -50.13 105.4 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.381 2.721 . . . . 0.0 113.348 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.023 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -118.84 122.59 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.269 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.49 128.8 34.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.805 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.561 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -110.78 144.42 17.25 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.782 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -50.38 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.709 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 170.43 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.767 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.61 31.52 3.42 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.212 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 14.0 mm -133.4 143.39 39.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.0 m -103.28 98.55 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.283 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.784 ' CE1' HD21 ' A' ' 29' ' ' LEU . 20.6 m-85 -81.46 141.8 33.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.08 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 25' ' ' ASN . . . -58.86 -12.5 14.97 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.446 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 10' ' ' MET . 50.5 t-20 178.61 149.55 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.396 . . . . 0.0 110.634 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.28 -30.72 18.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 1.5 m -76.02 -39.5 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.131 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.556 ' HG3' ' HB3' ' A' ' 25' ' ' ASN . 12.1 mtp -63.74 -17.56 63.14 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -71.3 -55.2 8.51 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.692 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.551 HD12 ' HG3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -48.15 -31.73 6.04 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -71.41 -31.68 65.61 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.37 -55.52 4.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.193 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.819 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -48.24 -38.51 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 110.574 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.09 -29.64 34.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.6 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 7.4 ptm180 -84.92 -18.77 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.5 t -82.67 -96.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.636 0.255 . . . . 0.0 111.11 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 179.11 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.08 124.54 32.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.09 87.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.937 2.425 . . . . 0.0 112.99 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.991 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -67.07 175.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 26.1 mt-10 -138.94 -177.61 4.96 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.587 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.023 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 139.39 36.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.794 HG22 ' CD2' ' A' ' 44' ' ' HIS . 7.4 p -134.8 -43.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.317 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.794 ' CD2' HG22 ' A' ' 43' ' ' VAL . 1.1 m80 -125.16 126.82 45.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 15' ' ' VAL . 9.2 mmtt -85.98 58.17 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 176.8 -144.29 6.78 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.865 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -90.61 58.45 3.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.892 0.377 . . . . 0.0 110.957 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.129 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 92.1 m . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.851 0.358 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -86.91 -171.9 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.957 2.438 . . . . 0.0 112.847 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -118.62 62.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.347 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 10.4 mt 67.4 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.333 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.59 -83.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 t -161.95 161.8 28.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.092 0.472 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.0 25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.401 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' TYR . 36.9 mt-30 -83.66 63.44 7.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.81 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.6 99.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.769 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -133.43 64.85 70.56 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.0 Cg_endo -50.31 121.82 8.34 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.256 2.637 . . . . 0.0 113.067 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.017 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.5 m -127.3 132.87 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.728 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -77.88 123.0 26.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.16 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.722 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.54 135.99 12.5 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.203 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 12.0 t -49.43 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.097 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' GLY . 5.1 t0 169.15 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.845 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.24 31.79 2.97 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.729 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 mm -138.05 129.43 38.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 55.1 m -89.84 100.1 12.98 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 36.4 m-85 -79.34 163.84 24.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.253 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -69.42 -20.24 75.16 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.703 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 42.6 m-20 -174.23 147.96 1.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 110.878 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -53.31 -25.16 13.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.023 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 18.2 m -76.64 -37.7 55.87 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 7.9 mtt -68.07 -18.94 64.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.974 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -73.26 -60.84 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.905 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -48.79 -29.59 4.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -75.04 -28.77 61.76 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.87 -53.13 5.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.995 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -55.39 -34.53 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.156 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -76.12 -45.73 32.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.656 0.265 . . . . 0.0 111.132 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -87.74 9.4 21.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -97.71 -95.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.604 0.24 . . . . 0.0 111.517 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -180.0 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.404 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.42 144.45 28.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.27 78.53 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.723 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 3.7 mt -65.72 149.43 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.557 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mt-10 -137.12 -177.09 4.61 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.794 0.331 . . . . 0.0 111.517 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.017 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.68 132.94 52.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.76 -45.14 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.8 138.75 47.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.906 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.967 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -91.78 57.59 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 179.14 -154.27 13.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.115 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 57.32 3.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.846 0.355 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.853 0.359 . . . . 0.0 110.768 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD3' ' CA ' ' A' ' 31' ' ' GLY . 74.1 Cg_endo -79.22 131.72 9.9 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.649 2.232 . . . . 0.0 112.836 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.89 45.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 7' ' ' ILE . 47.2 mt 44.76 86.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -78.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 156.63 8.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.33 17.52 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.517 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 5.8 tt0 -72.66 65.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.39 103.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.484 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.6 t0 -132.31 68.37 79.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.384 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.4 Cg_endo -58.87 93.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.132 2.555 . . . . 0.0 113.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.962 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.7 m -109.97 128.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.317 0.579 . . . . 0.0 111.178 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -79.9 130.68 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.78 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.3 149.9 18.7 Favored Glycine 0 C--O 1.25 1.111 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.152 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 t -48.59 93.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.067 -1.066 . . . . 0.0 109.586 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' SER . 10.3 t0 170.69 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.017 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.81 33.92 3.16 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.689 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.5 mm -140.15 139.13 36.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 119.493 -0.883 . . . . 0.0 113.223 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 54.4 m -91.14 114.38 26.89 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.065 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 26.9 m-85 -99.92 135.7 40.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -49.12 -26.05 5.95 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.827 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -167.28 138.43 3.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.948 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.72 -19.31 10.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 1.072 ' HA ' HD23 ' A' ' 30' ' ' LEU . 10.8 m -81.11 -33.98 32.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.32 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.465 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 3.0 mtt -73.57 -40.01 64.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.154 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.75 -17.82 46.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.445 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.072 HD23 ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -63.07 -41.41 99.43 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -64.46 -35.65 92.21 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -57.72 -34.59 69.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.875 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -51.86 33.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.7 t -63.64 -26.83 68.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.566 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 5.0 ptm180 -80.04 -39.27 30.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.6 t -76.09 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t0 179.66 -33.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -94.49 117.66 66.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' ILE . 43.0 Cg_endo -68.22 75.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.335 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.006 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.28 176.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.43 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.8 mm-40 -137.84 -177.16 4.69 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.377 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.962 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.13 132.1 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 44' ' ' HIS . 12.0 p -122.63 -35.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.064 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.3 m-70 -136.11 140.39 43.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 57.58 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.96 -143.33 6.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -90.12 57.54 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.112 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.988 0.423 . . . . 0.0 111.678 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.635 ' CG ' HD11 ' A' ' 30' ' ' LEU . 63.0 Cg_endo -94.3 -163.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.442 2.761 . . . . 0.0 112.159 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 tp -124.07 61.39 1.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 68.73 107.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.19 -75.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -161.36 165.99 28.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.062 0.458 . . . . 0.0 111.68 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.9 mmm -100.87 23.91 9.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.438 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 2.0 mt-30 -83.18 61.29 6.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -20.4 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.494 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -123.35 60.91 18.69 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.6 Cg_endo -47.83 116.29 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.403 2.736 . . . . 0.0 112.773 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.966 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -125.4 129.73 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.577 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.37 127.21 31.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.571 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.563 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -107.7 140.54 15.44 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.333 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.75 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.631 -0.785 . . . . 0.0 109.113 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' GLY . 6.0 t70 167.8 -27.97 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.722 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.02 31.81 3.73 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.2 mm -136.56 135.97 48.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 56.4 m -93.86 98.24 10.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.463 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.889 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 30.4 m-85 -79.53 147.88 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.158 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -56.32 -21.71 34.44 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.215 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 49.5 m-20 -173.69 147.13 1.36 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.667 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -51.77 -27.48 12.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.575 . . . . 0.0 109.772 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.753 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 m -72.27 -42.62 65.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.683 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -64.84 -16.38 63.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.102 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.929 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -75.08 -55.5 5.68 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.232 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.0 OUTLIER -47.38 -35.89 8.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -73.45 -30.95 61.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.805 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -72.09 -52.25 17.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.755 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -60.76 -22.52 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.573 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -39.66 36.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.984 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.24 6.4 44.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.491 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t -81.69 -95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.07 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.8 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -131.69 146.65 62.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 38' ' ' THR . 51.0 Cg_exo -52.99 94.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 0.0 112.638 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 33' ' ' SER . 18.1 mt -71.86 156.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 4.1 mm-40 -135.46 -176.51 4.3 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.627 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.966 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.77 142.03 47.29 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.518 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.448 ' C ' ' CD2' ' A' ' 44' ' ' HIS . 2.4 t -137.15 -37.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.467 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.448 ' CD2' ' C ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -135.4 136.81 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.922 0.391 . . . . 0.0 111.337 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.915 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -94.48 57.15 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.869 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.87 -143.54 5.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -90.23 52.97 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.798 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.159 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.648 ' HB3' HD23 ' A' ' 30' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' CD ' ' HB3' ' A' ' 30' ' ' LEU . 49.6 Cg_endo -103.62 -161.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 113.232 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -162.46 55.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.979 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 8.3 mt 69.74 118.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -110.75 -84.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.1 t -166.87 -175.73 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.471 ' N ' ' OG1' ' A' ' 9' ' ' THR . 43.0 mmm -109.41 17.37 21.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.349 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -69.88 60.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -24.4 96.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.351 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -130.96 66.17 78.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.61 107.08 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.411 2.741 . . . . 0.0 112.902 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.018 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.0 m -109.14 127.4 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.628 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.69 117.94 20.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.824 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -102.32 140.6 14.93 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.063 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 6.7 t -50.18 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.09 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.37 -29.82 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.947 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.931 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 114.33 25.7 3.99 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.387 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.7 mp -132.82 154.38 39.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 CA-C-O 121.651 0.739 . . . . 0.0 112.5 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 53.8 m -112.29 99.28 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.047 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.732 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 26.4 m-85 -79.05 135.96 37.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 112.082 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -46.0 -23.45 1.09 Allowed Glycine 0 CA--C 1.506 -0.506 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.272 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 66.8 m-20 -175.55 152.23 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 0.0 110.715 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.705 ' O ' HD12 ' A' ' 30' ' ' LEU . . . -51.85 -28.75 16.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 109.523 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HA ' HD13 ' A' ' 30' ' ' LEU . 89.8 m -74.43 -42.67 58.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -61.72 -23.26 66.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -66.49 -53.72 31.94 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.7 177.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.4 mp -42.75 -40.41 2.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -67.24 -31.22 76.78 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.251 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.99 -44.17 18.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.589 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.11 -50.46 73.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 111.13 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 12.4 m -74.83 -26.5 59.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 13.1 mmm180 -94.0 -13.07 27.4 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 40.5 t -79.1 -93.08 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.819 0.342 . . . . 0.0 111.127 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.37 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.459 . . . . 0.0 110.116 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.33 127.09 26.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.539 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 44.8 Cg_exo -55.79 92.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.444 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -66.1 167.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.405 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 17.6 mt-10 -123.67 -177.46 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.82 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.018 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.77 134.59 55.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.109 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.41 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -119.88 -46.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -147.78 126.69 12.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.803 0.335 . . . . 0.0 111.09 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HA ' HG12 ' A' ' 15' ' ' VAL . 74.4 mttt -74.56 67.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.48 -164.75 30.49 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.057 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 53.0 2.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.998 0.427 . . . . 0.0 110.665 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.122 179.839 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.929 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 74.5 Cg_endo -93.03 177.69 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.166 2.577 . . . . 0.0 112.215 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -102.88 48.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.437 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 27.2 mt 68.17 98.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -89.97 -82.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.167 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -170.76 138.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.63 29.03 3.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.603 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 -104.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.651 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 101.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.442 0.639 . . . . 0.0 112.444 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -139.32 50.08 2.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.5 Cg_endo -48.59 114.19 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.626 2.884 . . . . 0.0 113.278 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -127.03 134.59 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.97 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.51 121.65 24.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.911 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.16 134.56 11.9 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -51.72 96.62 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.611 0.719 . . . . 0.0 110.116 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 18' ' ' SER . 62.1 t0 172.53 -29.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.716 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.71 2.04 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.257 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.606 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.2 mm -138.59 146.79 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -107.45 98.2 7.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.287 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.929 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.8 m-85 -82.39 139.76 33.87 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.404 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -47.74 -31.29 7.38 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.642 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.57 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 63.7 m-20 -160.09 144.94 14.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.514 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -54.6 -30.11 53.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.675 0.75 . . . . 0.0 109.236 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 88.8 m -72.45 -38.69 68.2 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.851 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.491 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -61.32 -18.56 59.15 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.929 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -74.98 -51.47 13.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.257 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.4 mt -47.71 -32.72 6.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' CD ' ' A' ' 35' ' ' ARG . . . -75.56 -32.24 54.96 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.09 -55.61 9.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.239 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.67 -27.08 66.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.284 0.564 . . . . 0.0 109.586 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 t -82.22 -15.95 51.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.258 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -92.86 -32.53 14.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.272 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -94.76 -111.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.137 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -176.32 30.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.78 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 m -142.8 114.69 6.02 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.33 78.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.68 2.253 . . . . 0.0 112.684 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.808 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.31 168.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.393 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.2 mt-10 -126.56 -177.27 3.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.446 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -119.8 137.42 53.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.587 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -119.47 -52.04 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.487 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.401 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.21 151.65 50.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.067 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.754 ' HA ' HG12 ' A' ' 15' ' ' VAL . 3.3 mmtt -95.24 61.75 2.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.72 -153.54 14.26 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.39 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -83.65 55.9 3.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.009 179.689 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 1.027 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 30' ' ' LEU . 33.8 Cg_endo -97.5 -164.49 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.94 2.427 . . . . 0.0 113.921 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.87 55.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.666 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 1.1 mp 71.44 160.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.508 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.79 -166.81 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.332 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -69.15 157.06 37.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.11 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtt -91.77 18.22 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.898 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -72.29 60.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.08 98.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.457 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.62 61.49 22.09 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.06 109.68 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.106 2.537 . . . . 0.0 112.093 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.802 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.9 m -122.38 125.48 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 111.175 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 118.49 20.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.214 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -97.95 136.51 12.77 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.931 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -53.18 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.614 179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 177.25 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.372 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.14 31.29 1.44 Allowed Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.91 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.6 mm -142.0 142.86 27.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.5 m -101.35 98.85 9.17 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.991 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.865 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.2 m-85 -80.0 159.21 26.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -67.08 -10.8 57.39 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.972 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 6.5 p30 165.99 156.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.34 -24.98 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.173 0.511 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 8.8 m -74.84 -49.44 20.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.773 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.522 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -61.38 -21.99 64.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.9 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.865 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -66.84 -59.18 3.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.027 HD12 ' HB3' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -53.88 -29.39 41.42 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.97 75.64 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -79.5 -52.7 7.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.752 -0.724 . . . . 0.0 110.06 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -52.74 -35.92 56.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.286 179.251 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -35.03 63.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.404 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 4.7 ptm180 -73.52 -27.66 61.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.403 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 t -83.38 -94.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.338 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t0 179.69 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -100.43 147.84 34.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.909 0.385 . . . . 0.0 111.175 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 16.4 Cg_exo -67.66 79.7 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.963 2.442 . . . . 0.0 112.416 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.666 HD13 ' OH ' ' A' ' 23' ' ' TYR . 74.4 mt -44.19 152.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 22.7 mt-10 -123.34 -177.29 3.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.345 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -118.82 147.27 44.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -43.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 135.97 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.75 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -88.99 66.36 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.08 -155.38 16.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.166 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.09 54.1 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 0.0 110.515 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 1.6 m . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HB3' HD12 ' A' ' 30' ' ' LEU . 66.8 Cg_endo -103.14 42.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.492 2.795 . . . . 0.0 113.189 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 5' ' ' PRO . 9.8 mt 28.7 49.58 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.229 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 13.6 mm 68.72 161.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.746 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.12 -166.53 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.462 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 10' ' ' MET . 0.7 OUTLIER -69.63 179.21 2.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.339 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.47 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.31 28.66 8.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.503 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 4.1 mm-40 -80.85 62.98 5.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.275 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.63 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.159 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.758 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -122.8 63.75 21.29 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.8 Cg_endo -49.06 101.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.077 2.518 . . . . 0.0 112.192 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.3 m -108.0 126.63 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.308 0.575 . . . . 0.0 110.921 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.85 121.87 25.37 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.733 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -99.88 137.33 13.19 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.229 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -50.25 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.803 0.811 . . . . 0.0 109.376 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' GLY . 2.5 p30 172.12 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.477 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.08 31.44 2.25 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.643 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 33.0 mm -137.8 138.86 43.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.5 m -99.13 102.93 14.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.357 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 21.0 m-85 -84.34 143.01 29.77 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.381 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -53.75 -16.59 5.78 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.374 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 15.6 m-20 177.41 150.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.16 -29.4 21.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 56.6 m -73.65 -39.84 64.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.268 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.467 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.45 -25.78 68.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.944 HD22 HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -65.77 -54.37 28.02 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.252 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.674 HD12 ' HB3' ' A' ' 5' ' ' PRO . 5.8 mt -48.71 -39.98 26.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -59.6 -31.92 72.25 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -73.72 -57.39 4.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.451 -0.874 . . . . 0.0 110.699 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.781 ' HB2' HD13 ' A' ' 40' ' ' ILE . 30.3 t -56.74 -50.49 72.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.605 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -61.08 -27.41 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.923 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.1 mtp180 -109.79 8.95 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 27.9 t -104.35 -98.98 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.505 0.193 . . . . 0.0 111.463 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.6 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 131.62 22.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 59.8 Cg_endo -71.12 82.24 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.623 2.215 . . . . 0.0 112.277 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.944 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -54.84 174.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.665 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 37.7 mt-10 -131.16 -177.65 4.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -113.03 132.25 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.194 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -111.85 -51.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.383 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.36 129.93 17.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.875 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -74.85 62.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.42 -168.59 33.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.13 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -80.3 51.71 1.46 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.741 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.022 179.717 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.832 0.349 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.508 ' HG2' ' CB ' ' A' ' 33' ' ' SER . 10.3 Cg_endo -52.19 -164.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.87 2.38 . . . . 0.0 112.295 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 15.0 p-10 -128.48 -166.29 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.549 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -108.03 157.56 35.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 56.1 Cg_endo -95.88 -163.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.492 2.795 . . . . 0.0 112.374 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 mp -132.09 58.54 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 61.2 mt 65.1 102.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.38 -84.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -169.5 178.98 3.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.235 0.541 . . . . 0.0 112.119 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.421 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -110.58 11.67 22.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.226 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.71 67.6 1.6 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.1 96.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.409 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -120.78 58.93 7.09 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 Cg_endo -48.77 115.55 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.646 2.897 . . . . 0.0 113.442 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.8 m -121.99 133.59 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 119.36 22.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.823 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -106.12 139.63 14.87 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.048 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 19.5 t -49.71 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.243 -0.979 . . . . 0.0 109.585 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 5.5 t0 170.48 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.352 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.55 2.98 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.607 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.2 mm -139.05 141.55 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.12 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -96.86 99.02 10.6 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.995 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.011 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.4 m-85 -82.26 138.94 34.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -40.69 -29.27 0.25 Allowed Glycine 0 CA--C 1.505 -0.593 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.717 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 10.1 p30 -173.89 147.01 1.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.088 0.471 . . . . 0.0 110.833 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.608 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -49.57 -26.24 3.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.513 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.1 m -72.66 -43.44 63.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.43 0.633 . . . . 0.0 110.222 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 1.8 mmm -61.46 -17.57 55.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.169 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 40' ' ' ILE . 1.8 mt -76.62 -50.52 13.6 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.598 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -48.61 -34.71 12.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -34.01 67.33 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -71.32 -61.69 1.68 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.619 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.823 ' N ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -48.79 -28.46 3.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.135 0.493 . . . . 0.0 110.017 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -73.42 -32.3 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.603 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.27 56.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 7.7 t -108.91 -71.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -173.78 -36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.211 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.64 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.06 174.98 2.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 38' ' ' THR . 56.4 Cg_endo -71.98 92.16 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.549 2.166 . . . . 0.0 112.013 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 29' ' ' LEU . 22.8 pt -83.4 167.28 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.505 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.4 mm-40 -149.38 -176.68 5.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.023 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.3 140.15 48.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.701 0.286 . . . . 0.0 110.812 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.5 -47.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 133.9 36.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.81 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG12 ' A' ' 15' ' ' VAL . 19.6 pttt -86.02 64.72 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.22 -150.01 9.5 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.175 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -90.3 53.9 2.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.818 0.342 . . . . 0.0 110.49 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' OXT' ' O ' ' A' ' 47' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.958 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.765 0.317 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.88 -169.64 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.693 2.262 . . . . 0.0 112.115 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 17.6 t70 -179.08 166.62 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.38 133.25 28.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 88.8 Cg_endo -78.16 -169.45 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.68 2.253 . . . . 0.0 112.211 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -125.66 64.0 1.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.648 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.3 mp 70.37 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -84.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.947 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -152.7 172.7 16.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -104.13 16.68 25.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' TYR . 84.8 mt-30 -73.66 59.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -25.66 92.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.132 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.916 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -121.9 65.51 19.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.186 178.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.3 Cg_endo -49.02 96.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.182 2.588 . . . . 0.0 112.053 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.2 m -105.58 131.64 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.409 0.623 . . . . 0.0 111.186 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.502 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.575 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -105.12 142.79 15.56 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.598 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 12.5 m -47.92 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.686 0.874 . . . . 0.0 109.079 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.754 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER 168.73 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.457 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.95 33.54 2.78 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.975 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.0 mm -140.71 139.36 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.988 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 9.2 m -94.84 100.93 12.73 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.606 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.828 ' CE1' HD21 ' A' ' 29' ' ' LEU . 21.6 m-85 -83.87 139.73 32.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.391 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -48.56 -20.75 1.77 Allowed Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 36.5 m-20 -177.92 150.76 0.64 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.04 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.623 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.5 m -73.32 -43.92 59.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.731 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -63.31 -19.98 65.08 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.693 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.952 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -68.64 -59.4 3.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.098 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -46.44 -33.12 3.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.12 -37.67 55.46 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.82 -54.46 15.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.313 -0.443 . . . . 0.0 110.848 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.31 -25.42 64.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.523 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLY . 1.5 p -75.81 -32.04 59.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 0.0 110.716 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -107.91 11.78 27.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 t -87.65 -93.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.226 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.87 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.32 . . . . 0.0 110.955 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -129.49 158.75 72.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.868 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 29.4 Cg_exo -62.22 89.68 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.831 2.354 . . . . 0.0 112.491 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' A' ' 19' ' ' ASP . 9.0 mt -71.02 149.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 4.6 mt-10 -133.28 -176.63 4.2 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.904 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -102.38 132.33 48.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 44' ' ' HIS . 9.6 p -123.44 -34.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.898 ' CE1' HG22 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -146.51 142.73 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.345 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 61.09 2.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 110.83 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.29 -153.87 11.87 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -90.3 53.89 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 110.603 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.06 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' PRO . 8.9 mttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.982 0.42 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 1' ' ' LYS . 71.7 Cg_exo -49.56 -166.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.907 2.405 . . . . 0.0 112.745 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.659 ' O ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -68.16 54.41 0.07 Allowed 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.976 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -113.22 166.55 10.9 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.903 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 61.2 Cg_endo -75.31 156.79 41.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.785 2.323 . . . . 0.0 113.62 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 1.1 tt 172.61 40.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt 61.68 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.223 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.34 -83.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.92 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -114.68 131.97 56.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.8 17.08 18.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.143 0.497 . . . . 0.0 110.296 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' TYR . 9.1 mt-30 -102.91 71.86 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.253 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.572 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -124.51 62.01 30.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.99 112.96 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.346 2.697 . . . . 0.0 112.978 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.013 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.9 m -121.02 130.53 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.747 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 128.13 33.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.367 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -105.52 137.57 13.81 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.124 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -50.55 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.578 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' SER . 21.1 t70 170.4 -29.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.832 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.99 33.14 2.25 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.607 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.6 mm -137.56 132.28 44.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.4 m -93.25 102.78 15.06 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.666 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.1 m-85 -81.47 166.58 20.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.218 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -78.71 -13.59 82.98 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.842 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 29.2 m-20 -179.4 149.81 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.632 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.54 5.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.454 0.645 . . . . 0.0 109.281 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.835 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -75.4 -45.62 37.9 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.991 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -55.89 -30.02 60.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.36 -51.07 65.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.887 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.835 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.4 pp -47.0 -39.9 13.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' ARG . . . -65.28 -35.65 91.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.873 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -60.33 -45.99 91.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.743 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.507 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.27 -50.34 73.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.849 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 15.6 t -70.12 -35.09 73.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.87 -32.93 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.725 0.298 . . . . 0.0 111.25 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 t -88.19 -93.68 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.779 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.81 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.043 0.449 . . . . 0.0 110.389 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.506 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -90.51 136.15 28.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.818 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 3.0 Cg_exo -74.68 64.29 5.73 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -44.05 166.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt-10 -132.45 -177.63 4.56 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.47 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -106.33 132.4 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.134 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.767 HG22 ' CD2' ' A' ' 44' ' ' HIS . 7.4 p -127.4 -42.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.463 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.767 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -128.38 115.35 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.835 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 15' ' ' VAL . 1.4 mtmt -76.62 53.53 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.35 -147.21 5.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 57.25 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 110.464 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.868 0.366 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 30' ' ' LEU . 57.8 Cg_endo -71.04 -171.87 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.766 2.31 . . . . 0.0 112.458 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -149.98 172.68 14.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.625 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -30.64 139.11 0.17 Allowed Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.734 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.2 Cg_endo -93.17 42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.172 2.581 . . . . 0.0 112.627 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 5' ' ' PRO . 3.7 mt 27.02 61.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.88 102.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -90.68 -86.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 10' ' ' MET . 9.7 t -171.58 -154.57 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.52 ' O ' ' C ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -107.41 -47.88 3.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.335 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER 9.15 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.13 0.894 . . . . 0.0 111.892 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -32.41 90.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.302 0.572 . . . . 0.0 111.362 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.884 ' O ' HG13 ' A' ' 15' ' ' VAL . 37.5 t0 -129.91 57.01 27.74 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.291 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.26 87.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.051 2.501 . . . . 0.0 112.076 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 13' ' ' ASP . 14.0 m -91.95 127.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.413 0.625 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.48 115.08 17.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.485 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.25 140.41 14.86 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.762 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -51.21 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.379 -0.911 . . . . 0.0 109.905 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.01 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.171 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.68 33.56 1.7 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.329 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -140.39 152.54 21.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 97.2 m -109.51 98.36 7.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.974 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 39.3 m-85 -80.8 134.74 35.84 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.67 -23.62 0.19 Allowed Glycine 0 CA--C 1.507 -0.423 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.426 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 28' ' ' MET . 14.1 p30 -178.52 149.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.271 0.557 . . . . 0.0 111.142 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.14 -24.49 4.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.484 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 10.0 m -74.22 -39.96 62.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.25 0.548 . . . . 0.0 110.402 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.03 -21.64 66.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.89 -179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 2.2 mt -75.13 -51.54 13.2 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 92.9 mt -48.86 -33.79 11.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.01 -27.4 64.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.856 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.03 -54.76 5.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.498 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -26.66 68.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 7.0 p -84.07 -31.39 25.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.634 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 9.1 mmm180 -100.71 3.64 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.594 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 38.4 t -93.89 -98.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' SER . 8.9 t70 179.11 -31.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.973 0.416 . . . . 0.0 110.644 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.0 m -115.68 103.4 53.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.253 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.27 92.75 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.102 2.535 . . . . 0.0 112.943 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.857 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.48 177.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.415 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.9 mt-10 -135.92 -177.86 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.531 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.891 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.68 137.11 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.081 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.47 -53.14 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.303 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 148.66 52.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -93.3 56.71 2.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.748 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' PRO . . . -178.69 -156.21 16.48 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.266 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.03 56.78 3.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.33 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.923 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.818 0.342 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 1' ' ' LYS . 86.8 Cg_endo -83.69 172.19 10.29 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.836 2.357 . . . . 0.0 112.537 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER 179.51 46.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.538 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' C ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -156.77 146.19 15.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 97.6 Cg_endo -93.31 -162.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.266 2.644 . . . . 0.0 113.112 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 6' ' ' LEU . 1.3 pt? -159.69 51.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.902 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm 60.72 87.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.426 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -80.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.5 t -168.63 -179.41 3.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.161 0.505 . . . . 0.0 111.77 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.3 OUTLIER -111.24 21.36 16.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.251 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 12' ' ' TYR . 7.3 mm-40 -78.23 59.7 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.929 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -21.43 94.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.496 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -123.37 65.94 32.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.58 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.349 2.699 . . . . 0.0 112.907 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.7 m -108.84 131.09 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.09 114.56 17.08 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.132 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -96.97 134.33 11.73 Favored Glycine 0 C--O 1.25 1.094 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.991 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -56.81 90.96 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.851 0.834 . . . . 0.0 109.32 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' GLY . 4.1 t70 -175.97 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.16 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.13 26.77 0.88 Allowed Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.324 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -148.09 168.83 3.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 21' ' ' ILE . 30.3 m -119.79 99.3 6.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.088 -1.414 . . . . 0.0 109.356 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.825 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 16.1 m-85 -82.8 136.17 34.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -43.81 -26.98 0.86 Allowed Glycine 0 CA--C 1.506 -0.515 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.752 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 76.3 m-20 -169.79 146.82 3.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -51.22 -28.35 11.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.659 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.626 ' HA ' HD12 ' A' ' 30' ' ' LEU . 95.1 m -73.38 -44.23 59.01 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.741 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.53 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 3.1 mtp -61.31 -19.82 62.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -70.19 -47.14 62.83 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.82 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.97 -36.62 12.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' NE ' ' A' ' 35' ' ' ARG . . . -71.27 -31.54 66.07 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.54 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -72.21 -56.5 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.089 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -41.01 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 109.646 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.02 -39.74 79.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.871 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 31' ' ' GLY . 10.0 mtt180 -74.66 -22.31 58.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.02 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -86.13 -99.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.536 0.207 . . . . 0.0 110.99 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.54 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.996 0.427 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.77 159.51 29.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.28 83.92 2.15 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.808 2.338 . . . . 0.0 112.588 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.807 HG21 HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -38.45 152.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.756 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.5 mm-40 -119.21 -179.74 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.428 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.843 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -126.31 137.36 53.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.608 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.553 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -115.65 -45.4 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.148 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.553 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -144.5 125.13 14.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -75.04 58.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -176.56 -153.48 10.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.95 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -87.48 56.44 3.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 mttt . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 17.9 Cg_endo -60.08 -165.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.659 2.239 . . . . 0.0 112.308 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.791 ' O ' HD12 ' A' ' 30' ' ' LEU . 12.9 p-10 -172.02 -158.01 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' HD12 ' A' ' 30' ' ' LEU . 8.8 m -40.04 169.78 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.226 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 90.7 Cg_endo -91.39 179.12 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.882 2.388 . . . . 0.0 113.579 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 6' ' ' LEU . 1.8 pt? -165.11 41.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.375 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt 58.08 86.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.282 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -85.3 -70.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.795 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -165.74 151.96 9.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.23 23.72 7.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -83.04 64.71 7.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.67 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.27 95.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.578 -178.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.1 t0 -123.55 63.07 25.51 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.081 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.6 Cg_endo -50.04 102.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.142 2.561 . . . . 0.0 112.351 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.4 m -108.74 139.37 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.914 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.93 117.11 19.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.39 134.3 11.67 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.838 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -51.55 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.698 -0.751 . . . . 0.0 109.557 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 177.23 -35.66 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.789 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.47 33.38 0.95 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.863 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.3 mt -146.06 157.99 11.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 85.9 m -110.01 98.35 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.195 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.845 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.4 m-85 -82.18 134.76 35.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -42.17 -27.14 0.4 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.774 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 76.3 m-20 -168.36 146.07 4.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.201 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.52 -28.0 28.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.405 0.621 . . . . 0.0 109.505 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.587 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.9 m -73.37 -40.68 64.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.608 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.49 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.1 mmt -66.99 -15.84 63.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.091 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.035 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -74.03 -61.91 1.69 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.442 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.791 HD12 ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -48.87 -32.1 8.31 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.644 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.546 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -73.18 -31.77 61.14 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.68 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.59 -56.87 4.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.568 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.51 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.96 -32.91 2.99 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 109.792 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -68.6 -47.84 65.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.142 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 4.0 mmm180 -60.38 -26.71 66.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.478 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -87.85 -108.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.322 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -179.52 33.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.878 0.371 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -158.27 124.54 2.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 15.3 Cg_exo -67.85 71.2 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.852 2.368 . . . . 0.0 112.61 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.675 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.43 176.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.825 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' OG ' ' A' ' 18' ' ' SER . 7.5 mt-10 -139.2 -177.21 4.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.561 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.035 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.0 140.67 49.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.5 t -123.66 -43.28 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.4 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.68 149.1 40.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -93.95 61.21 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.16 -149.79 11.07 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.05 56.5 4.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.972 0.415 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.984 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.974 0.416 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.85 -159.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.821 2.348 . . . . 0.0 112.496 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -82.86 44.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.052 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m -150.58 144.73 17.63 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 78.0 Cg_endo -98.64 -173.82 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.387 2.724 . . . . 0.0 112.214 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.11 61.74 1.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.681 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mm 63.04 87.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.828 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.98 -79.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.032 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.1 t -169.72 -178.58 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.175 0.512 . . . . 0.0 111.714 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -107.54 11.83 28.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.518 179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 12' ' ' TYR . 19.2 mm100 -66.91 62.37 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.513 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -22.54 94.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -117.34 58.63 2.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.7 Cg_endo -50.39 102.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.359 2.706 . . . . 0.0 112.745 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.05 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.2 m -113.42 123.23 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 116.6 18.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.418 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -95.59 135.65 12.47 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.365 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -50.0 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.692 0.758 . . . . 0.0 109.882 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 171.23 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.78 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.47 33.19 2.54 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -135.31 124.57 41.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -90.15 98.8 11.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.656 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 13.6 m-85 -80.76 148.66 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.91 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -59.16 -11.5 12.74 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.416 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 9.6 p30 163.85 155.23 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.24 -25.22 0.89 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.304 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.837 ' HA ' HD12 ' A' ' 30' ' ' LEU . 63.7 m -77.02 -46.23 24.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.62 0.724 . . . . 0.0 110.009 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -61.95 -22.46 65.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.454 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.656 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -68.05 -49.06 63.72 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.864 177.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.87 -38.32 15.96 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -64.4 -35.55 92.09 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.4 -64.83 0.82 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.099 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.438 ' N ' HD11 ' A' ' 40' ' ' ILE . 30.9 t -46.86 -36.83 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.054 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 13.1 t -54.96 -47.8 74.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.495 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 7.3 mtp180 -143.57 51.18 1.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 13.4 t -97.03 -73.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 110.529 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.71 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.523 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.499 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -152.15 159.62 32.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.233 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 18.4 Cg_endo -59.54 87.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.624 2.216 . . . . 0.0 112.146 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -64.72 145.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.099 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm-40 -113.29 -177.31 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.05 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.08 136.3 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.431 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.8 t -122.3 -49.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.514 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -133.67 143.49 48.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.815 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 15' ' ' VAL . 4.8 pttp -94.23 57.2 2.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.128 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.28 -150.64 7.58 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.013 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -89.43 57.43 3.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.944 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 1' ' ' LYS . 72.4 Cg_endo -79.41 -171.73 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 m-20 -155.86 56.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 30' ' ' LEU . 68.6 m -161.78 160.42 22.5 Favored Pre-proline 0 C--O 1.23 0.064 0 O-C-N 123.504 0.503 . . . . 0.0 110.659 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.536 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 6.0 Cg_endo -48.59 137.52 26.02 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.939 2.426 . . . . 0.0 112.605 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -160.77 44.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.748 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 27.95 105.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -104.04 -79.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.036 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.486 HG21 ' HG2' ' A' ' 11' ' ' GLN . 1.7 t -163.15 -178.44 6.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.901 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 12' ' ' TYR . 1.8 mtm -114.85 10.12 16.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.033 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.3 OUTLIER -67.06 62.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 109.968 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.492 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.43 93.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.433 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -119.87 65.39 9.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.89 108.69 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.019 2.48 . . . . 0.0 112.748 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.92 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.4 m -120.0 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.151 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.592 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.57 117.83 20.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.566 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 139.64 14.5 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.073 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 38.8 t -50.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.808 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CG ' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 171.56 -29.32 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.812 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.17 32.13 3.11 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.372 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 34.1 mm -135.64 133.61 51.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -94.76 98.33 10.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.095 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.749 ' CE1' HD21 ' A' ' 29' ' ' LEU . 24.8 m-85 -79.27 153.27 30.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.939 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' ASN . . . -64.03 -10.14 38.4 Favored Glycine 0 C--N 1.328 0.124 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.5 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 28' ' ' MET . 12.3 p30 166.8 153.31 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 0.0 110.184 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.71 -26.21 2.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HA ' HD23 ' A' ' 30' ' ' LEU . 9.0 m -75.12 -43.87 50.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.546 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.67 -18.53 65.06 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.905 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.17 -57.41 4.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.285 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -49.44 -35.82 20.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 5' ' ' PRO . . . -71.51 -27.85 70.57 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -76.8 -58.75 3.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.563 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.617 ' N ' HD11 ' A' ' 40' ' ' ILE . 3.7 t -42.1 -37.34 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.453 0.644 . . . . 0.0 109.347 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 21.6 t -64.61 -50.52 66.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.406 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 8.9 mmm180 -77.24 -10.47 59.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.049 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -82.65 -96.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 179.18 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.0 110.488 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.636 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -117.76 163.86 22.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.075 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.636 ' HD2' HG22 ' A' ' 38' ' ' THR . 71.7 Cg_endo -77.6 75.61 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.837 2.358 . . . . 0.0 112.048 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 33' ' ' SER . 1.5 pt -52.5 154.01 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.117 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -122.66 -175.99 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.92 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -112.08 132.48 54.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.369 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.23 -53.14 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.258 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.424 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.99 144.8 50.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.923 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -91.36 65.41 5.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 172.63 -159.77 30.61 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.102 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -79.52 55.05 1.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 110.688 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.992 179.808 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.828 0.347 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.4 38.32 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.111 2.541 . . . . 0.0 112.269 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 m-20 -113.08 40.78 2.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m -152.07 147.37 19.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 94.5 Cg_endo -94.83 -165.41 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.373 2.716 . . . . 0.0 112.891 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' LEU . 7.9 tp -164.9 52.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.928 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.0 mp 63.71 85.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.225 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -76.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.261 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -169.2 179.09 4.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.071 0.462 . . . . 0.0 111.502 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.52 19.38 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -73.19 58.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.963 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -25.49 97.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.928 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.4 t0 -126.48 61.71 44.64 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.055 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.8 Cg_endo -47.67 93.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.189 2.592 . . . . 0.0 112.035 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.036 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.8 m -102.76 131.85 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 121.64 24.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.328 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -100.73 141.4 15.35 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.39 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 66.3 m -53.29 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.184 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 40' ' ' ILE . 19.9 t70 176.57 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.261 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.33 32.49 1.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.885 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 22' ' ' THR . 6.7 mt -143.7 160.84 16.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 41.5 m -113.03 108.09 16.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 29' ' ' LEU . 15.0 m-85 -93.06 136.32 33.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.323 0.582 . . . . 0.0 112.31 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -47.06 -22.98 1.44 Allowed Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.202 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 61.0 m-20 -174.08 150.38 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.82 -28.9 10.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.348 0.594 . . . . 0.0 109.567 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.83 -45.5 58.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.501 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -60.56 -23.27 64.49 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.36 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -65.29 -50.77 64.45 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.381 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.1 mt -48.97 -36.3 17.21 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -65.2 -29.93 76.56 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.83 -64.67 0.99 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.95 -0.625 . . . . 0.0 110.179 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -30.09 12.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.186 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 7.4 t -63.43 -50.51 69.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.713 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 35' ' ' ARG . 1.2 mmm180 -100.87 18.74 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 9.7 t -103.42 -119.8 0.2 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' SER . 6.3 t70 178.84 29.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.064 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.439 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 2.4 m -160.47 139.66 7.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.371 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 29.6 Cg_endo -63.81 82.18 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.628 2.219 . . . . 0.0 112.414 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 29' ' ' LEU . 18.8 mt -67.43 139.54 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.666 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt-10 -126.3 -177.55 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.036 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -104.96 132.73 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -127.28 -32.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.328 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.895 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.7 m-70 -139.78 134.22 31.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.88 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -89.54 55.28 3.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . 177.08 -155.35 17.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.256 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 58.1 3.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.401 . . . . 0.0 110.606 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 13.2 mttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.918 0.39 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.39 40.16 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.109 2.54 . . . . 0.0 112.202 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.94 -169.5 3.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.838 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 141.29 75.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 89.7 Cg_endo -83.09 163.69 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.033 2.489 . . . . 0.0 112.597 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.5 tp -84.73 53.33 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.482 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 5.0 mt 68.57 96.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.29 -83.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.198 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -164.78 154.28 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.37 32.83 5.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.491 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -79.06 -104.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.247 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.43 91.67 0.09 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.19 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -129.46 53.32 11.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.1 Cg_endo -49.79 116.03 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.736 2.957 . . . . 0.0 113.902 -177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.2 m -129.6 124.83 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.865 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.38 134.74 37.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.937 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.02 142.24 17.41 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.325 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.08 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.359 -0.92 . . . . 0.0 109.035 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' SER . 8.7 t70 167.58 -28.11 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.422 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.795 ' C ' HD12 ' A' ' 21' ' ' ILE . . . 108.81 22.88 6.74 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.626 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.795 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.3 mp -123.21 152.54 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.56 0.695 . . . . 0.0 112.458 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 14.1 m -111.07 98.56 7.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.072 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.841 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.9 m-85 -81.09 138.95 35.93 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.986 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.63 -27.54 19.31 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.948 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 62.7 m-80 -164.08 148.41 10.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -55.68 -26.96 47.48 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 62.7 m -73.81 -37.79 64.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.855 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.1 mtt -67.5 -19.33 65.31 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.866 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -72.13 -57.5 4.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.015 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER -50.77 -31.43 16.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.59 -26.11 70.62 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.82 -59.57 2.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.019 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.881 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -54.32 -23.62 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.787 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' ARG . 11.9 p -89.96 -44.02 10.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.805 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.68 -30.16 59.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.964 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -73.76 -91.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.941 0.4 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.46 -35.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.372 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.23 116.11 64.26 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 49.0 Cg_endo -69.3 74.83 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.749 2.299 . . . . 0.0 112.328 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.897 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.81 177.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.3 mm-40 -134.69 -177.6 4.69 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.009 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.63 132.88 49.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 110.251 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.674 HG22 ' NE2' ' A' ' 44' ' ' HIS . 14.6 p -123.59 -40.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.235 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.674 ' NE2' HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -133.81 134.46 42.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.551 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.767 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.87 55.52 2.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -176.1 -145.08 5.41 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.203 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' CYS . 3.7 ptt85 -90.54 56.65 3.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.565 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 10.6 tttt . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 1' ' ' LYS . 34.2 Cg_endo -64.34 -173.18 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.327 2.018 . . . . 0.0 112.457 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 4' ' ' CYS . 13.9 m-20 -163.67 174.93 11.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -28.55 141.64 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.117 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 71.3 Cg_endo -94.96 -173.66 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.252 2.634 . . . . 0.0 112.426 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.75 57.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.8 mt 63.63 97.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.097 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.84 -85.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.2 t -170.68 -177.77 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 111.987 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' ' OG1' ' A' ' 9' ' ' THR . 2.8 ptt? -115.28 20.69 14.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.486 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.18 67.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.45 89.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.404 -178.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.39 61.05 14.33 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.9 Cg_endo -49.48 114.82 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.598 2.866 . . . . 0.0 112.942 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.944 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.7 m -119.04 133.64 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.424 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.79 117.83 19.55 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -98.42 134.48 11.72 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.079 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' A' ' 41' ' ' GLU . 30.8 t -51.34 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.412 0.713 . . . . 0.0 109.177 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 174.11 -31.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.491 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.11 30.63 2.24 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.678 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 15.6 mm -142.38 142.64 27.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -97.55 100.59 12.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.104 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.859 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.8 m-85 -79.97 142.49 35.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.367 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.71 -22.31 2.7 Favored Glycine 0 CA--C 1.507 -0.444 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 2.8 m-20 -173.04 146.15 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.882 0.372 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -52.91 -28.61 24.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.27 0.557 . . . . 0.0 109.518 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 88.9 m -71.79 -41.03 68.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.753 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.52 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 13.4 mtp -62.91 -23.43 67.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.959 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -69.83 -48.62 58.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.43 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 7.2 mt -50.57 -33.51 22.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . -68.62 -31.16 73.18 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.13 -65.11 0.88 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.175 0.512 . . . . 0.0 109.9 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.58 ' CA ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -48.49 -27.88 2.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 16.5 t -75.1 -30.82 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.933 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -55.07 -35.89 65.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . 8.1 t -100.68 -64.14 1.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.795 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 33' ' ' SER . 20.9 t0 179.68 -69.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.154 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.583 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 t -160.87 37.26 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.769 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -89.04 31.82 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 112.944 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.039 HG21 HD22 ' A' ' 29' ' ' LEU . 1.1 mm -138.06 133.06 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 18' ' ' SER . 1.2 tt0 -127.81 -178.1 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.693 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.944 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -117.1 142.38 47.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.919 0.39 . . . . 0.0 110.73 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.6 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -127.06 -49.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.6 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.42 153.56 45.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.287 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.795 ' HA ' HG12 ' A' ' 15' ' ' VAL . 6.2 mmtp -95.3 58.83 2.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.91 -153.78 15.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.9 57.77 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.625 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.007 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.2 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.269 2.646 . . . . 0.0 112.672 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.672 ' O ' HD22 ' A' ' 30' ' ' LEU . 1.1 p-10 -142.78 170.09 16.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 4.9 m -31.8 141.87 0.15 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 54.8 Cg_endo -89.85 -165.6 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.227 2.618 . . . . 0.0 112.998 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 11.9 mt -133.96 57.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.205 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 7.2 mt 70.15 99.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.992 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -82.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.821 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 10' ' ' MET . 2.5 t -146.4 -39.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.718 0.294 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.46 11.85 4.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.596 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.7 -76.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.436 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.84 96.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.586 0.708 . . . . 0.0 112.399 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -138.96 51.3 3.31 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.0 Cg_endo -47.76 109.37 0.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.924 3.082 . . . . 0.0 113.516 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.938 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.5 m -118.39 136.79 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.474 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.95 120.0 22.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.993 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -104.47 137.88 13.83 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.868 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.534 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 t -47.92 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.392 0.701 . . . . 0.0 109.395 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER 168.46 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.555 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.99 32.98 3.35 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.682 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.1 mm -137.68 132.49 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.839 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -89.26 98.01 11.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.149 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.902 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 56.8 m-85 -79.46 134.45 36.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.512 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -36.41 -31.94 0.05 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.551 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 55.8 m-80 -164.8 147.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.97 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -54.5 -27.2 36.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.282 0.563 . . . . 0.0 109.574 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.7 m -74.65 -40.14 61.65 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.404 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -59.63 -21.79 60.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.949 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.034 HD12 ' CD2' ' A' ' 42' ' ' LEU . 1.6 mt -75.91 -52.92 9.26 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.387 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 3' ' ' ASP . 11.6 mt -49.0 -28.84 4.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -76.69 -32.03 51.81 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.512 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 36' ' ' SER . . . -79.77 -52.36 8.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.36 -0.42 . . . . 0.0 112.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -61.68 -31.31 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.49 -23.38 22.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.6 mtt180 -113.82 8.77 17.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -100.97 -98.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -161.31 -40.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.64 131.83 21.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.745 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.87 72.67 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.548 2.165 . . . . 0.0 112.372 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.795 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.95 170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.1 mt-10 -134.13 -176.22 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.624 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.034 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -121.54 132.05 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.281 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.7 t -117.07 -38.61 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.217 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -146.17 147.07 31.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -94.87 57.7 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.303 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -174.44 -154.64 11.14 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.282 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.35 56.82 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.644 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.937 179.854 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.27 39.76 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.023 2.482 . . . . 0.0 112.477 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 58.3 p30 -126.26 150.49 48.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.062 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 73.9 m -80.53 127.58 75.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.007 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 30' ' ' LEU . 92.4 Cg_endo -90.54 173.6 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.173 2.582 . . . . 0.0 112.753 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.43 74.32 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.733 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mp 74.64 143.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.094 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -132.14 -101.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.686 HG23 ' N ' ' A' ' 10' ' ' MET . 9.8 t -173.12 -143.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.497 0.589 . . . . 0.0 110.863 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.686 ' N ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER 35.48 35.84 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' C ' ' O ' ' A' ' 10' ' ' MET . 3.2 tm0? -0.91 -64.25 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.25 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -121.33 84.48 2.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.719 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 15' ' ' VAL . 4.7 t70 -123.5 61.88 22.12 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.4 Cg_endo -50.13 105.4 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.381 2.721 . . . . 0.0 113.348 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.023 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -118.84 122.59 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.269 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.49 128.8 34.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.805 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.561 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -110.78 144.42 17.25 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.782 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -50.38 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.709 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 170.43 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.767 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.61 31.52 3.42 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.212 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 14.0 mm -133.4 143.39 39.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.0 m -103.28 98.55 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.283 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.784 ' CE1' HD21 ' A' ' 29' ' ' LEU . 20.6 m-85 -81.46 141.8 33.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.08 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 25' ' ' ASN . . . -58.86 -12.5 14.97 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.446 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 10' ' ' MET . 50.5 t-20 178.61 149.55 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.396 . . . . 0.0 110.634 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.28 -30.72 18.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 1.5 m -76.02 -39.5 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.131 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.556 ' HG3' ' HB3' ' A' ' 25' ' ' ASN . 12.1 mtp -63.74 -17.56 63.14 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -71.3 -55.2 8.51 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.692 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD12 ' HG3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -48.15 -31.73 6.04 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -71.41 -31.68 65.61 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.37 -55.52 4.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.193 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.819 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -48.24 -38.51 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 110.574 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.09 -29.64 34.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.6 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 7.4 ptm180 -84.92 -18.77 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.5 t -82.67 -96.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.636 0.255 . . . . 0.0 111.11 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 179.11 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.08 124.54 32.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.09 87.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.937 2.425 . . . . 0.0 112.99 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.991 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -67.07 175.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 26.1 mt-10 -138.94 -177.61 4.96 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.587 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.023 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 139.39 36.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.794 HG22 ' CD2' ' A' ' 44' ' ' HIS . 7.4 p -134.8 -43.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.317 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.794 ' CD2' HG22 ' A' ' 43' ' ' VAL . 1.1 m80 -125.16 126.82 45.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 15' ' ' VAL . 9.2 mmtt -85.98 58.17 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 176.8 -144.29 6.78 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.865 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -90.61 58.45 3.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.892 0.377 . . . . 0.0 110.957 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.129 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 1' ' ' LYS . 72.3 Cg_exo -49.01 -168.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.685 2.257 . . . . 0.0 112.572 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 5.5 p-10 -167.45 166.88 14.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 92.1 m -64.85 125.78 89.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.896 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -86.91 -171.9 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.957 2.438 . . . . 0.0 112.847 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -118.62 62.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.347 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 10.4 mt 67.4 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.333 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.59 -83.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 t -161.95 161.8 28.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.092 0.472 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.0 25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.401 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' TYR . 36.9 mt-30 -83.66 63.44 7.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.81 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.6 99.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.769 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -133.43 64.85 70.56 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.0 Cg_endo -50.31 121.82 8.34 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.256 2.637 . . . . 0.0 113.067 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.017 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.5 m -127.3 132.87 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.728 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -77.88 123.0 26.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.16 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.722 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.54 135.99 12.5 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.203 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 12.0 t -49.43 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.097 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' GLY . 5.1 t0 169.15 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.845 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.24 31.79 2.97 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.729 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 mm -138.05 129.43 38.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 55.1 m -89.84 100.1 12.98 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 36.4 m-85 -79.34 163.84 24.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.253 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -69.42 -20.24 75.16 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.703 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 42.6 m-20 -174.23 147.96 1.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 110.878 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -53.31 -25.16 13.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.023 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 18.2 m -76.64 -37.7 55.87 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 7.9 mtt -68.07 -18.94 64.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.974 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -73.26 -60.84 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.905 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -48.79 -29.59 4.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -75.04 -28.77 61.76 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.87 -53.13 5.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.995 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -55.39 -34.53 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.156 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -76.12 -45.73 32.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.656 0.265 . . . . 0.0 111.132 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -87.74 9.4 21.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -97.71 -95.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.604 0.24 . . . . 0.0 111.517 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -180.0 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.404 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.42 144.45 28.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.27 78.53 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.723 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 3.7 mt -65.72 149.43 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.557 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mt-10 -137.12 -177.09 4.61 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.794 0.331 . . . . 0.0 111.517 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.017 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.68 132.94 52.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.76 -45.14 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.8 138.75 47.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.906 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.967 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -91.78 57.59 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 179.14 -154.27 13.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.115 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 57.32 3.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.846 0.355 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.765 0.317 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' CYS . 37.3 Cg_endo -65.82 -161.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.71 2.274 . . . . 0.0 111.848 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.62 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 1.2 m-20 -49.88 82.96 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -116.91 162.72 25.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.768 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD3' ' CA ' ' A' ' 31' ' ' GLY . 74.1 Cg_endo -79.22 131.72 9.9 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.649 2.232 . . . . 0.0 112.836 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.89 45.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 7' ' ' ILE . 47.2 mt 44.76 86.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -78.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 156.63 8.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.33 17.52 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.517 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 5.8 tt0 -72.66 65.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.39 103.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.484 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.6 t0 -132.31 68.37 79.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.384 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.4 Cg_endo -58.87 93.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.132 2.555 . . . . 0.0 113.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.962 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.7 m -109.97 128.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.317 0.579 . . . . 0.0 111.178 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -79.9 130.68 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.78 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.3 149.9 18.7 Favored Glycine 0 C--O 1.25 1.111 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.152 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 t -48.59 93.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.067 -1.066 . . . . 0.0 109.586 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' SER . 10.3 t0 170.69 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.017 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.81 33.92 3.16 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.689 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.5 mm -140.15 139.13 36.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 119.493 -0.883 . . . . 0.0 113.223 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 54.4 m -91.14 114.38 26.89 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.065 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 26.9 m-85 -99.92 135.7 40.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -49.12 -26.05 5.95 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.827 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -167.28 138.43 3.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.948 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.72 -19.31 10.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 1.072 ' HA ' HD23 ' A' ' 30' ' ' LEU . 10.8 m -81.11 -33.98 32.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.32 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.465 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 3.0 mtt -73.57 -40.01 64.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.154 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.75 -17.82 46.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.445 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.072 HD23 ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -63.07 -41.41 99.43 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -64.46 -35.65 92.21 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -57.72 -34.59 69.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.875 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -51.86 33.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 3.7 t -63.64 -26.83 68.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.566 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 5.0 ptm180 -80.04 -39.27 30.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.6 t -76.09 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t0 179.66 -33.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -94.49 117.66 66.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' ILE . 43.0 Cg_endo -68.22 75.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.335 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.006 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.28 176.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.43 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.8 mm-40 -137.84 -177.16 4.69 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.377 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.962 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.13 132.1 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 44' ' ' HIS . 12.0 p -122.63 -35.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.064 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.3 m-70 -136.11 140.39 43.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 57.58 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.96 -143.33 6.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -90.12 57.54 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.112 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.881 0.372 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.73 -165.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.878 2.385 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 4' ' ' CYS . 41.2 m-20 -131.91 165.61 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -27.43 124.63 0.23 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.635 ' CG ' HD11 ' A' ' 30' ' ' LEU . 63.0 Cg_endo -94.3 -163.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.442 2.761 . . . . 0.0 112.159 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 tp -124.07 61.39 1.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 68.73 107.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.19 -75.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -161.36 165.99 28.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.062 0.458 . . . . 0.0 111.68 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.9 mmm -100.87 23.91 9.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.438 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 2.0 mt-30 -83.18 61.29 6.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -20.4 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.494 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -123.35 60.91 18.69 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.6 Cg_endo -47.83 116.29 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.403 2.736 . . . . 0.0 112.773 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.966 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -125.4 129.73 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.577 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.37 127.21 31.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.571 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.563 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -107.7 140.54 15.44 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.333 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.75 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.631 -0.785 . . . . 0.0 109.113 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' GLY . 6.0 t70 167.8 -27.97 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.722 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.02 31.81 3.73 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.2 mm -136.56 135.97 48.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 56.4 m -93.86 98.24 10.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.463 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.889 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 30.4 m-85 -79.53 147.88 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.158 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -56.32 -21.71 34.44 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.215 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 49.5 m-20 -173.69 147.13 1.36 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.667 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -51.77 -27.48 12.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.575 . . . . 0.0 109.772 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.753 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 m -72.27 -42.62 65.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.683 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -64.84 -16.38 63.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.102 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.929 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -75.08 -55.5 5.68 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.232 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.0 OUTLIER -47.38 -35.89 8.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -73.45 -30.95 61.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.805 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -72.09 -52.25 17.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.755 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -60.76 -22.52 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.573 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -39.66 36.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.984 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.24 6.4 44.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.491 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t -81.69 -95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.07 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.8 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -131.69 146.65 62.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 38' ' ' THR . 51.0 Cg_exo -52.99 94.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 0.0 112.638 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 33' ' ' SER . 18.1 mt -71.86 156.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 4.1 mm-40 -135.46 -176.51 4.3 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.627 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.966 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.77 142.03 47.29 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.518 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.448 ' C ' ' CD2' ' A' ' 44' ' ' HIS . 2.4 t -137.15 -37.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.467 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.448 ' CD2' ' C ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -135.4 136.81 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.922 0.391 . . . . 0.0 111.337 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.915 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -94.48 57.15 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.869 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.87 -143.54 5.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -90.23 52.97 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.798 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.159 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.867 0.365 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -167.81 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.785 2.323 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p30 -87.57 177.22 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.82 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.648 ' HB3' HD23 ' A' ' 30' ' ' LEU . 87.0 m -86.01 -43.91 0.6 Allowed Pre-proline 0 CA--C 1.529 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.132 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' CD ' ' HB3' ' A' ' 30' ' ' LEU . 49.6 Cg_endo -103.62 -161.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 113.232 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -162.46 55.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.979 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 8.3 mt 69.74 118.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -110.75 -84.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.1 t -166.87 -175.73 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.471 ' N ' ' OG1' ' A' ' 9' ' ' THR . 43.0 mmm -109.41 17.37 21.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.349 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -69.88 60.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -24.4 96.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.351 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -130.96 66.17 78.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.61 107.08 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.411 2.741 . . . . 0.0 112.902 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.018 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.0 m -109.14 127.4 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.628 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.69 117.94 20.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.824 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -102.32 140.6 14.93 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.063 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 6.7 t -50.18 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.09 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.37 -29.82 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.947 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.931 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 114.33 25.7 3.99 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.387 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.7 mp -132.82 154.38 39.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 CA-C-O 121.651 0.739 . . . . 0.0 112.5 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 53.8 m -112.29 99.28 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.047 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.732 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 26.4 m-85 -79.05 135.96 37.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 112.082 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -46.0 -23.45 1.09 Allowed Glycine 0 CA--C 1.506 -0.506 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.272 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 66.8 m-20 -175.55 152.23 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 0.0 110.715 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.705 ' O ' HD12 ' A' ' 30' ' ' LEU . . . -51.85 -28.75 16.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 109.523 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HA ' HD13 ' A' ' 30' ' ' LEU . 89.8 m -74.43 -42.67 58.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -61.72 -23.26 66.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -66.49 -53.72 31.94 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.7 177.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.4 mp -42.75 -40.41 2.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -67.24 -31.22 76.78 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.251 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.99 -44.17 18.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.589 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.11 -50.46 73.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 111.13 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 12.4 m -74.83 -26.5 59.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 13.1 mmm180 -94.0 -13.07 27.4 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 40.5 t -79.1 -93.08 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.819 0.342 . . . . 0.0 111.127 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.37 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.459 . . . . 0.0 110.116 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.33 127.09 26.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.539 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 44.8 Cg_exo -55.79 92.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.444 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -66.1 167.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.405 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 17.6 mt-10 -123.67 -177.46 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.82 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.018 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.77 134.59 55.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.109 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.41 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -119.88 -46.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -147.78 126.69 12.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.803 0.335 . . . . 0.0 111.09 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HA ' HG12 ' A' ' 15' ' ' VAL . 74.4 mttt -74.56 67.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.48 -164.75 30.49 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.057 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 53.0 2.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.998 0.427 . . . . 0.0 110.665 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.122 179.839 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 3.1 ttpt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 1' ' ' LYS . 18.9 Cg_endo -58.99 -173.38 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.822 2.348 . . . . 0.0 112.129 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -172.08 155.31 3.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.272 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -29.27 149.17 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.929 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 74.5 Cg_endo -93.03 177.69 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.166 2.577 . . . . 0.0 112.215 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -102.88 48.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.437 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 27.2 mt 68.17 98.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -89.97 -82.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.167 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -170.76 138.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.63 29.03 3.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.603 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 -104.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.651 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 101.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.442 0.639 . . . . 0.0 112.444 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -139.32 50.08 2.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.5 Cg_endo -48.59 114.19 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.626 2.884 . . . . 0.0 113.278 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -127.03 134.59 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.97 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.51 121.65 24.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.911 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.16 134.56 11.9 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -51.72 96.62 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.611 0.719 . . . . 0.0 110.116 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 18' ' ' SER . 62.1 t0 172.53 -29.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.716 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.71 2.04 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.257 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.606 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.2 mm -138.59 146.79 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -107.45 98.2 7.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.287 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.929 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.8 m-85 -82.39 139.76 33.87 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.404 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -47.74 -31.29 7.38 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.642 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.57 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 63.7 m-20 -160.09 144.94 14.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.514 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -54.6 -30.11 53.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.675 0.75 . . . . 0.0 109.236 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 88.8 m -72.45 -38.69 68.2 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.851 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.491 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -61.32 -18.56 59.15 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.929 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -74.98 -51.47 13.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.257 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.4 mt -47.71 -32.72 6.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' CD ' ' A' ' 35' ' ' ARG . . . -75.56 -32.24 54.96 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.09 -55.61 9.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.239 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.67 -27.08 66.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.284 0.564 . . . . 0.0 109.586 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 t -82.22 -15.95 51.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.258 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -92.86 -32.53 14.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.272 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -94.76 -111.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.137 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -176.32 30.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.78 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 m -142.8 114.69 6.02 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.33 78.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.68 2.253 . . . . 0.0 112.684 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.808 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.31 168.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.393 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.2 mt-10 -126.56 -177.27 3.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.446 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -119.8 137.42 53.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.587 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -119.47 -52.04 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.487 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.401 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.21 151.65 50.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.067 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.754 ' HA ' HG12 ' A' ' 15' ' ' VAL . 3.3 mmtt -95.24 61.75 2.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.72 -153.54 14.26 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.39 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -83.65 55.9 3.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.009 179.689 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.3 mttm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 48.0 Cg_endo -84.09 42.58 1.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 123.13 2.553 . . . . 0.0 112.302 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 122.91 28.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.34 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 1.027 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -39.6 -62.11 0.9 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.322 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 30' ' ' LEU . 33.8 Cg_endo -97.5 -164.49 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.94 2.427 . . . . 0.0 113.921 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.87 55.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.666 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 1.1 mp 71.44 160.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.508 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.79 -166.81 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.332 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -69.15 157.06 37.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.11 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtt -91.77 18.22 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.898 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -72.29 60.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.08 98.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.457 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.62 61.49 22.09 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.06 109.68 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.106 2.537 . . . . 0.0 112.093 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.802 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.9 m -122.38 125.48 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 111.175 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 118.49 20.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.214 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -97.95 136.51 12.77 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.931 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -53.18 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.614 179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 177.25 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.372 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.14 31.29 1.44 Allowed Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.91 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.6 mm -142.0 142.86 27.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.5 m -101.35 98.85 9.17 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.991 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.865 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.2 m-85 -80.0 159.21 26.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -67.08 -10.8 57.39 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.972 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 6.5 p30 165.99 156.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.34 -24.98 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.173 0.511 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 8.8 m -74.84 -49.44 20.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.773 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.522 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -61.38 -21.99 64.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.9 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.865 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -66.84 -59.18 3.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.027 HD12 ' HB3' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -53.88 -29.39 41.42 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' HA2' ' H ' ' A' ' 4' ' ' CYS . . . -66.6 -29.97 75.64 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -79.5 -52.7 7.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.752 -0.724 . . . . 0.0 110.06 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -52.74 -35.92 56.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.286 179.251 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -74.18 -35.03 63.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.404 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 4.7 ptm180 -73.52 -27.66 61.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.403 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 t -83.38 -94.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.338 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t0 179.69 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -100.43 147.84 34.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.909 0.385 . . . . 0.0 111.175 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 16.4 Cg_exo -67.66 79.7 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.963 2.442 . . . . 0.0 112.416 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.666 HD13 ' OH ' ' A' ' 23' ' ' TYR . 74.4 mt -44.19 152.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 22.7 mt-10 -123.34 -177.29 3.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.345 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -118.82 147.27 44.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -43.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 135.97 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.75 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -88.99 66.36 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.08 -155.38 16.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.166 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.09 54.1 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 0.0 110.515 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.811 0.338 . . . . 0.0 111.201 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 1' ' ' LYS . 64.9 Cg_exo -51.87 -160.16 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.814 2.342 . . . . 0.0 112.48 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.567 ' N ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -79.81 45.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.844 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 1.6 m -117.58 139.48 26.3 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HB3' HD12 ' A' ' 30' ' ' LEU . 66.8 Cg_endo -103.14 42.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.492 2.795 . . . . 0.0 113.189 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 5' ' ' PRO . 9.8 mt 28.7 49.58 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.229 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 13.6 mm 68.72 161.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.746 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.12 -166.53 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.462 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 10' ' ' MET . 0.7 OUTLIER -69.63 179.21 2.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.339 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.47 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.31 28.66 8.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.503 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 4.1 mm-40 -80.85 62.98 5.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.275 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.63 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.159 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.758 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -122.8 63.75 21.29 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.8 Cg_endo -49.06 101.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.077 2.518 . . . . 0.0 112.192 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.3 m -108.0 126.63 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.308 0.575 . . . . 0.0 110.921 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.85 121.87 25.37 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.733 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -99.88 137.33 13.19 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.229 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -50.25 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.803 0.811 . . . . 0.0 109.376 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' GLY . 2.5 p30 172.12 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.477 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.08 31.44 2.25 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.643 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 33.0 mm -137.8 138.86 43.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.5 m -99.13 102.93 14.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.357 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 21.0 m-85 -84.34 143.01 29.77 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.381 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -53.75 -16.59 5.78 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.374 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 15.6 m-20 177.41 150.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.16 -29.4 21.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 56.6 m -73.65 -39.84 64.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.268 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.467 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.45 -25.78 68.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.944 HD22 HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -65.77 -54.37 28.02 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.252 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.674 HD12 ' HB3' ' A' ' 5' ' ' PRO . 5.8 mt -48.71 -39.98 26.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -59.6 -31.92 72.25 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -73.72 -57.39 4.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.451 -0.874 . . . . 0.0 110.699 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.781 ' HB2' HD13 ' A' ' 40' ' ' ILE . 30.3 t -56.74 -50.49 72.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.605 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -61.08 -27.41 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.923 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.1 mtp180 -109.79 8.95 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 27.9 t -104.35 -98.98 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.505 0.193 . . . . 0.0 111.463 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.6 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 131.62 22.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 59.8 Cg_endo -71.12 82.24 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.623 2.215 . . . . 0.0 112.277 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.944 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -54.84 174.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.665 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 37.7 mt-10 -131.16 -177.65 4.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -113.03 132.25 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.194 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -111.85 -51.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.383 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.36 129.93 17.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.875 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -74.85 62.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.42 -168.59 33.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.13 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -80.3 51.71 1.46 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.741 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.022 179.717 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.549 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.87 0.366 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 56.1 Cg_endo -95.88 -163.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.492 2.795 . . . . 0.0 112.374 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 mp -132.09 58.54 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 61.2 mt 65.1 102.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.38 -84.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -169.5 178.98 3.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.235 0.541 . . . . 0.0 112.119 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.421 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -110.58 11.67 22.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.226 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.71 67.6 1.6 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.1 96.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.409 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -120.78 58.93 7.09 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 Cg_endo -48.77 115.55 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.646 2.897 . . . . 0.0 113.442 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.8 m -121.99 133.59 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 119.36 22.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.823 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -106.12 139.63 14.87 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.048 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 19.5 t -49.71 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.243 -0.979 . . . . 0.0 109.585 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 5.5 t0 170.48 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.352 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.55 2.98 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.607 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.2 mm -139.05 141.55 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.12 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -96.86 99.02 10.6 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.995 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.011 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.4 m-85 -82.26 138.94 34.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -40.69 -29.27 0.25 Allowed Glycine 0 CA--C 1.505 -0.593 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.717 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 10.1 p30 -173.89 147.01 1.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.088 0.471 . . . . 0.0 110.833 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.608 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -49.57 -26.24 3.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.513 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.1 m -72.66 -43.44 63.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.43 0.633 . . . . 0.0 110.222 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 1.8 mmm -61.46 -17.57 55.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.169 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 40' ' ' ILE . 1.8 mt -76.62 -50.52 13.6 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.598 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -48.61 -34.71 12.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -34.01 67.33 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -71.32 -61.69 1.68 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.619 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.823 ' N ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -48.79 -28.46 3.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.135 0.493 . . . . 0.0 110.017 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -73.42 -32.3 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.603 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.27 56.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 7.7 t -108.91 -71.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -173.78 -36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.211 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.64 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.06 174.98 2.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 38' ' ' THR . 56.4 Cg_endo -71.98 92.16 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.549 2.166 . . . . 0.0 112.013 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 29' ' ' LEU . 22.8 pt -83.4 167.28 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.505 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.4 mm-40 -149.38 -176.68 5.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.023 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.3 140.15 48.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.701 0.286 . . . . 0.0 110.812 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -122.5 -47.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -136.65 133.9 36.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.81 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG12 ' A' ' 15' ' ' VAL . 19.6 pttt -86.02 64.72 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.22 -150.01 9.5 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.175 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -90.3 53.9 2.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.818 0.342 . . . . 0.0 110.49 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' OXT' ' O ' ' A' ' 47' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.958 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.823 0.344 . . . . 0.0 110.525 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 88.8 Cg_endo -78.16 -169.45 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.68 2.253 . . . . 0.0 112.211 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -125.66 64.0 1.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.648 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.3 mp 70.37 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -84.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.947 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -152.7 172.7 16.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -104.13 16.68 25.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' TYR . 84.8 mt-30 -73.66 59.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -25.66 92.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.132 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.916 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -121.9 65.51 19.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.186 178.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.3 Cg_endo -49.02 96.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.182 2.588 . . . . 0.0 112.053 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.2 m -105.58 131.64 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.409 0.623 . . . . 0.0 111.186 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.502 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.575 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -105.12 142.79 15.56 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.598 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 12.5 m -47.92 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.686 0.874 . . . . 0.0 109.079 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.754 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER 168.73 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.457 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.95 33.54 2.78 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.975 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.0 mm -140.71 139.36 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.988 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 9.2 m -94.84 100.93 12.73 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.606 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.828 ' CE1' HD21 ' A' ' 29' ' ' LEU . 21.6 m-85 -83.87 139.73 32.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.391 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -48.56 -20.75 1.77 Allowed Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 36.5 m-20 -177.92 150.76 0.64 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.04 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.623 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.5 m -73.32 -43.92 59.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.731 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -63.31 -19.98 65.08 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.693 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.952 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -68.64 -59.4 3.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.098 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -46.44 -33.12 3.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.12 -37.67 55.46 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.82 -54.46 15.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.313 -0.443 . . . . 0.0 110.848 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.31 -25.42 64.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.523 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLY . 1.5 p -75.81 -32.04 59.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 0.0 110.716 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -107.91 11.78 27.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 t -87.65 -93.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.226 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.87 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.32 . . . . 0.0 110.955 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -129.49 158.75 72.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.868 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 29.4 Cg_exo -62.22 89.68 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.831 2.354 . . . . 0.0 112.491 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' A' ' 19' ' ' ASP . 9.0 mt -71.02 149.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 4.6 mt-10 -133.28 -176.63 4.2 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.904 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -102.38 132.33 48.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 44' ' ' HIS . 9.6 p -123.44 -34.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.898 ' CE1' HG22 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -146.51 142.73 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.345 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 61.09 2.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 110.83 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.29 -153.87 11.87 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -90.3 53.89 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 110.603 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.06 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.781 0.324 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 61.2 Cg_endo -75.31 156.79 41.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.785 2.323 . . . . 0.0 113.62 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 1.1 tt 172.61 40.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt 61.68 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.223 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.34 -83.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.92 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -114.68 131.97 56.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.8 17.08 18.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.143 0.497 . . . . 0.0 110.296 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' TYR . 9.1 mt-30 -102.91 71.86 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.253 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.572 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -124.51 62.01 30.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.99 112.96 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.346 2.697 . . . . 0.0 112.978 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.013 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.9 m -121.02 130.53 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.747 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 128.13 33.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.367 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -105.52 137.57 13.81 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.124 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -50.55 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.578 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' SER . 21.1 t70 170.4 -29.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.832 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.99 33.14 2.25 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.607 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.6 mm -137.56 132.28 44.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.4 m -93.25 102.78 15.06 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.666 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.1 m-85 -81.47 166.58 20.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.218 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -78.71 -13.59 82.98 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.842 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 29.2 m-20 -179.4 149.81 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.632 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.54 5.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.454 0.645 . . . . 0.0 109.281 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.835 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -75.4 -45.62 37.9 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.991 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -55.89 -30.02 60.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.36 -51.07 65.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.887 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.835 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.4 pp -47.0 -39.9 13.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' ARG . . . -65.28 -35.65 91.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.873 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -60.33 -45.99 91.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.743 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.507 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.27 -50.34 73.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.849 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 15.6 t -70.12 -35.09 73.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.87 -32.93 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.725 0.298 . . . . 0.0 111.25 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 t -88.19 -93.68 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.779 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.81 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.043 0.449 . . . . 0.0 110.389 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.506 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -90.51 136.15 28.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.818 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 3.0 Cg_exo -74.68 64.29 5.73 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -44.05 166.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt-10 -132.45 -177.63 4.56 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.47 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -106.33 132.4 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.134 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.822 HG22 ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -127.4 -42.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.463 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.822 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.9 m-70 -128.38 115.35 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.835 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 15' ' ' VAL . 1.4 mtmt -76.62 53.53 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.35 -147.21 5.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 57.25 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 110.464 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.866 0.365 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.2 Cg_endo -93.17 42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.172 2.581 . . . . 0.0 112.627 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 5' ' ' PRO . 3.7 mt 27.02 61.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.88 102.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -90.68 -86.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 10' ' ' MET . 9.7 t -171.58 -154.57 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.52 ' O ' ' C ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -107.41 -47.88 3.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.335 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 9.15 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.13 0.894 . . . . 0.0 111.892 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -32.41 90.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.302 0.572 . . . . 0.0 111.362 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.884 ' O ' HG13 ' A' ' 15' ' ' VAL . 37.5 t0 -129.91 57.01 27.74 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.291 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.26 87.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.051 2.501 . . . . 0.0 112.076 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 13' ' ' ASP . 14.0 m -91.95 127.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.413 0.625 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.48 115.08 17.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.485 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.25 140.41 14.86 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.762 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -51.21 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.379 -0.911 . . . . 0.0 109.905 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.01 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.171 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.68 33.56 1.7 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.329 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -140.39 152.54 21.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 97.2 m -109.51 98.36 7.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.974 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 39.3 m-85 -80.8 134.74 35.84 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.67 -23.62 0.19 Allowed Glycine 0 CA--C 1.507 -0.423 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.426 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 28' ' ' MET . 14.1 p30 -178.52 149.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.271 0.557 . . . . 0.0 111.142 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.14 -24.49 4.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.484 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 10.0 m -74.22 -39.96 62.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.25 0.548 . . . . 0.0 110.402 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.03 -21.64 66.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.89 -179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 2.2 mt -75.13 -51.54 13.2 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 92.9 mt -48.86 -33.79 11.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.01 -27.4 64.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.856 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.03 -54.76 5.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.498 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -26.66 68.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 7.0 p -84.07 -31.39 25.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.634 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 9.1 mmm180 -100.71 3.64 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.594 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 38.4 t -93.89 -98.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' SER . 8.9 t70 179.11 -31.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.973 0.416 . . . . 0.0 110.644 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.0 m -115.68 103.4 53.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.253 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.27 92.75 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.102 2.535 . . . . 0.0 112.943 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.857 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.48 177.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.415 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.9 mt-10 -135.92 -177.86 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.531 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.891 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.68 137.11 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.081 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.47 -53.14 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.303 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.575 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.14 148.66 52.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -93.3 56.71 2.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.748 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' PRO . . . -178.69 -156.21 16.48 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.266 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.03 56.78 3.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.33 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.55 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' C ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.004 0.43 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 97.6 Cg_endo -93.31 -162.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.266 2.644 . . . . 0.0 113.112 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 6' ' ' LEU . 1.3 pt? -159.69 51.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.902 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm 60.72 87.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.426 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -80.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.5 t -168.63 -179.41 3.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.161 0.505 . . . . 0.0 111.77 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.3 OUTLIER -111.24 21.36 16.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.251 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 12' ' ' TYR . 7.3 mm-40 -78.23 59.7 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.929 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -21.43 94.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.496 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -123.37 65.94 32.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.58 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.349 2.699 . . . . 0.0 112.907 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.7 m -108.84 131.09 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.09 114.56 17.08 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.132 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -96.97 134.33 11.73 Favored Glycine 0 C--O 1.25 1.094 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.991 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -56.81 90.96 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.851 0.834 . . . . 0.0 109.32 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' GLY . 4.1 t70 -175.97 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.16 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.13 26.77 0.88 Allowed Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.324 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -148.09 168.83 3.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 21' ' ' ILE . 30.3 m -119.79 99.3 6.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.088 -1.414 . . . . 0.0 109.356 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.825 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 16.1 m-85 -82.8 136.17 34.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -43.81 -26.98 0.86 Allowed Glycine 0 CA--C 1.506 -0.515 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.752 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 76.3 m-20 -169.79 146.82 3.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -51.22 -28.35 11.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.659 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.626 ' HA ' HD12 ' A' ' 30' ' ' LEU . 95.1 m -73.38 -44.23 59.01 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.741 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.53 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 3.1 mtp -61.31 -19.82 62.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -70.19 -47.14 62.83 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.82 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.97 -36.62 12.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' NE ' ' A' ' 35' ' ' ARG . . . -71.27 -31.54 66.07 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.54 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -72.21 -56.5 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.089 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -41.01 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 109.646 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.02 -39.74 79.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.871 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 31' ' ' GLY . 10.0 mtt180 -74.66 -22.31 58.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.02 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -86.13 -99.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.536 0.207 . . . . 0.0 110.99 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.54 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.996 0.427 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.77 159.51 29.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.28 83.92 2.15 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.808 2.338 . . . . 0.0 112.588 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.807 HG21 HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -38.45 152.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.756 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.5 mm-40 -119.21 -179.74 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.428 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.843 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -126.31 137.36 53.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.608 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -115.65 -45.4 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.148 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.559 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -144.5 125.13 14.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -75.04 58.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -176.56 -153.48 10.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.95 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -87.48 56.44 3.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' HD12 ' A' ' 30' ' ' LEU . 8.8 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.933 0.396 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 90.7 Cg_endo -91.39 179.12 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.882 2.388 . . . . 0.0 113.579 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 6' ' ' LEU . 1.8 pt? -165.11 41.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.375 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt 58.08 86.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.282 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -85.3 -70.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.795 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -165.74 151.96 9.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.23 23.72 7.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -83.04 64.71 7.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.67 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.27 95.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.578 -178.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.1 t0 -123.55 63.07 25.51 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.081 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.6 Cg_endo -50.04 102.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.142 2.561 . . . . 0.0 112.351 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.4 m -108.74 139.37 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.914 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.93 117.11 19.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.39 134.3 11.67 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.838 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -51.55 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.698 -0.751 . . . . 0.0 109.557 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 177.23 -35.66 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.789 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.47 33.38 0.95 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.863 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.3 mt -146.06 157.99 11.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 85.9 m -110.01 98.35 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.195 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.845 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.4 m-85 -82.18 134.76 35.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -42.17 -27.14 0.4 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.774 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 76.3 m-20 -168.36 146.07 4.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.201 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.52 -28.0 28.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.405 0.621 . . . . 0.0 109.505 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.587 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.9 m -73.37 -40.68 64.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.608 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.49 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.1 mmt -66.99 -15.84 63.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.091 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.035 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -74.03 -61.91 1.69 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.442 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -48.87 -32.1 8.31 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.644 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.546 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -73.18 -31.77 61.14 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.68 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.59 -56.87 4.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.568 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.51 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.96 -32.91 2.99 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 109.792 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -68.6 -47.84 65.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.142 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 4.0 mmm180 -60.38 -26.71 66.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.478 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -87.85 -108.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.322 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -179.52 33.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.878 0.371 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -158.27 124.54 2.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 15.3 Cg_exo -67.85 71.2 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.852 2.368 . . . . 0.0 112.61 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.675 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.43 176.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.825 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' OG ' ' A' ' 18' ' ' SER . 7.5 mt-10 -139.2 -177.21 4.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.561 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.035 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.0 140.67 49.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 1.5 t -123.66 -43.28 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.4 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.556 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -141.68 149.1 40.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -93.95 61.21 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.16 -149.79 11.07 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.05 56.5 4.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.972 0.415 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.5 m . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.984 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.857 0.36 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 78.0 Cg_endo -98.64 -173.82 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.387 2.724 . . . . 0.0 112.214 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.11 61.74 1.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.681 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mm 63.04 87.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.828 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.98 -79.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.1 t -169.72 -178.58 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.175 0.512 . . . . 0.0 111.714 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -107.54 11.83 28.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.518 179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 12' ' ' TYR . 19.2 mm100 -66.91 62.37 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.513 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -22.54 94.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -117.34 58.63 2.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.7 Cg_endo -50.39 102.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.359 2.706 . . . . 0.0 112.745 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.05 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.2 m -113.42 123.23 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 116.6 18.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.418 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -95.59 135.65 12.47 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.365 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -50.0 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.692 0.758 . . . . 0.0 109.882 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 171.23 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.78 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.47 33.19 2.54 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -135.31 124.57 41.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -90.15 98.8 11.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.656 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 13.6 m-85 -80.76 148.66 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.91 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -59.16 -11.5 12.74 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.416 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 9.6 p30 163.85 155.23 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.24 -25.22 0.89 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.304 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.837 ' HA ' HD12 ' A' ' 30' ' ' LEU . 63.7 m -77.02 -46.23 24.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.62 0.724 . . . . 0.0 110.009 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -61.95 -22.46 65.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.454 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.656 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -68.05 -49.06 63.72 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.864 177.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.87 -38.32 15.96 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -64.4 -35.55 92.09 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.4 -64.83 0.82 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.099 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.438 ' N ' HD11 ' A' ' 40' ' ' ILE . 30.9 t -46.86 -36.83 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.054 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 13.1 t -54.96 -47.8 74.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.495 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 7.3 mtp180 -143.57 51.18 1.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 13.4 t -97.03 -73.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 110.529 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.71 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.523 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.499 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -152.15 159.62 32.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.233 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 18.4 Cg_endo -59.54 87.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.624 2.216 . . . . 0.0 112.146 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -64.72 145.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.099 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm-40 -113.29 -177.31 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.05 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.08 136.3 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.431 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -122.3 -49.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.607 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.67 143.49 48.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.815 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 15' ' ' VAL . 4.8 pttp -94.23 57.2 2.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.128 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.28 -150.64 7.58 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.013 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -89.43 57.43 3.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 30' ' ' LEU . 68.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.342 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.536 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 6.0 Cg_endo -48.59 137.52 26.02 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.939 2.426 . . . . 0.0 112.605 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -160.77 44.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.748 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 27.95 105.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -104.04 -79.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.036 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.486 HG21 ' HG2' ' A' ' 11' ' ' GLN . 1.7 t -163.15 -178.44 6.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.901 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 12' ' ' TYR . 1.8 mtm -114.85 10.12 16.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.033 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.3 OUTLIER -67.06 62.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 109.968 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.492 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.43 93.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.433 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -119.87 65.39 9.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.89 108.69 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.019 2.48 . . . . 0.0 112.748 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.92 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.4 m -120.0 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.151 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.592 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.57 117.83 20.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.566 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 139.64 14.5 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.073 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 38.8 t -50.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.808 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CG ' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 171.56 -29.32 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.812 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.17 32.13 3.11 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.372 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 34.1 mm -135.64 133.61 51.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -94.76 98.33 10.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.095 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.749 ' CE1' HD21 ' A' ' 29' ' ' LEU . 24.8 m-85 -79.27 153.27 30.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.939 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' ASN . . . -64.03 -10.14 38.4 Favored Glycine 0 C--N 1.328 0.124 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.5 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 28' ' ' MET . 12.3 p30 166.8 153.31 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 0.0 110.184 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.71 -26.21 2.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HA ' HD23 ' A' ' 30' ' ' LEU . 9.0 m -75.12 -43.87 50.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.546 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.67 -18.53 65.06 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.905 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.17 -57.41 4.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.285 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -49.44 -35.82 20.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 5' ' ' PRO . . . -71.51 -27.85 70.57 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -76.8 -58.75 3.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.563 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.617 ' N ' HD11 ' A' ' 40' ' ' ILE . 3.7 t -42.1 -37.34 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.453 0.644 . . . . 0.0 109.347 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 21.6 t -64.61 -50.52 66.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.406 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 8.9 mmm180 -77.24 -10.47 59.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.049 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -82.65 -96.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 179.18 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.0 110.488 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.636 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -117.76 163.86 22.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.075 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.636 ' HD2' HG22 ' A' ' 38' ' ' THR . 71.7 Cg_endo -77.6 75.61 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.837 2.358 . . . . 0.0 112.048 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 33' ' ' SER . 1.5 pt -52.5 154.01 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.117 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -122.66 -175.99 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.92 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -112.08 132.48 54.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.369 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.23 -53.14 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.258 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.575 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -132.99 144.8 50.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.923 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -91.36 65.41 5.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 172.63 -159.77 30.61 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.102 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -79.52 55.05 1.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 110.688 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.462 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 94.5 Cg_endo -94.83 -165.41 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.373 2.716 . . . . 0.0 112.891 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' LEU . 7.9 tp -164.9 52.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.928 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.0 mp 63.71 85.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.225 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -76.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.261 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -169.2 179.09 4.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.071 0.462 . . . . 0.0 111.502 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.52 19.38 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -73.19 58.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.963 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -25.49 97.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.928 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.4 t0 -126.48 61.71 44.64 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.055 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.8 Cg_endo -47.67 93.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.189 2.592 . . . . 0.0 112.035 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.036 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.8 m -102.76 131.85 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 121.64 24.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.328 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -100.73 141.4 15.35 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.39 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 66.3 m -53.29 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.184 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 40' ' ' ILE . 19.9 t70 176.57 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.261 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.33 32.49 1.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.885 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 22' ' ' THR . 6.7 mt -143.7 160.84 16.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 41.5 m -113.03 108.09 16.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 29' ' ' LEU . 15.0 m-85 -93.06 136.32 33.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.323 0.582 . . . . 0.0 112.31 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -47.06 -22.98 1.44 Allowed Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.202 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 61.0 m-20 -174.08 150.38 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.82 -28.9 10.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.348 0.594 . . . . 0.0 109.567 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.83 -45.5 58.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.501 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -60.56 -23.27 64.49 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.36 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -65.29 -50.77 64.45 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.381 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.1 mt -48.97 -36.3 17.21 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -65.2 -29.93 76.56 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.83 -64.67 0.99 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.95 -0.625 . . . . 0.0 110.179 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -30.09 12.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.186 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 7.4 t -63.43 -50.51 69.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.713 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 35' ' ' ARG . 1.2 mmm180 -100.87 18.74 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 9.7 t -103.42 -119.8 0.2 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' SER . 6.3 t70 178.84 29.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.064 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.439 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 2.4 m -160.47 139.66 7.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.371 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 29.6 Cg_endo -63.81 82.18 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.628 2.219 . . . . 0.0 112.414 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 29' ' ' LEU . 18.8 mt -67.43 139.54 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.666 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt-10 -126.3 -177.55 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.036 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -104.96 132.73 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -127.28 -32.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.328 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.895 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.7 m-70 -139.78 134.22 31.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.88 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -89.54 55.28 3.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . 177.08 -155.35 17.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.256 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 58.1 3.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.401 . . . . 0.0 110.606 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 89.7 Cg_endo -83.09 163.69 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.033 2.489 . . . . 0.0 112.597 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.5 tp -84.73 53.33 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.482 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 5.0 mt 68.57 96.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.29 -83.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.198 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -164.78 154.28 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.37 32.83 5.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.491 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -79.06 -104.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.247 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.43 91.67 0.09 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.19 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -129.46 53.32 11.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.1 Cg_endo -49.79 116.03 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.736 2.957 . . . . 0.0 113.902 -177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.2 m -129.6 124.83 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.865 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.38 134.74 37.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.937 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.02 142.24 17.41 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.325 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.08 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.359 -0.92 . . . . 0.0 109.035 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' SER . 8.7 t70 167.58 -28.11 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.422 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.795 ' C ' HD12 ' A' ' 21' ' ' ILE . . . 108.81 22.88 6.74 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.626 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.795 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.3 mp -123.21 152.54 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.56 0.695 . . . . 0.0 112.458 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 14.1 m -111.07 98.56 7.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.072 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.841 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.9 m-85 -81.09 138.95 35.93 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.986 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.63 -27.54 19.31 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.948 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 62.7 m-80 -164.08 148.41 10.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -55.68 -26.96 47.48 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 62.7 m -73.81 -37.79 64.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.855 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.1 mtt -67.5 -19.33 65.31 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.866 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -72.13 -57.5 4.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.015 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -50.77 -31.43 16.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.59 -26.11 70.62 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.82 -59.57 2.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.019 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.881 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -54.32 -23.62 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.787 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' ARG . 11.9 p -89.96 -44.02 10.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.805 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.68 -30.16 59.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.964 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -73.76 -91.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.941 0.4 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.46 -35.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.372 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.23 116.11 64.26 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 49.0 Cg_endo -69.3 74.83 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.749 2.299 . . . . 0.0 112.328 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.897 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.81 177.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.3 mm-40 -134.69 -177.6 4.69 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.009 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.63 132.88 49.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 110.251 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.865 HG22 ' CE1' ' A' ' 44' ' ' HIS . 14.6 p -123.59 -40.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.235 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.865 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.7 m-70 -133.81 134.46 42.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.551 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.767 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.87 55.52 2.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -176.1 -145.08 5.41 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.203 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' CYS . 3.7 ptt85 -90.54 56.65 3.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 71.3 Cg_endo -94.96 -173.66 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.252 2.634 . . . . 0.0 112.426 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.75 57.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.8 mt 63.63 97.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.097 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.84 -85.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.2 t -170.68 -177.77 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 111.987 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' ' OG1' ' A' ' 9' ' ' THR . 2.8 ptt? -115.28 20.69 14.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.486 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.18 67.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.45 89.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.404 -178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.39 61.05 14.33 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.9 Cg_endo -49.48 114.82 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.598 2.866 . . . . 0.0 112.942 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.944 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.7 m -119.04 133.64 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.424 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.79 117.83 19.55 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -98.42 134.48 11.72 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.079 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' A' ' 41' ' ' GLU . 30.8 t -51.34 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.412 0.713 . . . . 0.0 109.177 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 174.11 -31.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.491 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.11 30.63 2.24 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.678 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 15.6 mm -142.38 142.64 27.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -97.55 100.59 12.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.104 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.859 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.8 m-85 -79.97 142.49 35.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.367 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.71 -22.31 2.7 Favored Glycine 0 CA--C 1.507 -0.444 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 2.8 m-20 -173.04 146.15 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.882 0.372 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -52.91 -28.61 24.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.27 0.557 . . . . 0.0 109.518 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 88.9 m -71.79 -41.03 68.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.753 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.52 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 13.4 mtp -62.91 -23.43 67.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.959 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -69.83 -48.62 58.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.43 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 7.2 mt -50.57 -33.51 22.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . -68.62 -31.16 73.18 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.13 -65.11 0.88 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.175 0.512 . . . . 0.0 109.9 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.58 ' CA ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -48.49 -27.88 2.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 16.5 t -75.1 -30.82 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.933 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -55.07 -35.89 65.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . 8.1 t -100.68 -64.14 1.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.795 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 33' ' ' SER . 20.9 t0 179.68 -69.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.154 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.583 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 t -160.87 37.26 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.769 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -89.04 31.82 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 112.944 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.039 HG21 HD22 ' A' ' 29' ' ' LEU . 1.1 mm -138.06 133.06 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 18' ' ' SER . 1.2 tt0 -127.81 -178.1 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.693 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.944 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -117.1 142.38 47.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.919 0.39 . . . . 0.0 110.73 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.589 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -127.06 -49.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.589 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.42 153.56 45.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.287 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.795 ' HA ' HG12 ' A' ' 15' ' ' VAL . 6.2 mmtp -95.3 58.83 2.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.91 -153.78 15.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.9 57.77 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.625 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.007 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 4.9 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.918 0.389 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 54.8 Cg_endo -89.85 -165.6 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.227 2.618 . . . . 0.0 112.998 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 11.9 mt -133.96 57.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.205 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 7.2 mt 70.15 99.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.992 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -82.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.821 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 10' ' ' MET . 2.5 t -146.4 -39.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.718 0.294 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.46 11.85 4.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.596 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.7 -76.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.436 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.84 96.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.586 0.708 . . . . 0.0 112.399 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -138.96 51.3 3.31 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.0 Cg_endo -47.76 109.37 0.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.924 3.082 . . . . 0.0 113.516 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.938 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.5 m -118.39 136.79 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.474 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.95 120.0 22.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.993 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -104.47 137.88 13.83 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.868 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.534 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 t -47.92 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.392 0.701 . . . . 0.0 109.395 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER 168.46 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.555 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.99 32.98 3.35 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.682 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.1 mm -137.68 132.49 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.839 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -89.26 98.01 11.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.149 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.902 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 56.8 m-85 -79.46 134.45 36.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.512 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -36.41 -31.94 0.05 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.551 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 55.8 m-80 -164.8 147.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.97 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -54.5 -27.2 36.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.282 0.563 . . . . 0.0 109.574 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.7 m -74.65 -40.14 61.65 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.404 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -59.63 -21.79 60.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.949 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.034 HD12 ' CD2' ' A' ' 42' ' ' LEU . 1.6 mt -75.91 -52.92 9.26 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.387 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 11.6 mt -49.0 -28.84 4.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -76.69 -32.03 51.81 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.512 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 36' ' ' SER . . . -79.77 -52.36 8.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.36 -0.42 . . . . 0.0 112.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -61.68 -31.31 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.49 -23.38 22.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.6 mtt180 -113.82 8.77 17.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -100.97 -98.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -161.31 -40.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.64 131.83 21.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.745 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.87 72.67 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.548 2.165 . . . . 0.0 112.372 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.795 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.95 170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.1 mt-10 -134.13 -176.22 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.624 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.034 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -121.54 132.05 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.281 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.624 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -117.07 -38.61 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.217 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -146.17 147.07 31.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -94.87 57.7 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.303 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -174.44 -154.64 11.14 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.282 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.35 56.82 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.644 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.937 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 73.9 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.985 0.421 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 30' ' ' LEU . 92.4 Cg_endo -90.54 173.6 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.173 2.582 . . . . 0.0 112.753 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.43 74.32 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.733 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mp 74.64 143.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.094 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -132.14 -101.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.686 HG23 ' N ' ' A' ' 10' ' ' MET . 9.8 t -173.12 -143.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.497 0.589 . . . . 0.0 110.863 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.686 ' N ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER 35.48 35.84 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' C ' ' O ' ' A' ' 10' ' ' MET . 3.2 tm0? -0.91 -64.25 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.25 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -121.33 84.48 2.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.719 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 15' ' ' VAL . 4.7 t70 -123.5 61.88 22.12 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.4 Cg_endo -50.13 105.4 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.381 2.721 . . . . 0.0 113.348 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.023 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -118.84 122.59 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.269 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.49 128.8 34.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.805 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.561 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -110.78 144.42 17.25 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.782 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -50.38 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.709 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 170.43 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.767 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.61 31.52 3.42 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.212 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 14.0 mm -133.4 143.39 39.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.0 m -103.28 98.55 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.283 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.784 ' CE1' HD21 ' A' ' 29' ' ' LEU . 20.6 m-85 -81.46 141.8 33.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.08 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 25' ' ' ASN . . . -58.86 -12.5 14.97 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.446 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 10' ' ' MET . 50.5 t-20 178.61 149.55 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.396 . . . . 0.0 110.634 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.28 -30.72 18.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 1.5 m -76.02 -39.5 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.131 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.556 ' HG3' ' HB3' ' A' ' 25' ' ' ASN . 12.1 mtp -63.74 -17.56 63.14 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -71.3 -55.2 8.51 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.692 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.551 HD12 ' HG3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -48.15 -31.73 6.04 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -71.41 -31.68 65.61 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.37 -55.52 4.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.193 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.819 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -48.24 -38.51 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 110.574 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.09 -29.64 34.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.6 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 7.4 ptm180 -84.92 -18.77 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.5 t -82.67 -96.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.636 0.255 . . . . 0.0 111.11 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 179.11 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.08 124.54 32.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.09 87.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.937 2.425 . . . . 0.0 112.99 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.991 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -67.07 175.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 26.1 mt-10 -138.94 -177.61 4.96 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.587 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.023 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 139.39 36.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.825 HG22 ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -134.8 -43.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.317 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.825 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.4 m-70 -125.16 126.82 45.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 15' ' ' VAL . 9.2 mmtt -85.98 58.17 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 176.8 -144.29 6.78 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.865 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -90.61 58.45 3.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.892 0.377 . . . . 0.0 110.957 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.129 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 92.1 m . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.851 0.358 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -86.91 -171.9 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.957 2.438 . . . . 0.0 112.847 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -118.62 62.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.347 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 10.4 mt 67.4 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.333 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.59 -83.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 t -161.95 161.8 28.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.092 0.472 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.0 25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.401 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' TYR . 36.9 mt-30 -83.66 63.44 7.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.81 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.6 99.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.769 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -133.43 64.85 70.56 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.0 Cg_endo -50.31 121.82 8.34 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.256 2.637 . . . . 0.0 113.067 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.017 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.5 m -127.3 132.87 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.728 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -77.88 123.0 26.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.16 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.722 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.54 135.99 12.5 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.203 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 12.0 t -49.43 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.097 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' GLY . 5.1 t0 169.15 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.845 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.24 31.79 2.97 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.729 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 mm -138.05 129.43 38.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 55.1 m -89.84 100.1 12.98 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 36.4 m-85 -79.34 163.84 24.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.253 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -69.42 -20.24 75.16 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.703 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 42.6 m-20 -174.23 147.96 1.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 110.878 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -53.31 -25.16 13.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.023 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 18.2 m -76.64 -37.7 55.87 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 7.9 mtt -68.07 -18.94 64.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.974 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -73.26 -60.84 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.905 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -48.79 -29.59 4.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -75.04 -28.77 61.76 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.87 -53.13 5.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.995 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -55.39 -34.53 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.156 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -76.12 -45.73 32.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.656 0.265 . . . . 0.0 111.132 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -87.74 9.4 21.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -97.71 -95.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.604 0.24 . . . . 0.0 111.517 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -180.0 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.404 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.42 144.45 28.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.27 78.53 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.723 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 3.7 mt -65.72 149.43 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.557 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mt-10 -137.12 -177.09 4.61 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.794 0.331 . . . . 0.0 111.517 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.017 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.68 132.94 52.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.604 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -121.76 -45.14 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.604 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER -132.8 138.75 47.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.906 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.967 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -91.78 57.59 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 179.14 -154.27 13.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.115 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 57.32 3.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.846 0.355 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.853 0.359 . . . . 0.0 110.768 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD3' ' CA ' ' A' ' 31' ' ' GLY . 74.1 Cg_endo -79.22 131.72 9.9 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.649 2.232 . . . . 0.0 112.836 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.89 45.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 7' ' ' ILE . 47.2 mt 44.76 86.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -78.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 156.63 8.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.33 17.52 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.517 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 5.8 tt0 -72.66 65.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.39 103.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.484 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.6 t0 -132.31 68.37 79.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.384 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.4 Cg_endo -58.87 93.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.132 2.555 . . . . 0.0 113.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.962 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.7 m -109.97 128.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.317 0.579 . . . . 0.0 111.178 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -79.9 130.68 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.78 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.3 149.9 18.7 Favored Glycine 0 C--O 1.25 1.111 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.152 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 t -48.59 93.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.067 -1.066 . . . . 0.0 109.586 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' SER . 10.3 t0 170.69 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.017 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.81 33.92 3.16 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.689 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.5 mm -140.15 139.13 36.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 119.493 -0.883 . . . . 0.0 113.223 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 54.4 m -91.14 114.38 26.89 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.065 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 26.9 m-85 -99.92 135.7 40.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -49.12 -26.05 5.95 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.827 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -167.28 138.43 3.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.948 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.72 -19.31 10.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 1.072 ' HA ' HD23 ' A' ' 30' ' ' LEU . 10.8 m -81.11 -33.98 32.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.32 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.465 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 3.0 mtt -73.57 -40.01 64.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.154 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.75 -17.82 46.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.445 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.072 HD23 ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -63.07 -41.41 99.43 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -64.46 -35.65 92.21 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -57.72 -34.59 69.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.875 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -51.86 33.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.7 t -63.64 -26.83 68.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.566 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 5.0 ptm180 -80.04 -39.27 30.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.6 t -76.09 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t0 179.66 -33.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -94.49 117.66 66.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' ILE . 43.0 Cg_endo -68.22 75.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.335 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.006 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.28 176.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.43 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.8 mm-40 -137.84 -177.16 4.69 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.377 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.962 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.13 132.1 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 44' ' ' HIS . 12.0 p -122.63 -35.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.064 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.3 m-70 -136.11 140.39 43.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 57.58 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.96 -143.33 6.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -90.12 57.54 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.112 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.988 0.423 . . . . 0.0 111.678 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.635 ' CG ' HD11 ' A' ' 30' ' ' LEU . 63.0 Cg_endo -94.3 -163.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.442 2.761 . . . . 0.0 112.159 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 tp -124.07 61.39 1.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 68.73 107.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.19 -75.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -161.36 165.99 28.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.062 0.458 . . . . 0.0 111.68 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.9 mmm -100.87 23.91 9.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.438 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 2.0 mt-30 -83.18 61.29 6.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -20.4 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.494 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -123.35 60.91 18.69 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.6 Cg_endo -47.83 116.29 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.403 2.736 . . . . 0.0 112.773 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.966 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -125.4 129.73 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.577 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.37 127.21 31.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.571 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.563 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -107.7 140.54 15.44 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.333 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.75 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.631 -0.785 . . . . 0.0 109.113 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' GLY . 6.0 t70 167.8 -27.97 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.722 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.02 31.81 3.73 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.2 mm -136.56 135.97 48.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 56.4 m -93.86 98.24 10.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.463 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.889 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 30.4 m-85 -79.53 147.88 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.158 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -56.32 -21.71 34.44 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.215 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 49.5 m-20 -173.69 147.13 1.36 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.667 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -51.77 -27.48 12.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.575 . . . . 0.0 109.772 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.753 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 m -72.27 -42.62 65.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.683 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -64.84 -16.38 63.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.102 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.929 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -75.08 -55.5 5.68 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.232 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.0 OUTLIER -47.38 -35.89 8.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -73.45 -30.95 61.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.805 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -72.09 -52.25 17.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.755 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -60.76 -22.52 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.573 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -39.66 36.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.984 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.24 6.4 44.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.491 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t -81.69 -95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.07 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.8 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -131.69 146.65 62.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 38' ' ' THR . 51.0 Cg_exo -52.99 94.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 0.0 112.638 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 33' ' ' SER . 18.1 mt -71.86 156.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 4.1 mm-40 -135.46 -176.51 4.3 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.627 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.966 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.77 142.03 47.29 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.518 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -137.15 -37.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.467 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.503 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 1.5 m-70 -135.4 136.81 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.922 0.391 . . . . 0.0 111.337 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.915 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -94.48 57.15 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.869 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.87 -143.54 5.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -90.23 52.97 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.798 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.159 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.648 ' HB3' HD23 ' A' ' 30' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' CD ' ' HB3' ' A' ' 30' ' ' LEU . 49.6 Cg_endo -103.62 -161.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 113.232 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -162.46 55.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.979 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 8.3 mt 69.74 118.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -110.75 -84.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.1 t -166.87 -175.73 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.471 ' N ' ' OG1' ' A' ' 9' ' ' THR . 43.0 mmm -109.41 17.37 21.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.349 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -69.88 60.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -24.4 96.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.351 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -130.96 66.17 78.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.61 107.08 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.411 2.741 . . . . 0.0 112.902 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.018 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.0 m -109.14 127.4 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.628 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.69 117.94 20.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.824 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -102.32 140.6 14.93 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.063 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 6.7 t -50.18 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.09 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.37 -29.82 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.947 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.931 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 114.33 25.7 3.99 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.387 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.7 mp -132.82 154.38 39.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 CA-C-O 121.651 0.739 . . . . 0.0 112.5 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 53.8 m -112.29 99.28 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.047 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.732 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 26.4 m-85 -79.05 135.96 37.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 112.082 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -46.0 -23.45 1.09 Allowed Glycine 0 CA--C 1.506 -0.506 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.272 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 66.8 m-20 -175.55 152.23 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 0.0 110.715 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.705 ' O ' HD12 ' A' ' 30' ' ' LEU . . . -51.85 -28.75 16.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 109.523 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HA ' HD13 ' A' ' 30' ' ' LEU . 89.8 m -74.43 -42.67 58.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -61.72 -23.26 66.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -66.49 -53.72 31.94 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.7 177.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.4 mp -42.75 -40.41 2.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -67.24 -31.22 76.78 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.251 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.99 -44.17 18.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.589 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.11 -50.46 73.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 111.13 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 12.4 m -74.83 -26.5 59.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 13.1 mmm180 -94.0 -13.07 27.4 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 40.5 t -79.1 -93.08 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.819 0.342 . . . . 0.0 111.127 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.37 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.459 . . . . 0.0 110.116 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.33 127.09 26.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.539 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 44.8 Cg_exo -55.79 92.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.444 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -66.1 167.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.405 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 17.6 mt-10 -123.67 -177.46 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.82 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.018 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.77 134.59 55.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.109 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -119.88 -46.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -147.78 126.69 12.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.803 0.335 . . . . 0.0 111.09 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HA ' HG12 ' A' ' 15' ' ' VAL . 74.4 mttt -74.56 67.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.48 -164.75 30.49 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.057 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 53.0 2.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.998 0.427 . . . . 0.0 110.665 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.122 179.839 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.929 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 74.5 Cg_endo -93.03 177.69 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.166 2.577 . . . . 0.0 112.215 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -102.88 48.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.437 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 27.2 mt 68.17 98.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -89.97 -82.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.167 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -170.76 138.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.63 29.03 3.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.603 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 -104.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.651 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 101.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.442 0.639 . . . . 0.0 112.444 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -139.32 50.08 2.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.5 Cg_endo -48.59 114.19 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.626 2.884 . . . . 0.0 113.278 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -127.03 134.59 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.97 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.51 121.65 24.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.911 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.16 134.56 11.9 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -51.72 96.62 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.611 0.719 . . . . 0.0 110.116 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 18' ' ' SER . 62.1 t0 172.53 -29.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.716 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.71 2.04 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.257 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.606 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.2 mm -138.59 146.79 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -107.45 98.2 7.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.287 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.929 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.8 m-85 -82.39 139.76 33.87 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.404 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -47.74 -31.29 7.38 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.642 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.57 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 63.7 m-20 -160.09 144.94 14.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.514 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -54.6 -30.11 53.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.675 0.75 . . . . 0.0 109.236 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 88.8 m -72.45 -38.69 68.2 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.851 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.491 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -61.32 -18.56 59.15 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.929 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -74.98 -51.47 13.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.257 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.4 mt -47.71 -32.72 6.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' CD ' ' A' ' 35' ' ' ARG . . . -75.56 -32.24 54.96 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.09 -55.61 9.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.239 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.67 -27.08 66.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.284 0.564 . . . . 0.0 109.586 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 t -82.22 -15.95 51.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.258 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -92.86 -32.53 14.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.272 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -94.76 -111.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.137 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -176.32 30.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.78 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 m -142.8 114.69 6.02 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.33 78.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.68 2.253 . . . . 0.0 112.684 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.808 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.31 168.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.2 mt-10 -126.56 -177.27 3.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.446 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -119.8 137.42 53.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.587 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -119.47 -52.04 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.487 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.21 151.65 50.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.067 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.754 ' HA ' HG12 ' A' ' 15' ' ' VAL . 3.3 mmtt -95.24 61.75 2.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.72 -153.54 14.26 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.39 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -83.65 55.9 3.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.6 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.009 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 1.027 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 30' ' ' LEU . 33.8 Cg_endo -97.5 -164.49 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.94 2.427 . . . . 0.0 113.921 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.87 55.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.666 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 1.1 mp 71.44 160.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.508 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.79 -166.81 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.332 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -69.15 157.06 37.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.11 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtt -91.77 18.22 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.898 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -72.29 60.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.08 98.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.457 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.62 61.49 22.09 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.06 109.68 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.106 2.537 . . . . 0.0 112.093 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.802 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.9 m -122.38 125.48 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 111.175 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 118.49 20.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.214 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -97.95 136.51 12.77 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.931 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -53.18 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.614 179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 177.25 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.372 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.14 31.29 1.44 Allowed Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.91 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.6 mm -142.0 142.86 27.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.5 m -101.35 98.85 9.17 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.991 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.865 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.2 m-85 -80.0 159.21 26.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -67.08 -10.8 57.39 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.972 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 6.5 p30 165.99 156.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.34 -24.98 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.173 0.511 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 8.8 m -74.84 -49.44 20.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.773 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.522 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -61.38 -21.99 64.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.9 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.865 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -66.84 -59.18 3.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.027 HD12 ' HB3' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -53.88 -29.39 41.42 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.97 75.64 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -79.5 -52.7 7.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.752 -0.724 . . . . 0.0 110.06 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -52.74 -35.92 56.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.286 179.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -35.03 63.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.404 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 4.7 ptm180 -73.52 -27.66 61.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.403 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 t -83.38 -94.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.338 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t0 179.69 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -100.43 147.84 34.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.909 0.385 . . . . 0.0 111.175 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 16.4 Cg_exo -67.66 79.7 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.963 2.442 . . . . 0.0 112.416 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.666 HD13 ' OH ' ' A' ' 23' ' ' TYR . 74.4 mt -44.19 152.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 22.7 mt-10 -123.34 -177.29 3.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.345 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -118.82 147.27 44.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.555 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -133.89 -43.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.555 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -142.23 135.97 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.04 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.75 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -88.99 66.36 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.08 -155.38 16.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.166 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.09 54.1 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 0.0 110.515 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 1.6 m . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HB3' HD12 ' A' ' 30' ' ' LEU . 66.8 Cg_endo -103.14 42.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.492 2.795 . . . . 0.0 113.189 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 5' ' ' PRO . 9.8 mt 28.7 49.58 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.229 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 13.6 mm 68.72 161.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.746 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.12 -166.53 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.462 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 10' ' ' MET . 0.7 OUTLIER -69.63 179.21 2.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.339 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.47 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.31 28.66 8.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 4.1 mm-40 -80.85 62.98 5.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.275 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.63 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.159 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.758 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -122.8 63.75 21.29 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.8 Cg_endo -49.06 101.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.077 2.518 . . . . 0.0 112.192 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.3 m -108.0 126.63 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.308 0.575 . . . . 0.0 110.921 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.85 121.87 25.37 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.733 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -99.88 137.33 13.19 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.229 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -50.25 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.803 0.811 . . . . 0.0 109.376 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' GLY . 2.5 p30 172.12 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.477 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.08 31.44 2.25 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.643 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 33.0 mm -137.8 138.86 43.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.5 m -99.13 102.93 14.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.357 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 21.0 m-85 -84.34 143.01 29.77 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.381 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -53.75 -16.59 5.78 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.374 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 15.6 m-20 177.41 150.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.16 -29.4 21.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 56.6 m -73.65 -39.84 64.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.268 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.467 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.45 -25.78 68.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.944 HD22 HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -65.77 -54.37 28.02 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.252 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.674 HD12 ' HB3' ' A' ' 5' ' ' PRO . 5.8 mt -48.71 -39.98 26.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -59.6 -31.92 72.25 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -73.72 -57.39 4.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.451 -0.874 . . . . 0.0 110.699 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.781 ' HB2' HD13 ' A' ' 40' ' ' ILE . 30.3 t -56.74 -50.49 72.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.605 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -61.08 -27.41 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.923 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.1 mtp180 -109.79 8.95 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 27.9 t -104.35 -98.98 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.505 0.193 . . . . 0.0 111.463 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.6 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 131.62 22.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 59.8 Cg_endo -71.12 82.24 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.623 2.215 . . . . 0.0 112.277 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.944 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -54.84 174.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.665 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 37.7 mt-10 -131.16 -177.65 4.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -113.03 132.25 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.194 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -111.85 -51.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.383 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.573 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.36 129.93 17.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.875 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -74.85 62.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.42 -168.59 33.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.13 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -80.3 51.71 1.46 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.741 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.022 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.832 0.349 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.508 ' HG2' ' CB ' ' A' ' 33' ' ' SER . 10.3 Cg_endo -52.19 -164.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.87 2.38 . . . . 0.0 112.295 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 15.0 p-10 -128.48 -166.29 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.549 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -108.03 157.56 35.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 56.1 Cg_endo -95.88 -163.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.492 2.795 . . . . 0.0 112.374 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 mp -132.09 58.54 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 61.2 mt 65.1 102.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.38 -84.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -169.5 178.98 3.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.235 0.541 . . . . 0.0 112.119 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.421 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -110.58 11.67 22.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.226 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.71 67.6 1.6 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.1 96.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.409 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -120.78 58.93 7.09 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 Cg_endo -48.77 115.55 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.646 2.897 . . . . 0.0 113.442 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.8 m -121.99 133.59 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 119.36 22.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.823 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -106.12 139.63 14.87 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.048 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 19.5 t -49.71 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.243 -0.979 . . . . 0.0 109.585 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 5.5 t0 170.48 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.352 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.55 2.98 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.607 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.2 mm -139.05 141.55 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.12 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -96.86 99.02 10.6 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.995 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.011 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.4 m-85 -82.26 138.94 34.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -40.69 -29.27 0.25 Allowed Glycine 0 CA--C 1.505 -0.593 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.717 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 10.1 p30 -173.89 147.01 1.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.088 0.471 . . . . 0.0 110.833 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.608 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -49.57 -26.24 3.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.513 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.1 m -72.66 -43.44 63.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.43 0.633 . . . . 0.0 110.222 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 1.8 mmm -61.46 -17.57 55.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.169 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 40' ' ' ILE . 1.8 mt -76.62 -50.52 13.6 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.598 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -48.61 -34.71 12.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -34.01 67.33 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -71.32 -61.69 1.68 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.619 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.823 ' N ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -48.79 -28.46 3.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.135 0.493 . . . . 0.0 110.017 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -73.42 -32.3 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.603 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.27 56.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 7.7 t -108.91 -71.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -173.78 -36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.211 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.64 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -148.06 174.98 2.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 38' ' ' THR . 56.4 Cg_endo -71.98 92.16 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.549 2.166 . . . . 0.0 112.013 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 29' ' ' LEU . 22.8 pt -83.4 167.28 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.505 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.4 mm-40 -149.38 -176.68 5.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.023 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.3 140.15 48.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.701 0.286 . . . . 0.0 110.812 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -122.5 -47.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -136.65 133.9 36.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.81 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG12 ' A' ' 15' ' ' VAL . 19.6 pttt -86.02 64.72 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.22 -150.01 9.5 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.175 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -90.3 53.9 2.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.818 0.342 . . . . 0.0 110.49 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' OXT' ' O ' ' A' ' 47' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.958 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.765 0.317 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.88 -169.64 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.693 2.262 . . . . 0.0 112.115 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 17.6 t70 -179.08 166.62 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.38 133.25 28.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 88.8 Cg_endo -78.16 -169.45 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.68 2.253 . . . . 0.0 112.211 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -125.66 64.0 1.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.648 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.3 mp 70.37 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -84.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.947 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -152.7 172.7 16.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -104.13 16.68 25.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' TYR . 84.8 mt-30 -73.66 59.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -25.66 92.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.132 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.916 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -121.9 65.51 19.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.186 178.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.3 Cg_endo -49.02 96.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.182 2.588 . . . . 0.0 112.053 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.2 m -105.58 131.64 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.409 0.623 . . . . 0.0 111.186 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.502 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.99 121.98 24.93 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.575 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -105.12 142.79 15.56 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.598 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 12.5 m -47.92 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.686 0.874 . . . . 0.0 109.079 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.754 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER 168.73 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.457 -178.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.95 33.54 2.78 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.975 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.0 mm -140.71 139.36 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.988 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 9.2 m -94.84 100.93 12.73 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.606 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.828 ' CE1' HD21 ' A' ' 29' ' ' LEU . 21.6 m-85 -83.87 139.73 32.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.391 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -48.56 -20.75 1.77 Allowed Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 36.5 m-20 -177.92 150.76 0.64 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.04 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.623 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.5 m -73.32 -43.92 59.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.731 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -63.31 -19.98 65.08 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.693 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.952 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -68.64 -59.4 3.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.098 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -46.44 -33.12 3.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.12 -37.67 55.46 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.82 -54.46 15.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.313 -0.443 . . . . 0.0 110.848 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.31 -25.42 64.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.523 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLY . 1.5 p -75.81 -32.04 59.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 0.0 110.716 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -107.91 11.78 27.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 t -87.65 -93.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.226 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.87 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.32 . . . . 0.0 110.955 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -129.49 158.75 72.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.868 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 29.4 Cg_exo -62.22 89.68 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.831 2.354 . . . . 0.0 112.491 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' A' ' 19' ' ' ASP . 9.0 mt -71.02 149.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 4.6 mt-10 -133.28 -176.63 4.2 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.904 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -102.38 132.33 48.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 44' ' ' HIS . 9.6 p -123.44 -34.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.898 ' CE1' HG22 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -146.51 142.73 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.345 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 61.09 2.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 110.83 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.29 -153.87 11.87 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -90.3 53.89 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 110.603 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.205 -0.903 . . . . 0.0 111.06 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' PRO . 8.9 mttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.982 0.42 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 1' ' ' LYS . 71.7 Cg_exo -49.56 -166.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.907 2.405 . . . . 0.0 112.745 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.659 ' O ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -68.16 54.41 0.07 Allowed 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.976 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -113.22 166.55 10.9 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.903 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 61.2 Cg_endo -75.31 156.79 41.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.785 2.323 . . . . 0.0 113.62 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 1.1 tt 172.61 40.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt 61.68 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.223 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.34 -83.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.92 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -114.68 131.97 56.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.8 17.08 18.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.143 0.497 . . . . 0.0 110.296 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' TYR . 9.1 mt-30 -102.91 71.86 1.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.253 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -18.91 97.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.572 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -124.51 62.01 30.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.99 112.96 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.346 2.697 . . . . 0.0 112.978 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.013 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.9 m -121.02 130.53 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.747 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 128.13 33.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.367 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -105.52 137.57 13.81 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.124 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -50.55 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.578 179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' SER . 21.1 t70 170.4 -29.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.832 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.99 33.14 2.25 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.607 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.6 mm -137.56 132.28 44.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.4 m -93.25 102.78 15.06 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.666 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.1 m-85 -81.47 166.58 20.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.218 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -78.71 -13.59 82.98 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.842 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 29.2 m-20 -179.4 149.81 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.632 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.54 5.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.454 0.645 . . . . 0.0 109.281 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.835 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -75.4 -45.62 37.9 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.991 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -55.89 -30.02 60.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.044 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.36 -51.07 65.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.887 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.835 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.4 pp -47.0 -39.9 13.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' ARG . . . -65.28 -35.65 91.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.873 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -60.33 -45.99 91.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.743 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.507 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.27 -50.34 73.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.849 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 15.6 t -70.12 -35.09 73.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -69.87 -32.93 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.725 0.298 . . . . 0.0 111.25 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 t -88.19 -93.68 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.779 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.81 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.043 0.449 . . . . 0.0 110.389 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.506 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -90.51 136.15 28.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.818 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 3.0 Cg_exo -74.68 64.29 5.73 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.724 2.283 . . . . 0.0 112.28 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -44.05 166.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt-10 -132.45 -177.63 4.56 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.47 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.044 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -106.33 132.4 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.134 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.822 HG22 ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -127.4 -42.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.463 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.822 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.9 m-70 -128.38 115.35 18.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.835 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 15' ' ' VAL . 1.4 mtmt -76.62 53.53 0.89 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.35 -147.21 5.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 57.25 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 110.464 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.868 0.366 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 30' ' ' LEU . 57.8 Cg_endo -71.04 -171.87 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.766 2.31 . . . . 0.0 112.458 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -149.98 172.68 14.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.625 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -30.64 139.11 0.17 Allowed Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.734 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 66.2 Cg_endo -93.17 42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.172 2.581 . . . . 0.0 112.627 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 5' ' ' PRO . 3.7 mt 27.02 61.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.88 102.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -90.68 -86.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 10' ' ' MET . 9.7 t -171.58 -154.57 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.52 ' O ' ' C ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -107.41 -47.88 3.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.335 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 9.15 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.13 0.894 . . . . 0.0 111.892 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -32.41 90.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.302 0.572 . . . . 0.0 111.362 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.884 ' O ' HG13 ' A' ' 15' ' ' VAL . 37.5 t0 -129.91 57.01 27.74 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.291 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.26 87.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.051 2.501 . . . . 0.0 112.076 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 13' ' ' ASP . 14.0 m -91.95 127.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 121.413 0.625 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.631 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.48 115.08 17.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.485 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.25 140.41 14.86 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.762 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -51.21 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.379 -0.911 . . . . 0.0 109.905 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.01 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.171 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.68 33.56 1.7 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.329 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -140.39 152.54 21.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 97.2 m -109.51 98.36 7.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.974 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 39.3 m-85 -80.8 134.74 35.84 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.67 -23.62 0.19 Allowed Glycine 0 CA--C 1.507 -0.423 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.426 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 28' ' ' MET . 14.1 p30 -178.52 149.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.271 0.557 . . . . 0.0 111.142 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.14 -24.49 4.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.484 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 10.0 m -74.22 -39.96 62.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.25 0.548 . . . . 0.0 110.402 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.03 -21.64 66.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.89 -179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 2.2 mt -75.13 -51.54 13.2 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 92.9 mt -48.86 -33.79 11.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.01 -27.4 64.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.856 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.03 -54.76 5.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.498 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -26.66 68.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 7.0 p -84.07 -31.39 25.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.634 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 9.1 mmm180 -100.71 3.64 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.594 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 38.4 t -93.89 -98.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' SER . 8.9 t70 179.11 -31.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.973 0.416 . . . . 0.0 110.644 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.0 m -115.68 103.4 53.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.253 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.27 92.75 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.102 2.535 . . . . 0.0 112.943 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.857 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.48 177.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.415 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.9 mt-10 -135.92 -177.86 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.531 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.891 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.68 137.11 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.081 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.47 -53.14 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.303 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.575 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.14 148.66 52.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -93.3 56.71 2.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.748 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' PRO . . . -178.69 -156.21 16.48 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.266 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.03 56.78 3.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.33 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.55 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.818 0.342 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 1' ' ' LYS . 86.8 Cg_endo -83.69 172.19 10.29 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.836 2.357 . . . . 0.0 112.537 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER 179.51 46.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.538 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' C ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -156.77 146.19 15.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . 97.6 Cg_endo -93.31 -162.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.266 2.644 . . . . 0.0 113.112 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 6' ' ' LEU . 1.3 pt? -159.69 51.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.902 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm 60.72 87.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.426 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -80.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.5 t -168.63 -179.41 3.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.161 0.505 . . . . 0.0 111.77 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.3 OUTLIER -111.24 21.36 16.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.251 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 12' ' ' TYR . 7.3 mm-40 -78.23 59.7 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.929 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -21.43 94.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.496 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -123.37 65.94 32.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -49.58 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.349 2.699 . . . . 0.0 112.907 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.7 m -108.84 131.09 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.09 114.56 17.08 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.132 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -96.97 134.33 11.73 Favored Glycine 0 C--O 1.25 1.094 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.991 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -56.81 90.96 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.851 0.834 . . . . 0.0 109.32 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' GLY . 4.1 t70 -175.97 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.16 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.13 26.77 0.88 Allowed Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.324 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -148.09 168.83 3.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 21' ' ' ILE . 30.3 m -119.79 99.3 6.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.088 -1.414 . . . . 0.0 109.356 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.825 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 16.1 m-85 -82.8 136.17 34.74 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -43.81 -26.98 0.86 Allowed Glycine 0 CA--C 1.506 -0.515 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.752 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 76.3 m-20 -169.79 146.82 3.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -51.22 -28.35 11.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.659 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.626 ' HA ' HD12 ' A' ' 30' ' ' LEU . 95.1 m -73.38 -44.23 59.01 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.741 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.53 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 3.1 mtp -61.31 -19.82 62.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -70.19 -47.14 62.83 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.82 177.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.97 -36.62 12.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' NE ' ' A' ' 35' ' ' ARG . . . -71.27 -31.54 66.07 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.54 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -72.21 -56.5 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.089 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -41.01 62.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 109.646 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.02 -39.74 79.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.871 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 31' ' ' GLY . 10.0 mtt180 -74.66 -22.31 58.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.02 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 t -86.13 -99.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.536 0.207 . . . . 0.0 110.99 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.54 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.996 0.427 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.77 159.51 29.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.28 83.92 2.15 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.808 2.338 . . . . 0.0 112.588 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.807 HG21 HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -38.45 152.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.756 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 2.5 mm-40 -119.21 -179.74 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.428 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.843 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -126.31 137.36 53.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.608 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -115.65 -45.4 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.148 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.559 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -144.5 125.13 14.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -75.04 58.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -176.56 -153.48 10.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.95 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -87.48 56.44 3.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 mttt . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 17.9 Cg_endo -60.08 -165.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.659 2.239 . . . . 0.0 112.308 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.791 ' O ' HD12 ' A' ' 30' ' ' LEU . 12.9 p-10 -172.02 -158.01 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' HD12 ' A' ' 30' ' ' LEU . 8.8 m -40.04 169.78 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.226 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 90.7 Cg_endo -91.39 179.12 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.882 2.388 . . . . 0.0 113.579 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 6' ' ' LEU . 1.8 pt? -165.11 41.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.375 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt 58.08 86.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.282 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -85.3 -70.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.795 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -165.74 151.96 9.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.23 23.72 7.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -83.04 64.71 7.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.67 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.27 95.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.578 -178.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.1 t0 -123.55 63.07 25.51 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.081 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.6 Cg_endo -50.04 102.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.142 2.561 . . . . 0.0 112.351 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.4 m -108.74 139.37 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.914 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.93 117.11 19.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.39 134.3 11.67 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.838 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -51.55 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.698 -0.751 . . . . 0.0 109.557 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 177.23 -35.66 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.789 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.47 33.38 0.95 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.863 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.3 mt -146.06 157.99 11.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 85.9 m -110.01 98.35 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.195 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.845 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.4 m-85 -82.18 134.76 35.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -42.17 -27.14 0.4 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.774 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 76.3 m-20 -168.36 146.07 4.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.201 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.52 -28.0 28.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.405 0.621 . . . . 0.0 109.505 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.587 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 2.9 m -73.37 -40.68 64.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.608 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.49 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.1 mmt -66.99 -15.84 63.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.091 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.035 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -74.03 -61.91 1.69 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.442 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.791 HD12 ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -48.87 -32.1 8.31 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.644 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.546 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -73.18 -31.77 61.14 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.68 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.59 -56.87 4.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.568 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.51 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.96 -32.91 2.99 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.144 0.497 . . . . 0.0 109.792 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -68.6 -47.84 65.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.142 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 4.0 mmm180 -60.38 -26.71 66.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.478 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -87.85 -108.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.322 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -179.52 33.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.878 0.371 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -158.27 124.54 2.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 15.3 Cg_exo -67.85 71.2 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.852 2.368 . . . . 0.0 112.61 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.675 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.43 176.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.825 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' OG ' ' A' ' 18' ' ' SER . 7.5 mt-10 -139.2 -177.21 4.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.561 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.035 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.0 140.67 49.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 1.5 t -123.66 -43.28 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.4 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.556 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -141.68 149.1 40.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -93.95 61.21 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.16 -149.79 11.07 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.05 56.5 4.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.972 0.415 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.5 m . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.984 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.974 0.416 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.85 -159.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.821 2.348 . . . . 0.0 112.496 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -82.86 44.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.052 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m -150.58 144.73 17.63 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 78.0 Cg_endo -98.64 -173.82 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.387 2.724 . . . . 0.0 112.214 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.11 61.74 1.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.681 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mm 63.04 87.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.828 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.98 -79.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.1 t -169.72 -178.58 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.175 0.512 . . . . 0.0 111.714 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -107.54 11.83 28.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.518 179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 12' ' ' TYR . 19.2 mm100 -66.91 62.37 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.513 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -22.54 94.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.632 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -117.34 58.63 2.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 8.7 Cg_endo -50.39 102.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.359 2.706 . . . . 0.0 112.745 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.05 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.2 m -113.42 123.23 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 116.6 18.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.418 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -95.59 135.65 12.47 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.365 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -50.0 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.692 0.758 . . . . 0.0 109.882 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 171.23 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.78 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.47 33.19 2.54 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -135.31 124.57 41.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -90.15 98.8 11.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.656 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 13.6 m-85 -80.76 148.66 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.91 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -59.16 -11.5 12.74 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.416 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 9.6 p30 163.85 155.23 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.24 -25.22 0.89 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.304 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.837 ' HA ' HD12 ' A' ' 30' ' ' LEU . 63.7 m -77.02 -46.23 24.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.62 0.724 . . . . 0.0 110.009 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.532 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -61.95 -22.46 65.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.454 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.656 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -68.05 -49.06 63.72 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.864 177.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.3 mt -47.87 -38.32 15.96 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -64.4 -35.55 92.09 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.4 -64.83 0.82 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.099 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.438 ' N ' HD11 ' A' ' 40' ' ' ILE . 30.9 t -46.86 -36.83 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.054 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 13.1 t -54.96 -47.8 74.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.495 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 7.3 mtp180 -143.57 51.18 1.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 13.4 t -97.03 -73.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 110.529 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.71 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.523 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.499 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -152.15 159.62 32.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.233 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 18.4 Cg_endo -59.54 87.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.624 2.216 . . . . 0.0 112.146 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -64.72 145.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.099 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm-40 -113.29 -177.31 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.05 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.08 136.3 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.431 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -122.3 -49.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.607 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -133.67 143.49 48.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.815 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 15' ' ' VAL . 4.8 pttp -94.23 57.2 2.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.128 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.28 -150.64 7.58 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.013 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -89.43 57.43 3.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 1' ' ' LYS . 72.4 Cg_endo -79.41 -171.73 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 m-20 -155.86 56.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 30' ' ' LEU . 68.6 m -161.78 160.42 22.5 Favored Pre-proline 0 C--O 1.23 0.064 0 O-C-N 123.504 0.503 . . . . 0.0 110.659 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.536 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 6.0 Cg_endo -48.59 137.52 26.02 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.939 2.426 . . . . 0.0 112.605 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -160.77 44.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.748 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 27.95 105.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.639 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -104.04 -79.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.036 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.486 HG21 ' HG2' ' A' ' 11' ' ' GLN . 1.7 t -163.15 -178.44 6.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.901 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 12' ' ' TYR . 1.8 mtm -114.85 10.12 16.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.033 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.3 OUTLIER -67.06 62.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 109.968 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.492 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.43 93.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.433 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -119.87 65.39 9.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.89 108.69 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.019 2.48 . . . . 0.0 112.748 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.92 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.4 m -120.0 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.151 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.592 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.57 117.83 20.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.566 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -101.54 139.64 14.5 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.073 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 38.8 t -50.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.808 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CG ' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 171.56 -29.32 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.812 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.17 32.13 3.11 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.372 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 34.1 mm -135.64 133.61 51.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -94.76 98.33 10.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.095 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.749 ' CE1' HD21 ' A' ' 29' ' ' LEU . 24.8 m-85 -79.27 153.27 30.03 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.939 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' ASN . . . -64.03 -10.14 38.4 Favored Glycine 0 C--N 1.328 0.124 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.5 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 28' ' ' MET . 12.3 p30 166.8 153.31 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 0.0 110.184 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.71 -26.21 2.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HA ' HD23 ' A' ' 30' ' ' LEU . 9.0 m -75.12 -43.87 50.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.274 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.546 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.67 -18.53 65.06 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.905 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.17 -57.41 4.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.285 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -49.44 -35.82 20.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 5' ' ' PRO . . . -71.51 -27.85 70.57 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -76.8 -58.75 3.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.563 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.617 ' N ' HD11 ' A' ' 40' ' ' ILE . 3.7 t -42.1 -37.34 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.453 0.644 . . . . 0.0 109.347 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 21.6 t -64.61 -50.52 66.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.406 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 8.9 mmm180 -77.24 -10.47 59.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.049 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -82.65 -96.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 0.0 111.231 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 179.18 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.0 110.488 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.636 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -117.76 163.86 22.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.075 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.636 ' HD2' HG22 ' A' ' 38' ' ' THR . 71.7 Cg_endo -77.6 75.61 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.837 2.358 . . . . 0.0 112.048 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 33' ' ' SER . 1.5 pt -52.5 154.01 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.117 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -122.66 -175.99 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.92 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -112.08 132.48 54.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.369 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -116.23 -53.14 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.258 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.575 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -132.99 144.8 50.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.923 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -91.36 65.41 5.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 172.63 -159.77 30.61 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.102 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -79.52 55.05 1.87 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 110.688 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.462 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.828 0.347 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.4 38.32 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.111 2.541 . . . . 0.0 112.269 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 m-20 -113.08 40.78 2.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 m -152.07 147.37 19.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 31' ' ' GLY . 94.5 Cg_endo -94.83 -165.41 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.373 2.716 . . . . 0.0 112.891 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 6' ' ' LEU . 7.9 tp -164.9 52.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.928 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.0 mp 63.71 85.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.225 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -76.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.261 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -169.2 179.09 4.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.071 0.462 . . . . 0.0 111.502 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.52 19.38 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.661 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -73.19 58.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.963 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -25.49 97.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.928 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.4 t0 -126.48 61.71 44.64 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.055 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.8 Cg_endo -47.67 93.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.189 2.592 . . . . 0.0 112.035 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.036 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.8 m -102.76 131.85 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.66 121.64 24.94 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.328 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 41' ' ' GLU . . . -100.73 141.4 15.35 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.39 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 66.3 m -53.29 91.9 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.184 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 40' ' ' ILE . 19.9 t70 176.57 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.261 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.33 32.49 1.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.885 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 22' ' ' THR . 6.7 mt -143.7 160.84 16.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.545 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 41.5 m -113.03 108.09 16.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 29' ' ' LEU . 15.0 m-85 -93.06 136.32 33.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.323 0.582 . . . . 0.0 112.31 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -47.06 -22.98 1.44 Allowed Glycine 0 CA--C 1.507 -0.448 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.202 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 61.0 m-20 -174.08 150.38 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.82 -28.9 10.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.348 0.594 . . . . 0.0 109.567 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.83 -45.5 58.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.501 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -60.56 -23.27 64.49 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.36 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -65.29 -50.77 64.45 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.381 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.1 mt -48.97 -36.3 17.21 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . -65.2 -29.93 76.56 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.83 -64.67 0.99 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.95 -0.625 . . . . 0.0 110.179 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -30.09 12.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.186 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 7.4 t -63.43 -50.51 69.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.713 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 35' ' ' ARG . 1.2 mmm180 -100.87 18.74 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 9.7 t -103.42 -119.8 0.2 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' SER . 6.3 t70 178.84 29.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.064 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.439 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 2.4 m -160.47 139.66 7.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.371 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 29.6 Cg_endo -63.81 82.18 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.628 2.219 . . . . 0.0 112.414 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 29' ' ' LEU . 18.8 mt -67.43 139.54 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.666 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 95.6 mt-10 -126.3 -177.55 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.036 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -104.96 132.73 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -127.28 -32.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.328 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.895 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.7 m-70 -139.78 134.22 31.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.88 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -89.54 55.28 3.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . 177.08 -155.35 17.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.256 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 58.1 3.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.401 . . . . 0.0 110.606 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 13.2 mttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.918 0.39 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.39 40.16 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.109 2.54 . . . . 0.0 112.202 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.94 -169.5 3.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.838 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 141.29 75.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 89.7 Cg_endo -83.09 163.69 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.033 2.489 . . . . 0.0 112.597 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.5 tp -84.73 53.33 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.482 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 5.0 mt 68.57 96.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.29 -83.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.198 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -164.78 154.28 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.37 32.83 5.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.491 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -79.06 -104.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.247 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.43 91.67 0.09 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.19 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -129.46 53.32 11.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.1 Cg_endo -49.79 116.03 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.736 2.957 . . . . 0.0 113.902 -177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.2 m -129.6 124.83 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.865 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.38 134.74 37.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.937 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.02 142.24 17.41 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.325 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.08 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.359 -0.92 . . . . 0.0 109.035 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' SER . 8.7 t70 167.58 -28.11 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.422 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.795 ' C ' HD12 ' A' ' 21' ' ' ILE . . . 108.81 22.88 6.74 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.626 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.795 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.3 mp -123.21 152.54 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.56 0.695 . . . . 0.0 112.458 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 14.1 m -111.07 98.56 7.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.072 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.841 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.9 m-85 -81.09 138.95 35.93 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.986 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.63 -27.54 19.31 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.948 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 62.7 m-80 -164.08 148.41 10.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -55.68 -26.96 47.48 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 62.7 m -73.81 -37.79 64.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.855 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.1 mtt -67.5 -19.33 65.31 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.866 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -72.13 -57.5 4.2 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.015 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER -50.77 -31.43 16.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' CG ' ' A' ' 35' ' ' ARG . . . -73.59 -26.11 70.62 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.82 -59.57 2.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.019 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.881 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -54.32 -23.62 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.787 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' ARG . 11.9 p -89.96 -44.02 10.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.805 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.68 -30.16 59.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.964 -178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -73.76 -91.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.941 0.4 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.46 -35.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.372 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.23 116.11 64.26 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 49.0 Cg_endo -69.3 74.83 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.749 2.299 . . . . 0.0 112.328 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.897 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.81 177.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.3 mm-40 -134.69 -177.6 4.69 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.009 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.63 132.88 49.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 110.251 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.865 HG22 ' CE1' ' A' ' 44' ' ' HIS . 14.6 p -123.59 -40.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.235 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.865 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.7 m-70 -133.81 134.46 42.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.551 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.767 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.87 55.52 2.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.115 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -176.1 -145.08 5.41 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.203 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' CYS . 3.7 ptt85 -90.54 56.65 3.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.565 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 10.6 tttt . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 1' ' ' LYS . 34.2 Cg_endo -64.34 -173.18 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.327 2.018 . . . . 0.0 112.457 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 4' ' ' CYS . 13.9 m-20 -163.67 174.93 11.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -28.55 141.64 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.117 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 71.3 Cg_endo -94.96 -173.66 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.252 2.634 . . . . 0.0 112.426 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.75 57.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.8 mt 63.63 97.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.097 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.84 -85.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.2 t -170.68 -177.77 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 111.987 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' ' OG1' ' A' ' 9' ' ' THR . 2.8 ptt? -115.28 20.69 14.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.486 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -74.18 67.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.45 89.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.404 -178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.39 61.05 14.33 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.9 Cg_endo -49.48 114.82 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.598 2.866 . . . . 0.0 112.942 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.944 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.7 m -119.04 133.64 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.424 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.79 117.83 19.55 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -98.42 134.48 11.72 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.079 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' A' ' 41' ' ' GLU . 30.8 t -51.34 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.412 0.713 . . . . 0.0 109.177 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 174.11 -31.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.491 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.11 30.63 2.24 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.678 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 15.6 mm -142.38 142.64 27.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -97.55 100.59 12.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.104 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.859 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 32.8 m-85 -79.97 142.49 35.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.367 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.71 -22.31 2.7 Favored Glycine 0 CA--C 1.507 -0.444 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 2.8 m-20 -173.04 146.15 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.882 0.372 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -52.91 -28.61 24.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.27 0.557 . . . . 0.0 109.518 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 88.9 m -71.79 -41.03 68.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.753 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.52 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 13.4 mtp -62.91 -23.43 67.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.959 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.039 HD22 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -69.83 -48.62 58.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.43 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 7.2 mt -50.57 -33.51 22.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . -68.62 -31.16 73.18 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -74.13 -65.11 0.88 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.175 0.512 . . . . 0.0 109.9 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.58 ' CA ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -48.49 -27.88 2.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 16.5 t -75.1 -30.82 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.933 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -55.07 -35.89 65.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . 8.1 t -100.68 -64.14 1.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.795 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 33' ' ' SER . 20.9 t0 179.68 -69.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.154 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.583 ' N ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 t -160.87 37.26 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.769 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -89.04 31.82 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 112.944 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.039 HG21 HD22 ' A' ' 29' ' ' LEU . 1.1 mm -138.06 133.06 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 18' ' ' SER . 1.2 tt0 -127.81 -178.1 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.693 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.944 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -117.1 142.38 47.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.919 0.39 . . . . 0.0 110.73 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -127.06 -49.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.589 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.42 153.56 45.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.287 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.795 ' HA ' HG12 ' A' ' 15' ' ' VAL . 6.2 mmtp -95.3 58.83 2.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.91 -153.78 15.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.9 57.77 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.625 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.007 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.2 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.269 2.646 . . . . 0.0 112.672 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.672 ' O ' HD22 ' A' ' 30' ' ' LEU . 1.1 p-10 -142.78 170.09 16.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 4.9 m -31.8 141.87 0.15 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 30' ' ' LEU . 54.8 Cg_endo -89.85 -165.6 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.227 2.618 . . . . 0.0 112.998 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 11.9 mt -133.96 57.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.205 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 7.2 mt 70.15 99.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.992 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -82.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.821 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 10' ' ' MET . 2.5 t -146.4 -39.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.718 0.294 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.46 11.85 4.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.596 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.7 -76.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.436 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.84 96.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.586 0.708 . . . . 0.0 112.399 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.7 t0 -138.96 51.3 3.31 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.0 Cg_endo -47.76 109.37 0.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.924 3.082 . . . . 0.0 113.516 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.938 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.5 m -118.39 136.79 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.474 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.95 120.0 22.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.993 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -104.47 137.88 13.83 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.868 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.534 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 t -47.92 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.392 0.701 . . . . 0.0 109.395 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER 168.46 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.555 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.99 32.98 3.35 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.682 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.1 mm -137.68 132.49 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.839 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -89.26 98.01 11.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.149 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.902 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 56.8 m-85 -79.46 134.45 36.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.512 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -36.41 -31.94 0.05 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.551 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 55.8 m-80 -164.8 147.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.97 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -54.5 -27.2 36.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.282 0.563 . . . . 0.0 109.574 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 1.7 m -74.65 -40.14 61.65 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.404 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -59.63 -21.79 60.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.949 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.034 HD12 ' CD2' ' A' ' 42' ' ' LEU . 1.6 mt -75.91 -52.92 9.26 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.387 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 3' ' ' ASP . 11.6 mt -49.0 -28.84 4.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -76.69 -32.03 51.81 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.512 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 36' ' ' SER . . . -79.77 -52.36 8.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.36 -0.42 . . . . 0.0 112.088 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -61.68 -31.31 71.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -89.49 -23.38 22.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.6 mtt180 -113.82 8.77 17.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -100.97 -98.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -161.31 -40.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.64 131.83 21.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.745 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.87 72.67 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.548 2.165 . . . . 0.0 112.372 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.795 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.95 170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 2.1 mt-10 -134.13 -176.22 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.624 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.034 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -121.54 132.05 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.281 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.624 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -117.07 -38.61 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.217 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -146.17 147.07 31.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -94.87 57.7 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.303 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . -174.44 -154.64 11.14 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.282 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.35 56.82 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.644 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.937 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.27 39.76 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.023 2.482 . . . . 0.0 112.477 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 58.3 p30 -126.26 150.49 48.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.062 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 73.9 m -80.53 127.58 75.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.007 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 30' ' ' LEU . 92.4 Cg_endo -90.54 173.6 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.173 2.582 . . . . 0.0 112.753 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.43 74.32 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.733 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mp 74.64 143.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.094 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -132.14 -101.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.686 HG23 ' N ' ' A' ' 10' ' ' MET . 9.8 t -173.12 -143.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.497 0.589 . . . . 0.0 110.863 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.686 ' N ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER 35.48 35.84 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' C ' ' O ' ' A' ' 10' ' ' MET . 3.2 tm0? -0.91 -64.25 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.25 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -121.33 84.48 2.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.719 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 15' ' ' VAL . 4.7 t70 -123.5 61.88 22.12 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.4 Cg_endo -50.13 105.4 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.381 2.721 . . . . 0.0 113.348 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.023 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -118.84 122.59 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.269 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.49 128.8 34.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.805 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.561 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -110.78 144.42 17.25 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.782 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -50.38 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.709 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 170.43 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.767 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.61 31.52 3.42 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.212 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 14.0 mm -133.4 143.39 39.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 95.0 m -103.28 98.55 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.283 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.784 ' CE1' HD21 ' A' ' 29' ' ' LEU . 20.6 m-85 -81.46 141.8 33.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.08 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 25' ' ' ASN . . . -58.86 -12.5 14.97 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.446 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 10' ' ' MET . 50.5 t-20 178.61 149.55 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.396 . . . . 0.0 110.634 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . -51.28 -30.72 18.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 1.5 m -76.02 -39.5 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.131 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.556 ' HG3' ' HB3' ' A' ' 25' ' ' ASN . 12.1 mtp -63.74 -17.56 63.14 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -71.3 -55.2 8.51 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.692 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD12 ' HG3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -48.15 -31.73 6.04 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -71.41 -31.68 65.61 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -81.37 -55.52 4.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.193 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.819 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -48.24 -38.51 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 110.574 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.09 -29.64 34.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.6 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 7.4 ptm180 -84.92 -18.77 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.5 t -82.67 -96.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.636 0.255 . . . . 0.0 111.11 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 179.11 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.08 124.54 32.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.09 87.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.937 2.425 . . . . 0.0 112.99 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.991 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -67.07 175.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 26.1 mt-10 -138.94 -177.61 4.96 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.587 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.023 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 139.39 36.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.825 HG22 ' CE1' ' A' ' 44' ' ' HIS . 7.4 p -134.8 -43.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.317 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.825 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.4 m-70 -125.16 126.82 45.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 15' ' ' VAL . 9.2 mmtt -85.98 58.17 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 176.8 -144.29 6.78 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.865 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -90.61 58.45 3.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.892 0.377 . . . . 0.0 110.957 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.129 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 1' ' ' LYS . 72.3 Cg_exo -49.01 -168.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.685 2.257 . . . . 0.0 112.572 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 5.5 p-10 -167.45 166.88 14.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 92.1 m -64.85 125.78 89.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.896 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -86.91 -171.9 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.957 2.438 . . . . 0.0 112.847 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -118.62 62.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.347 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 10.4 mt 67.4 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.333 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.59 -83.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 t -161.95 161.8 28.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.092 0.472 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.0 25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.401 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' TYR . 36.9 mt-30 -83.66 63.44 7.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.81 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.6 99.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.769 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -133.43 64.85 70.56 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.0 Cg_endo -50.31 121.82 8.34 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.256 2.637 . . . . 0.0 113.067 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.017 ' HB ' HD11 ' A' ' 42' ' ' LEU . 10.5 m -127.3 132.87 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.728 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -77.88 123.0 26.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.16 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.722 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -101.54 135.99 12.5 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.203 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 12.0 t -49.43 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.097 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' GLY . 5.1 t0 169.15 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.845 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.24 31.79 2.97 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.729 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 mm -138.05 129.43 38.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 55.1 m -89.84 100.1 12.98 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 36.4 m-85 -79.34 163.84 24.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.253 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -69.42 -20.24 75.16 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.703 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 42.6 m-20 -174.23 147.96 1.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.924 0.392 . . . . 0.0 110.878 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -53.31 -25.16 13.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.023 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 18.2 m -76.64 -37.7 55.87 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.516 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 7.9 mtt -68.07 -18.94 64.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.974 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -73.26 -60.84 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.905 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -48.79 -29.59 4.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -75.04 -28.77 61.76 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -83.87 -53.13 5.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.995 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -55.39 -34.53 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.156 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -76.12 -45.73 32.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.656 0.265 . . . . 0.0 111.132 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -87.74 9.4 21.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 33.5 t -97.71 -95.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.604 0.24 . . . . 0.0 111.517 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -180.0 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 0.0 110.404 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.42 144.45 28.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.27 78.53 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.723 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 3.7 mt -65.72 149.43 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.557 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mt-10 -137.12 -177.09 4.61 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.794 0.331 . . . . 0.0 111.517 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.017 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -106.68 132.94 52.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.604 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -121.76 -45.14 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.604 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER -132.8 138.75 47.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.906 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.967 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -91.78 57.59 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 179.14 -154.27 13.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.115 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 57.32 3.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.846 0.355 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.765 0.317 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' CYS . 37.3 Cg_endo -65.82 -161.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.71 2.274 . . . . 0.0 111.848 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.62 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 1.2 m-20 -49.88 82.96 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -116.91 162.72 25.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.768 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD3' ' CA ' ' A' ' 31' ' ' GLY . 74.1 Cg_endo -79.22 131.72 9.9 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.649 2.232 . . . . 0.0 112.836 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.89 45.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 7' ' ' ILE . 47.2 mt 44.76 86.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.366 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -78.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 156.63 8.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.33 17.52 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.517 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 5.8 tt0 -72.66 65.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.724 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -18.39 103.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.484 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.6 t0 -132.31 68.37 79.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.384 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.4 Cg_endo -58.87 93.87 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.132 2.555 . . . . 0.0 113.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.962 ' HB ' HD11 ' A' ' 42' ' ' LEU . 14.7 m -109.97 128.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.317 0.579 . . . . 0.0 111.178 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -79.9 130.68 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.78 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -114.3 149.9 18.7 Favored Glycine 0 C--O 1.25 1.111 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.152 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 t -48.59 93.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.067 -1.066 . . . . 0.0 109.586 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' SER . 10.3 t0 170.69 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.017 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.81 33.92 3.16 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.689 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.5 mm -140.15 139.13 36.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 119.493 -0.883 . . . . 0.0 113.223 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 54.4 m -91.14 114.38 26.89 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.065 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 26.9 m-85 -99.92 135.7 40.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -49.12 -26.05 5.95 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.827 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -167.28 138.43 3.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.948 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.72 -19.31 10.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 1.072 ' HA ' HD23 ' A' ' 30' ' ' LEU . 10.8 m -81.11 -33.98 32.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.32 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.465 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 3.0 mtt -73.57 -40.01 64.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.154 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.75 -17.82 46.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.445 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.072 HD23 ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -63.07 -41.41 99.43 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -64.46 -35.65 92.21 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -57.72 -34.59 69.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.875 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -51.86 33.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 3.7 t -63.64 -26.83 68.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.583 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.566 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 5.0 ptm180 -80.04 -39.27 30.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.6 t -76.09 -92.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t0 179.66 -33.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -94.49 117.66 66.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' ILE . 43.0 Cg_endo -68.22 75.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.335 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.006 HD11 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.28 176.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.43 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 1.8 mm-40 -137.84 -177.16 4.69 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.377 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.962 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.13 132.1 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 44' ' ' HIS . 12.0 p -122.63 -35.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.064 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.3 m-70 -136.11 140.39 43.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 57.58 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.96 -143.33 6.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -90.12 57.54 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.112 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.881 0.372 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.73 -165.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.878 2.385 . . . . 0.0 112.334 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 4' ' ' CYS . 41.2 m-20 -131.91 165.61 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -27.43 124.63 0.23 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.635 ' CG ' HD11 ' A' ' 30' ' ' LEU . 63.0 Cg_endo -94.3 -163.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.442 2.761 . . . . 0.0 112.159 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 1.7 tp -124.07 61.39 1.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp 68.73 107.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.19 -75.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -161.36 165.99 28.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.062 0.458 . . . . 0.0 111.68 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.9 mmm -100.87 23.91 9.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.438 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 2.0 mt-30 -83.18 61.29 6.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -20.4 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.494 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -123.35 60.91 18.69 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.6 Cg_endo -47.83 116.29 1.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.403 2.736 . . . . 0.0 112.773 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.966 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -125.4 129.73 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.577 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.37 127.21 31.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.571 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.563 ' HA3' HD11 ' A' ' 29' ' ' LEU . . . -107.7 140.54 15.44 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.333 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -47.75 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.631 -0.785 . . . . 0.0 109.113 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' GLY . 6.0 t70 167.8 -27.97 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.722 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.02 31.81 3.73 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.2 mm -136.56 135.97 48.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 56.4 m -93.86 98.24 10.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.463 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.889 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 30.4 m-85 -79.53 147.88 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.158 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -56.32 -21.71 34.44 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.215 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 49.5 m-20 -173.69 147.13 1.36 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.667 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -51.77 -27.48 12.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.575 . . . . 0.0 109.772 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.753 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 m -72.27 -42.62 65.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.683 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -64.84 -16.38 63.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.102 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.929 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -75.08 -55.5 5.68 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.232 178.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD23 ' HA ' ' A' ' 27' ' ' CYS . 1.0 OUTLIER -47.38 -35.89 8.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 4' ' ' CYS . . . -73.45 -30.95 61.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.805 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HA ' ' CD ' ' A' ' 35' ' ' ARG . . . -72.09 -52.25 17.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.755 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -60.76 -22.52 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.573 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -39.66 36.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.984 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' CD ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.24 6.4 44.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.491 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t -81.69 -95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.07 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.8 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -131.69 146.65 62.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.963 0.411 . . . . 0.0 110.964 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 38' ' ' THR . 51.0 Cg_exo -52.99 94.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 0.0 112.638 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 33' ' ' SER . 18.1 mt -71.86 156.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 4.1 mm-40 -135.46 -176.51 4.3 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.627 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.966 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -115.77 142.03 47.29 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.518 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -137.15 -37.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.467 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.503 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 1.5 m-70 -135.4 136.81 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.922 0.391 . . . . 0.0 111.337 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.915 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -94.48 57.15 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.869 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.87 -143.54 5.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -90.23 52.97 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.798 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.159 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.867 0.365 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -167.81 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.785 2.323 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p30 -87.57 177.22 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.82 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.648 ' HB3' HD23 ' A' ' 30' ' ' LEU . 87.0 m -86.01 -43.91 0.6 Allowed Pre-proline 0 CA--C 1.529 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.132 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' CD ' ' HB3' ' A' ' 30' ' ' LEU . 49.6 Cg_endo -103.62 -161.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 113.232 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -162.46 55.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.979 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 8.3 mt 69.74 118.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -110.75 -84.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 10' ' ' MET . 3.1 t -166.87 -175.73 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.471 ' N ' ' OG1' ' A' ' 9' ' ' THR . 43.0 mmm -109.41 17.37 21.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.349 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -69.88 60.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.228 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -24.4 96.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.351 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -130.96 66.17 78.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -50.61 107.08 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.411 2.741 . . . . 0.0 112.902 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.018 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.0 m -109.14 127.4 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.628 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -78.69 117.94 20.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.824 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -102.32 140.6 14.93 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.063 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 6.7 t -50.18 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.09 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.37 -29.82 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.947 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.931 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 114.33 25.7 3.99 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.387 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.7 mp -132.82 154.38 39.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 CA-C-O 121.651 0.739 . . . . 0.0 112.5 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 53.8 m -112.29 99.28 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.047 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.732 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 26.4 m-85 -79.05 135.96 37.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 112.082 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -46.0 -23.45 1.09 Allowed Glycine 0 CA--C 1.506 -0.506 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.272 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 66.8 m-20 -175.55 152.23 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 0.0 110.715 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.705 ' O ' HD12 ' A' ' 30' ' ' LEU . . . -51.85 -28.75 16.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 109.523 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HA ' HD13 ' A' ' 30' ' ' LEU . 89.8 m -74.43 -42.67 58.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -61.72 -23.26 66.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -66.49 -53.72 31.94 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.7 177.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 26' ' ' ALA . 3.4 mp -42.75 -40.41 2.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . . . -67.24 -31.22 76.78 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.251 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.99 -44.17 18.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.589 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.11 -50.46 73.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 111.13 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 12.4 m -74.83 -26.5 59.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 35' ' ' ARG . 13.1 mmm180 -94.0 -13.07 27.4 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 40.5 t -79.1 -93.08 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.819 0.342 . . . . 0.0 111.127 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.37 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.459 . . . . 0.0 110.116 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.33 127.09 26.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.539 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 44.8 Cg_exo -55.79 92.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.444 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -66.1 167.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.405 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 17.6 mt-10 -123.67 -177.46 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.82 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.018 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -120.77 134.59 55.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.109 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -119.88 -46.31 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -147.78 126.69 12.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.803 0.335 . . . . 0.0 111.09 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.631 ' HA ' HG12 ' A' ' 15' ' ' VAL . 74.4 mttt -74.56 67.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.48 -164.75 30.49 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.057 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 53.0 2.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.998 0.427 . . . . 0.0 110.665 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.122 179.839 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 3.1 ttpt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 1' ' ' LYS . 18.9 Cg_endo -58.99 -173.38 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.822 2.348 . . . . 0.0 112.129 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -172.08 155.31 3.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.272 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -29.27 149.17 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.929 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' CYS . 74.5 Cg_endo -93.03 177.69 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.166 2.577 . . . . 0.0 112.215 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -102.88 48.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.437 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 6' ' ' LEU . 27.2 mt 68.17 98.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -89.97 -82.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.167 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -170.76 138.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.63 29.03 3.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.603 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 -104.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.651 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 101.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.442 0.639 . . . . 0.0 112.444 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -139.32 50.08 2.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.5 Cg_endo -48.59 114.19 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.626 2.884 . . . . 0.0 113.278 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 16.1 m -127.03 134.59 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.97 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.51 121.65 24.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.911 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.16 134.56 11.9 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -51.72 96.62 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.611 0.719 . . . . 0.0 110.116 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 18' ' ' SER . 62.1 t0 172.53 -29.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.716 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.71 2.04 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.257 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.606 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 4.2 mm -138.59 146.79 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -107.45 98.2 7.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.287 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.929 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 28.8 m-85 -82.39 139.76 33.87 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.404 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -47.74 -31.29 7.38 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.642 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.57 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 63.7 m-20 -160.09 144.94 14.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.514 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -54.6 -30.11 53.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.675 0.75 . . . . 0.0 109.236 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 88.8 m -72.45 -38.69 68.2 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.851 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.491 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -61.32 -18.56 59.15 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.929 HD21 ' CZ ' ' A' ' 23' ' ' TYR . 1.3 mt -74.98 -51.47 13.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.257 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 30' ' ' LEU . 2.4 mt -47.71 -32.72 6.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' CD ' ' A' ' 35' ' ' ARG . . . -75.56 -32.24 54.96 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -70.09 -55.61 9.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.239 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -59.67 -27.08 66.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.284 0.564 . . . . 0.0 109.586 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 t -82.22 -15.95 51.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.258 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -92.86 -32.53 14.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.272 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -94.76 -111.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.137 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -176.32 30.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.78 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 m -142.8 114.69 6.02 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.33 78.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.68 2.253 . . . . 0.0 112.684 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.808 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.31 168.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 7.2 mt-10 -126.56 -177.27 3.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.446 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -119.8 137.42 53.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.587 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -119.47 -52.04 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.487 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.21 151.65 50.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.067 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.754 ' HA ' HG12 ' A' ' 15' ' ' VAL . 3.3 mmtt -95.24 61.75 2.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.72 -153.54 14.26 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.39 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -83.65 55.9 3.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.6 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.009 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.3 mttm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 48.0 Cg_endo -84.09 42.58 1.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 123.13 2.553 . . . . 0.0 112.302 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 122.91 28.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.34 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 1.027 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -39.6 -62.11 0.9 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.322 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 30' ' ' LEU . 33.8 Cg_endo -97.5 -164.49 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.94 2.427 . . . . 0.0 113.921 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.87 55.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.666 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 1.1 mp 71.44 160.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.508 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.79 -166.81 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.332 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -69.15 157.06 37.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.11 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtt -91.77 18.22 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.898 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -72.29 60.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.08 98.73 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.457 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.62 61.49 22.09 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 6.9 Cg_endo -48.06 109.68 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.106 2.537 . . . . 0.0 112.093 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.802 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.9 m -122.38 125.48 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 111.175 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 118.49 20.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.214 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -97.95 136.51 12.77 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.931 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -53.18 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.409 -0.895 . . . . 0.0 109.614 179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 177.25 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.372 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.14 31.29 1.44 Allowed Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.91 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 25.6 mm -142.0 142.86 27.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.5 m -101.35 98.85 9.17 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.991 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.865 ' CE2' HD21 ' A' ' 29' ' ' LEU . 28.2 m-85 -80.0 159.21 26.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 25' ' ' ASN . . . -67.08 -10.8 57.39 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.972 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 6.5 p30 165.99 156.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.34 -24.98 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.173 0.511 . . . . 0.0 109.944 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 8.8 m -74.84 -49.44 20.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.773 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.522 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -61.38 -21.99 64.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.9 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.865 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -66.84 -59.18 3.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.027 HD12 ' HB3' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -53.88 -29.39 41.42 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' HA2' ' H ' ' A' ' 4' ' ' CYS . . . -66.6 -29.97 75.64 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -79.5 -52.7 7.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.752 -0.724 . . . . 0.0 110.06 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -52.74 -35.92 56.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.286 179.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -74.18 -35.03 63.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.404 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 4.7 ptm180 -73.52 -27.66 61.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.403 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 t -83.38 -94.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.338 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t0 179.69 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -100.43 147.84 34.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.909 0.385 . . . . 0.0 111.175 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 16.4 Cg_exo -67.66 79.7 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.963 2.442 . . . . 0.0 112.416 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.666 HD13 ' OH ' ' A' ' 23' ' ' TYR . 74.4 mt -44.19 152.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' ' CB ' ' A' ' 18' ' ' SER . 22.7 mt-10 -123.34 -177.29 3.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.345 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -118.82 147.27 44.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.555 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -133.89 -43.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.555 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -142.23 135.97 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.04 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.75 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -88.99 66.36 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . 178.08 -155.38 16.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.166 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.09 54.1 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 0.0 110.515 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.811 0.338 . . . . 0.0 111.201 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 1' ' ' LYS . 64.9 Cg_exo -51.87 -160.16 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.814 2.342 . . . . 0.0 112.48 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.567 ' N ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -79.81 45.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.844 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 31' ' ' GLY . 1.6 m -117.58 139.48 26.3 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HB3' HD12 ' A' ' 30' ' ' LEU . 66.8 Cg_endo -103.14 42.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.492 2.795 . . . . 0.0 113.189 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 5' ' ' PRO . 9.8 mt 28.7 49.58 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.229 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 8' ' ' CYS . 13.6 mm 68.72 161.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.746 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.12 -166.53 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.462 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 10' ' ' MET . 0.7 OUTLIER -69.63 179.21 2.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.339 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.47 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.31 28.66 8.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 12' ' ' TYR . 4.1 mm-40 -80.85 62.98 5.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.275 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.63 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.159 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.758 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -122.8 63.75 21.29 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.8 Cg_endo -49.06 101.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.077 2.518 . . . . 0.0 112.192 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.3 m -108.0 126.63 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.308 0.575 . . . . 0.0 110.921 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.85 121.87 25.37 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.733 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -99.88 137.33 13.19 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.229 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -50.25 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.803 0.811 . . . . 0.0 109.376 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' GLY . 2.5 p30 172.12 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.477 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.08 31.44 2.25 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.643 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 33.0 mm -137.8 138.86 43.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.5 m -99.13 102.93 14.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.357 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 21.0 m-85 -84.34 143.01 29.77 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.381 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -53.75 -16.59 5.78 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.374 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 13' ' ' ASP . 15.6 m-20 177.41 150.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.16 -29.4 21.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 56.6 m -73.65 -39.84 64.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.268 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.467 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -64.45 -25.78 68.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.944 HD22 HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -65.77 -54.37 28.02 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.252 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.674 HD12 ' HB3' ' A' ' 5' ' ' PRO . 5.8 mt -48.71 -39.98 26.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . -59.6 -31.92 72.25 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -73.72 -57.39 4.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.451 -0.874 . . . . 0.0 110.699 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.781 ' HB2' HD13 ' A' ' 40' ' ' ILE . 30.3 t -56.74 -50.49 72.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.605 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -61.08 -27.41 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.923 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.1 mtp180 -109.79 8.95 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 27.9 t -104.35 -98.98 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.505 0.193 . . . . 0.0 111.463 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.6 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 131.62 22.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 59.8 Cg_endo -71.12 82.24 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.623 2.215 . . . . 0.0 112.277 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.944 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -54.84 174.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.665 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 37.7 mt-10 -131.16 -177.65 4.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -113.03 132.25 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.194 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -111.85 -51.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.383 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.573 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.36 129.93 17.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.875 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -74.85 62.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.42 -168.59 33.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.13 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -80.3 51.71 1.46 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.741 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.022 179.717 . . . . . . . . 1 1 . 1 stop_ save_